Page last updated: 2024-08-23

dobutamine and Cardiac Failure

dobutamine has been researched along with Cardiac Failure in 736 studies

Research

Studies (736)

TimeframeStudies, this research(%)All Research%
pre-1990189 (25.68)18.7374
1990's192 (26.09)18.2507
2000's207 (28.13)29.6817
2010's121 (16.44)24.3611
2020's27 (3.67)2.80

Authors

AuthorsStudies
Erhardt, PW1
Bostwick, JS; Brigance, R; Finlay, HJ; Gargalovic, PS; Generaux, CN; Luk, CE; Meng, W; Onorato, JM; Pi, Z; Rossi, KA; Schumacher, WA; Wang, T; Wexler, RR1
Ambinathan, JPN; Burns, KD; Cherney, DZI; Godoy, LC; Lytvyn, A; Lytvyn, Y; Osuntokun, O; Parker, JD; Testani, JM1
Ochiai, ME; Pereira Barretto, AC; Silva, EVC; Vieira, KRN1
Filipiak, KJ; Gasecka, A; Jaguszewski, MJ; Pruc, M; Rafique, Z; Szarpak, L; Szwed, P1
Bandyopadhyay, D; Biswas, S; Briasoulis, A; Fonarow, GC; Goel, A; Gupta, R; Lanier, GM; Malik, AH; Naidu, SS1
Bader, I; Bergin, P; Dagan, M; Easton, K; Hare, JL; Kaye, DM; Lankaputhra, M; Leet, A; Linton, A; McLean, C; Patel, HC; Taylor, A; Tee, SL; Yeung, T1
Anand, V; Kane, GC; Lee, AT; McCully, RB; Pellikka, PA; Pislaru, C; Pislaru, SV; Scott, CG1
Le Jemtel, T; Rajapreyar, I; Samson, R; Stencel, J1
Acharya, P; Al-Masry, AA; Bajwa, S; Bakel, AV; Boda, I; Dalia, T; Goyal, A; Mastoris, I; Maurides, S; Noonan, G; Parimi, N; Sami, F; Sauer, A; Shah, Z; Tran, C1
Eaton, RE; Haas, GJ; Kissling, KT; McLaughlin, EM; Pickworth, KK1
Aydın, C; Kaplangoray, M1
Alkadri, J; Hu, R; Jeffers, MS; McDonald, B; McIsaac, DI; Ross, J1
Billia, F; Brahmbhatt, DH; Fung, NL; Luis Scolari, F; Luk, A; Mihajlovic, V; Otsuki, M; Overgaard, CB; Rodenas-Alesina, E; Wang, VN1
Dong, N; Guo, Q; Lan, H; Li, C; Shi, J; Wang, G; Xiong, T; Zhang, J; Zheng, Q1
Fujita, T; Fukushima, N; Fukushima, S; Hada, T; Kainuma, S; Kamiya, H; Kunioka, S; Mochizuki, H; Seguchi, O; Shimojima, M; Tadokoro, N; Tsukamoto, Y; Watanabe, T1
AbouEzzeddine, OF; Behfar, A; Borlaug, BA; Chareonthaitawee, P; Fudim, M; Kemp, BJ; Mullan, BP; Pislaru, SV; Redfield, MM1
How, OJ; Kildal, AB; Myrmel, T; Rødland, L; Rønning, L1
Cheng, J; Kelly, J; Lupi, K; Malloy, R1
Araújo, I; Campos, L; Cunha, GJL; Fernandes, L; Ferraz, M; Fonseca, C; Gomes, RV; Morais, R; Rocha, BML1
Gyoda, Y; Kawauchi, J; Oikawa, Y; Sakuma, E; Watanabe, J1
Agoston, G; Amor, M; Arbucci, R; Barbieri, A; Beleslin, B; Bombardini, T; Borguezan Daros, C; Boshchenko, A; Boskovic, N; Bossone, E; Camarozano, AC; Carpeggiani, C; Celutkiene, J; Ciampi, Q; Citro, R; Colonna, P; Cortigiani, L; Costantino, FM; D'Alfonso, MG; D'Andrea, A; de Castro E Silva Pretto, JL; DE Nes, M; Dekleva, M; DI Salvo, G; Djordjevic-Dikic, A; Dodi, C; Ferrara, F; Gaibazzi, N; Gligorova, S; Gregori, D; Haberka, M; Kasprzak, JD; Kovacevic Preradovic, T; Lattanzi, F; Lowenstein, J; Merlo, PM; Monte, IP; Mori, F; Morrone, D; Nikolic, A; Ostojic, M; Paterni, M; Petrovic, M; Picano, E; Rabia, G; Re, F; Reisenhofer, B; Rigo, F; Rodrìguez-Zanella, H; Ryabova, T; Salamé, M; Salustri, A; Scali, MC; Severino, S; Simova, I; Szymczyk, E; Tesic, M; Torres, MA; Varga, A; Vargas Mieles, PE; Vladova, M; Wdowiak-Okrojek, K; Wejner-Mik, P; Wierzbowska-Drabik, K; Zagatina, A; Zhuravskaya, N1
Bottio, T; Gerosa, G; Piperata, A1
Jakovljevic, DG; MacGowan, GA; Mungulmare, K; Okwose, NC; Sengupta, SP1
Ahn, C; Aronow, WS; Cooper, HA; Gass, AL; Gupta, CA; Khan, MH; Lanier, GM; Levine, A; Lloji, A; Mody, BP; Zaid, S1
Cun, Y; Jianlong, W1
Alvarez, J; Bettex, D; Bouchez, S; Fruhwald, S; Girardis, M; Grossini, E; Guarracino, F; Heringlake, M; Herpain, A; Pollesello, P; Toller, W; Tritapepe, L1
Filipiak, KJ; Gasecka, A; Jaguszewski, MJ; Szarpak, L; Targonski, R1
Dadfar, B; Doye, AA; Gwathmey, JK; Jaleel, R; Naushad, J; Parambathazhath, J; Siri-Angkul, N; Xie, LH1
Biskupiak, J; Bress, AP; King, JB; Munger, MA; Sainski-Nguyen, A; Shah, RU1
Balik, M; Mokotedi, CM1
Carpeggiani, C; Ciampi, Q; Michelassi, C; Picano, E; Villari, B1
Almeida, I; Caetano, F; Costa, M; Fernandes, A; Gonçalves, L; Madeira, M; Reis, L1
Hirai, T; Joho, S; Kinugawa, K; Nakagaito, M; Nakamura, M; Ushijima, R1
Ceyssens, W; Dupont, M; Jacobs, L; Luwel, E; Martens, P; Mullens, W; Potargent, P; Renaers, M; Van Aerde, H; Vercammen, J1
Gerds, TA; Jakobsen, CJ; Karaliunaite, Z; Nielsen, DV; Skals, RK; Torp-Pedersen, C1
Al Madfai, F; Ming, LC; Patel, RP; Peterson, GM; Valah, B; Wanandy, T; Zaidi, STR1
Bischoff, E; Boehme, P; Dinh, W; Hoffmann, J; Hüser, J; Kolkhof, P; Mondritzki, T; Park, JW; Sandner, P; Truebel, H; Vogel, J; Walsh, S; White, J1
Apostolopoulou, SC; Kakava, F; Rammos, S; Tsoutsinos, A; Vagenakis, GA1
Adesiyun, T; Beard, D; Davis, RE; Hashimoto, T; Hendrick, JP; Hoxie, HR; Hsu, S; Kass, DA; Kim, GE; Lee, DI; Nakagawa, R; O'Brien, JJ; Tunin, RS; Wennogle, LP; Yao, W; Zhu, G1
Anker, SD; Balligand, JL; Bauersachs, J; Brutsaert, D; Carrier, L; Chlopicki, S; Cleland, JG; de Boer, RA; de Keulenaer, G; Dietl, A; Eschenhagen, T; Fischmeister, R; Hamdani, N; Harjola, VP; Heinzel, FR; Heymans, S; Hilfiker-Kleiner, D; Holzmeister, J; Limongelli, G; Linke, WA; Lund, LH; Lyon, AR; Maack, C; Manstein, DJ; Masip, J; Mebazaa, A; Metra, M; Metzger, J; Mueller, C; Papp, Z; Pieske, B; Ponikowski, P; Ristić, A; Ruschitzka, F; Seferović, PM; Skouri, H; Tocchetti, CG; Yilmaz, MB; Zimmermann, WH1
Bakkehaug, JP; How, OJ; Kildal, AB; Myrmel, T; Rødland, L; Rønning, L1
Andersson, B; Bartfay, SE; Bergh, N; Bollano, E; Dahlberg, P; Gilljam, T; Hjalmarsson, C; Karason, K; Lannemyr, L; Ljungman, C; Ricksten, SE; Rundqvist, B1
Bovenzi, F; Coltelli, M; Cortigiani, L; Picano, E; Ramirez, P1
Aggeli, C; Couloheri, S; Dilaveris, P; Gatzoulis, K; Giannoulis, E; Kallikazaros, I; Katsaros, A; Koukos, M; Koutagiar, I; Lagoudakou, S; Margioula, E; Poulidakis, E; Sfendouraki, E; Sideris, S; Stefanadis, C; Tousoulis, D1
Ishido, H; Iwamoto, Y; Kuwata, S; Masutani, S; Nishida, T; Saiki, H; Senzaki, H; Taketazu, M1
Bellagamba, CCA; Bertoluci, C; Bombardini, T; Camarozano, AC; Ciampi, Q; De Nes, M; Junior, AIH; Picano, E; Quevedo, NM; Texeira, TF; Torres, MAR1
B Bastos, M; Brugts, JJ; Bunge, JJH; Constantinescu, AA; Daemen, J; den Uil, CA; Engstrom, AE; Jewbali, LS; Lenzen, MJ; Manintveld, OC; Van Mieghem, NM; Wilschut, JM; Zijlstra, F1
Caballero, LG; Clausell, N; Domingues, FB; Goldraich, LA; Hastenteufel, LCT; Neyeloff, JL; Silva, ERRD1
Khemka, A; Sawada, SG1
Izumi, C1
Abe, Y; Arai, K; Ashihara, K; Hagiwara, N; Haze, K; Itoh, A; Naruko, T; Shoda, M; Takagi, A; Yagishita, D; Yagishita-Tagawa, Y; Yoshikawa, J1
Barbosa, AC; Oliveira, MG; Passos, LC; Santos, EG1
Apitz, C; Binder, W; Hofbeck, M; Kerst, G; Latus, H; Sieverding, L1
Ayik, F; Balcioglu, O; Baysal, B; Engin, C; Erkul, S; Oguz, E; Ozbaran, M; Ozturk, P; Yagdi, T1
Huang, LQ; Huang, X; Jiang, RL; Lei, S; Xia, GL; Zhi, YH; Zhu, MF1
C Marboe, C; Mancini, D; Sugiyama Kato, T; Yoshizawa, S1
Carll, AP; Cascio, WE; Costa, DL; Farraj, AK; Haykal-Coates, N; Hazari, MS; King, CJ; Krantz, QT; Perez, CM1
Hata, N; Kobayashi, N; Okazaki, H; Shinada, T; Shirakabe, A; Tomita, K; Tsurumi, M; Yamamoto, Y; Yokoyama, S1
Chłopicki, S; Drelicharz, L; Heinze-Paluchowska, S; Jabłońska, M; Skórka, T; Tyrankiewicz, U; Woźniak, M1
McNally, EM1
Garcia-Menendez, L; Gong, G; Karamanlidis, G; Kolwicz, SC; Lee, CF; Morgan, PG; Sedensky, MM; Suthammarak, W; Tian, R; Wang, W1
Barrett, NA; Berry, WT; Hewson, RW; Langrish, CJ; McKenzie, CA1
Bacaksiz, A; Erdogan, E; Ergelen, M; Erturk, M; Karakurt, H; Sonmez, O; Tasal, A; Turfan, M; Uyarel, H; Vatankulu, MA1
Balk, AH; Caliskan, K; Constantinescu, AA; Jewbali, L; Manintveld, OC; van Domburg, R1
Mitro, P; Murin, P; Simurda, M; Valocik, G1
Gu, Y; Niu, HY; Pan, HY; Pan, M; Yu, XH; Zhu, JH1
Baleine, J; Cambonie, G; de la Villéon, G; Durand, S; Jacquot, A; Milesi, C; Novais, AR; Roujeau, T1
Barretto, AC; Brancalhão, EC; Cardoso, JN; Ochiai, ME; Oliveira, MT; Puig, RS; Vieira, KR1
Akturk, IF; Birant, A; Erturk, M; Karakurt, H; Kurtar Mansıroglu, A; Oner, E; Somuncu, MU; Uzun, F; Yalcin, AA; Yildirim, A1
Cavusoglu, Y; Mert, U; Morrad, B; Mutlu, F; Nadir, A; Ulus, T1
Cepeda, JM; Conthe, P1
Chivite, D; Corbella, X; Formiga, F1
Mitro, P; Murín, P; Spurný, P; Valocik, G1
Butterick, TA; Cabrera, JA; Duffy, CM; Holley, CT; Kelly, RF; Lindsey, ME; Long, EK; McFalls, EO; Ward, HB1
Czer, LS; Lee, CC; Luthringer, DJ1
Balestra, GM; Eerbeek, O; Mik, EG; Specht, PA; van der Laarse, WJ; Zuurbier, CJ1
Abroug, F; Dachraoui, F; Fekih-Hassen, M; Ouanes Besbes, L; Ouanes, I; Souheil, E1
Andersen, MJ; Borlaug, BA; Fetterly, K; Hwang, SJ; Kane, GC; Melenovsky, V; Olson, TP1
Abdellatif, M; Falcão-Pires, I; Fontoura, D; Leite, S; Leite-Moreira, AF; Lourenço, AP; Oliveira-Pinto, J; Tavares-Silva, M1
Arai, M; Horiguchi, J; Koitabashi, N; Kurabayashi, M; Ohyama, Y; Rokutanda, N; Tateno, R1
Charles, CJ; Ellmers, LJ; Mark Richards, A; Rademaker, MT1
Shan, YX; Wang, XC; Zhu, DM1
Mittal, M; Radhakrishnan, M; UmamaheswaraRao, GS1
Çavuşoğlu, Y; Demirtaş, S; Gencer, E; Güneş, H; Kalaycı, S; Korkmaz, Ş; Mert, UK; Mutlu, F; Özdemir, S; Şaşmaz, H; Yılmaz, MB1
Ban, T; Chen, H; Chen, WR; Fan, Y; Li, BY; Qiao, QF; Sun, HL; Yan, ZY1
Al-Hesayen, A; Cherney, DZ; Floras, JS; Gilbert, C; Mak, S; Parker, AB; Parker, JD1
Bode, EF; Borland, SJ; Briston, SJ; Dibb, KM; Horn, MA; Kirkwood, GJ; Richards, MA; Trafford, AW1
Acharya, D; Hashim, T; Loyaga-Rendon, RY; Morgan, CJ; Pamboukian, SV; Revilla-Martinez, M; Sanam, K; Tallaj, JA1
Ertl, G; Pauschinger, M; von Scheidt, W1
Harjola, VP; Kivikko, M; Nieminen, MS; Pollesello, P; Sarapohja, T; Tarvasmäki, T1
Dupont Birkler, RI; Frederiksen, CA; Heiberg, J; Hyldebrandt, JA; Johannsen, M; Ravn, HB; Schmidt, MR; Støttrup, NB1
Bauersachs, J; Bengel, FM; Bogeski, I; Erschow, S; Haghikia, A; Hagl, C; Hilfiker-Kleiner, D; Jauhiainen, M; Kappl, R; Knuuti, J; Kohlhaas, M; Maack, C; Müller, M; Nickel, AG; Pietzsch, S; Ricke-Hoch, M; Roivainen, A; Saar, JA; Saraste, A; Scherr, M; Sieve, I; Silvola, JM; Stapel, B; Thackeray, JT; Tudorache, I1
Brugaletta, S; Comerci, G; Di Giannuario, G; Forni, F; Lombardo, A; Loperfido, F; Lotrionte, M; Marchese, N; Natali, R; Pisanello, C; Savino, M; Vigna, C1
Anastasiou-Nana, M; Dimopoulos, S; Gerovasili, V; Kaldara, E; Kourtidou, S; Nanas, J; Nanas, S; Pierrakos, C; Roussos, C; Sarafoglou, S; Venetsanakos, J1
Bacal, F; Bocchi, EA; Cardoso, LF; Ferreira, SM; Grativvol, PS; Mangini, S; Mocelin, AO; Seguro, LF; Silva, CP; Silveira, FS1
Carlson, M; Jones, JA; Ma, YJ; Rajagopalan, V; Zucker, IH1
Amour, J; Coriat, P; Ibanez-Esteve, C; Langeron, O; Nicolas-Robin, A; Riou, B1
Akyuz, S; Alioglu, E; Bozkaya, YT; Duygu, H; Gunduz, R; Kirilmaz, B; Ozdogan, O; Payzin, S; Turk, U; Turkoglu, C1
Bulsara, M; Chamberlain, J; Harding, R; Ho, KM1
Bistola, V; Filippatos, G; Ikonomidis, I; Kremastinos, DT; Papadopoulos, C; Paraskevaidis, IA; Parissis, JT1
Fischer, G; Stephani, U; van Baalen, A; von Spiczak, S1
Blake, SL; Bloch, KD; Brownell, AL; Buys, ES; Derumeaux, G; Kaneki, M; Kuruppu, D; Picard, MH; Raher, MJ; Rieusset, J; Scherrer-Crosbie, M; Shimizu, N; Thibault, HB1
Akilli, A; Akin, M; Duygu, H; Ergene, O; Erturk, U; Nalbantgil, S; Nazli, C; Ozerkan, F; Zoghi, M1
Donati, A; Elisei, D; Falzetti, G; Pelaia, P; Principi, T1
Mebazaa, A; Paraskevaidis, I; Parissis, JT; Rafouli-Stergiou, P1
Cleland, JG; Cohen-Solal, A; Filippatos, GS; Huang, B; Mebazaa, A; Nieminen, MS; Padley, RJ; Salon, JE; Thakkar, R1
Erdem, A; Karadas, F; Tandogan, I; Turgut, OO; Yalta, K; Yilmaz, A; Yilmaz, MB; Yontar, C2
Bonios, M; Drakos, SG; Kaldara, E; Kanakakis, JV; Katsaros, F; Nanas, JN; Nanas, S; Pantsios, C1
Blair, JE; Filippatos, GS; Gheorghiade, M; Harinstein, ME; Khan, H; Metra, M; Porchet, H; Sabbah, HN; Valentini, G; Vogel, M1
Ciampi, Q; Citro, R; Piacenti, M; Picano, E; Pratali, L; Villari, B1
Donlan, SM; Gheorghiade, M; Pang, PS; Quattromani, E1
Chay Woodward, T; de Lissovoy, G; Fraeman, K; Salon, J; Sterz, R1
Cai, D; Cohen-Solal, A; Huang, B; Logeart, D; Mebazaa, A; Nieminen, MS1
Böhm, M; Link, A; Reil, JC; Selejan, S1
Boyd, JH; Indrambarya, T; McConechy, M; Walley, KR; Wang, Y1
Bodi, V; Chaustre, F; Chorro, FJ; Forteza, MJ; Husser, O; Llacer, A; Lopez-Lereu, MP; Mainar, L; Monmeneu, JV; Nunez, J; Rumiz, E; Sanchis, J; Trapero, I1
Wu, KC1
Braz, JC; Corbly, AK; Gill, RM; Jin, N; Jones, BD; Shen, W; Vlahos, CJ; Wu, Q1
Chughtai, H; Dall'Armellina, E; Hamilton, CA; Hundley, WG; Kitzman, DW; Link, KM; Morgan, TM; Ntim, W; Walsh, TF1
Blier, L; Champagne, J; Dubois, M; Dumesnil, JG; Garceau, P; Lancellotti, P; Magne, J; Molin, F; O'Hara, G; Philippon, F; Pierard, L; Sénéchal, M1
Kiviniemi, V; Kurola, J; Leppikangas, H; Lindgren, L; Ruokonen, E; Rutanen, J1
Chu, EC; Gorodeski, EZ; Hsich, E; Reese, JR; Shishehbor, MH; Starling, RC1
Kato, M; Kitakaze, M; Sanada, S1
Bilgehan, K; Duman, D; Palit, F; Sacide, A; Simsek, E1
Cas, LD; Cotter, G; Gheorghiade, M; Metra, M; Sabbah, HN; Teerlink, JR; Zacà, V1
Bertoletti, L; Humbert, M; Jaïs, X; Price, LC; Simonneau, G; Sitbon, O; Souza, R; Sztrymf, B1
Bombardini, T; Ciampi, Q; Della Porta, M; Petruzziello, B; Picano, E; Pratali, L; Sicari, R; Villari, B1
Lage, SG; Lagudis, S; Mansur, AJ; Medeiros, CC; Vieira, ML; Yamada, AT1
Agresti, C; Baroncini, C; Caldi, F; Innocenti, F; Mannucci, E; Monami, M; Pini, R1
Omerovic, E; Swedberg, K; Waagstein, F1
Andersson, B; Bergh, CH; Dahlström, U; Forfang, K; Kivikko, M; Sarapohja, T; Ullman, B; Wikström, G1
Barretto, AC; Cardoso, JN; Morgado, PC; Munhoz, RT; Ochiai, ME; Ramires, JA1
Alexander, PM; Butt, WW; Penny, DJ; Ryerson, LM; Shann, FA; Shekerdemian, LS1
Azam, S; Berthiaume, JM; Bray, MS; Chandler, MP; Chen, X; Hoit, BD; McElfresh, TA; Young, ME1
Campia, U; Gheorghiade, M; Nodari, S1
Bauer, R; Blain, A; Bushby, K; Greally, E; Laval, S; Lochmüller, H; MacGowan, GA; Straub, V1
Wikström, BG1
Ayub-Ferreira, SM; Bacal, F; Bocchi, EA; Mangini, S; Marcondes-Braga, FG1
Barretto, AC; Brancalhão, EC; Cardoso, JN; Grativvol, KM; Grativvol, PS; Lima, MV; Morgado, PC; Munhoz, RT; Ochiai, ME; Scipioni, AR1
Gjessing, PF; Hermansen, SE; How, OJ; Kildal, AB; Myrmel, T; Røsner, A; Stenberg, TA1
Cui, L; Hao, YM; Jiang, DJ; Li, GP; Li, HM; Liu, J; Qi, GX; Wang, L; Wang, WZ; Wei, JP; Zhang, YD1
Kawada, T; Sugimachi, M; Sunagawa, K; Uemura, K1
Erdem, A; Tandogan, I; Yalta, K; Yilmaz, MB; Yontar, OC1
Coons, JC; McGraw, M; Murali, S1
Anastasiou-Nana, M; Bistola, V; Ikonomidis, I; Papadopoulos, C; Paraskevaidis, IA; Parissis, J; Stassinos, V1
Ata, N; Birdane, A; Cavuşoğlu, Y; Demirüstü, C; Göktekin, Ö; Görenek, B; Tek, M; Ünalır, A1
Böhm, M; Cai, D; Cohen Solal, A; Filippatos, GS; Huang, B; Kivikko, M; Link, A; Mebazaa, A; Nieminen, MS; Padley, RJ; Salem, R1
Ashley, EA; Denault, AY; Deschamps, A; Haddad, F; Haddad, H; Vrtovec, B1
Charoenpanichkit, C; Dall'Armellina, E; Hamilton, CA; Hundley, WG; Little, WC; Mandapaka, S; Morgan, TM1
Chiribiri, A; Egnell, C; Fleck, E; Gebker, R; Hamdan, A; Jahnke, C; Kelle, S; Klein, C; Paetsch, I; Vierecke, J; Wellnhofer, E1
Garot, J; O h-Ici, D1
Cheng, XW; Funahashi, H; Hirashiki, A; Inden, Y; Izawa, H; Murohara, T; Nomura, M1
Arai, AE; Schwitter, J1
Bettari, L; Bugatti, S; Carubelli, V; Danesi, R; Dei Cas, L; Lazzarini, V; Lombardi, C; Metra, M; Monti, A; Villa, C1
Ding, ZM; Hansen, G; Read, RW; Shi, ZZ; Van Sligtenhorst, I; Vogel, P1
Altman, RK; Chen-Tournoux, AA; McCarty, D; Orencole, M; Park, MY; Picard, MH; Riedl, L; Singh, JP; Tournoux, FB1
Ekholm, S; Germin, BI; Hu, R; Huang, Y; Kolar, B; Liu, X; Tian, W; Zhong, J1
Brasolin, B; Bruno, N; Caira, C; D'Ambrosi, A; Fedele, F; Mancone, M1
Montalto, M1
Barbosa, AC; Passos, LC; Santos, EG1
Burger, AJ; Josephson, ME; Mittleman, MA; Nearing, BD; Verrier, RL; Wellenius, GA1
Delaney, A; McCaffrey, J; Tacon, CL1
Aquaro, GD; Cospite, V; De Marchi, D; Emdin, M; Gallotta, M; L'Abbate, A; Lionetti, V; Lombardi, M; Lorenzoni, V; Molinaro, S; Passino, C; Pingitore, A1
Jovicić, B; Kosutić, J; Nikolić, L; Prijić, S; Rakić, S; Stajević, M; Vukomanović, V1
Akki, A; Caceres, V; Chacko, VP; Foster, DB; Gerstenblith, G; Gupta, A; Kirk, JA; Lai, S; Leppo, MK; Paolocci, N; Shi, S; Steenbergen, C; Su, J; Wang, Y; Weiss, RG1
Borlu, F; Dal, MS; Oztekin, E; Paksoy, F; Tursun, I; Ulaş, T1
Bonadei, I; Bugatti, S; Caretta, G; D'Aloia, A; Dei Cas, L; Vizzardi, E; Zanini, G1
Nagdev, A; Sivitz, A1
Fujiwara, H; Fukuhara, R; Miyamoto, T; Nishi, K; Saijo, S; Sato, Y; Takatsu, Y; Taniguchi, R; Toma, M1
Alalawi, R; Alexopoulos, D; Davlouros, P; Jumper, C; Karabinis, A; Karakitsos, D; Papanikolaou, J; Wachtel, M1
Besancon, A; de Haro, L; Glaizal, M; Hayek-Lanthois, M; Klouche, K; Schmitt, C; Tichadou, L1
An, T; Huang, Y; Lü, R; Qing, EM; Qing, P; Wei, BQ; Zhang, J; Zhang, YH; Zhou, Q; Zou, CH1
Bai, XJ; Huang, Y; Jiang, YN; Li, H; Liu, WX; Qing, EM; Qu, P; Sun, YX; Wei, BQ; Zhang, J; Zhang, L; Zhang, YH; Zhou, Q1
Amir, O; Zafrir, B1
Bonadei, I; Bugatti, S; Curnis, A; D'Aloia, A; Dei Cas, L; Del Magro, F; Rovetta, R; Vizzardi, E1
Hirayama, A; Kato, M1
Chaanine, AH; Chemaly, ER; Hajjar, RJ; Sakata, S1
Cai, D; Cohen-Solal, A; Deye, N; Kivikko, M; Laribi, S; Laterre, PF; Mebazaa, A; Nikolaou, M; Parissis, J; Paugam-Burtz, C; Poder, P; Pohjanjousi, P; Seronde, MF; Yilmaz, MB1
Chlopicki, S; Jablonska, M; Petkow-Dimitrow, P; Skorka, T; Tyrankiewicz, U1
Apajasalo, M; D'Ambrosi, A; Fedele, F; Lucioni, C; Mazzi, S; Pollesello, P1
Abe, T; Kobayashi, S; Misawa, H; Sakata, S; Tabayashi, N; Takaki, M; Takenaka, C; Taniguchi, S; Yoshikawa, Y1
Blackburn, B; Chandler, MP; Morita, H; Roth, BA; Sabbah, HN; Stanley, WC; Suzuki, G; Wolff, A1
Reek, S1
Bristow, MR; D'Aloia, A; Dei Cas, L; Metra, M; Muneretto, C; Nodari, S; Robertson, AD1
Himura, Y; Kashiki, M; Liang, CS; Stevens, SY1
Corbly, AK; Gill, RM; Jones, BD; Shen, W; Steinberg, MI; Zhang, JP1
Böhm, M1
Akintürk, H; Benson, M; Bräu, M; Hempelmann, G; Junger, A; Kwapisz, MM; Müller, M; Schindler, E1
Duboc, D1
Burger, AJ; Cheng, ML; Dennish, G; Dinerman, J; Elkayam, U; Ghali, JK; Horton, DP; Koren, M; LeJemtel, T; Silver, M; Torre, G1
Allanic, L; Da Conceiçao, M; Fassassi, M; Favier, JC; Pitti, R; Steiner, T1
Asanoi, H; Inoue, H; Ishizaka, S; Joho, S; Kameyama, T1
Cerný, J; Frélich, M; Groch, L; Hude, P; Krejcí, J; Meluzín, J; Panovský, R; Rambousková, L; Spinarová, L; Stetka, F; Toman, J1
Apajasalo, M; Cleland, JG; Kobelt, G; Takala, A; Zethraeus, N1
Gattis, WA; Gheorghiade, M; Jain, P; Klein, L; Massie, BM1
Adams, KF; Gheorghiade, M; Mathur, VS1
Adams, KF; Gattis, WA; Gheorghiade, M; Jaffe, AS; O'Connor, CM1
Felker, GM; O'connor, CM1
Aranda, JM; Cleeton, TS; Hill, JA; Leach, D; Lopez, LM; Monroe, VS; Pauly, DF; Schofield, RS; Walker, TC1
Bax, JJ; Borghetti, A; De Sutter, J; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; van Domburg, RT; Vourvouri, EC1
Edwards, N; Hankins, S; Hauff, H; Lang, CC; Mancini, DM; Maybaum, S1
Gronda, E; Mangiavacchi, M1
Chatterjee, K; De Marco, T1
Aronson, D; Burger, AJ3
Rich, MW; Shore, BL1
Andersson, B; Bollano, E; Hjalmarson, A; Täng, MS; Waagstein, F1
Chana, JS; Kocheril, AG; Moazemi, K; Willard, AM1
Aronson, D; Burger, AJ; Burger, MR; Horton, DP1
Aranda, JM; Hill, JA; Hsu, K; Pauly, DF; Schofield, R1
Castelli, G; Dolara, A; Favilli, S; Mori, F; Olivotto, I; Zuppiroli, A1
Stevenson, LW1
Adamson, PB; Carminati, P; Gagnol, JP; Germany, R; Mattera, GG; Schwartz, PJ; Vanoli, E1
Bender, C; Braun, K; Dittrich, S; Germanakis, I; Hentschel, R; Kececioglu, D1
Carron, C; Gibbons, W; López-Candales, A; Schwartz, J; Simmons, P; Vora, T1
Burger, AJ; Ciesla, G; de Lissovoy, G; Munger, M; Stier, DM1
Boldt, J; Kirchner, J; Lehmann, A1
Burger, AJ; Silver, MA1
Mak, S; Newton, GE1
Somers, VK; van de Borne, P; Velez-Roa, S1
Campana, C; Constantin, C; Fontana, A; Ghio, S; Klersy, C; Raineri, C; Tavazzi, L1
Appleton, C; DeMaria, A; Eichhorn, EJ; Frantz, R; Grayburn, PA; Greenberg, B; Krause-Steinrauf, H; Mayer, SA; Oh, J; Plehn, J; St John Sutton, M1
Degaute, JP; Renard, M; van de Borne, P; Velez-Roa, S1
Follath, F1
Anifantakis, A; Athanassopoulos, G; Chatzigeorgiou, G; Cokkinos, DV; Iakovis, P; Karatasakis, G; Koutsogiannis, N; Manginas, A; Maounis, T; Papadakis, M; Spargias, KS1
Adamopoulos, S; Karatzas, D; Kremastinos, DT; Paraskevaidis, IA; Tsiapras, D1
Carron, C; López-Candales, AL; Schwartz, J1
Doi, M; Kobayashi, S; Kohno, M; Matsuzaki, M; Oda, T; Ohkusa, T; Okuda, S; Tokuhisa, T; Yamamoto, T; Yano, M1
Kaplinsky, EJ; Manito, N; Pujol, R1
Airaksinen, KE; Bax, JJ; Engblom, E; Kalliokoski, R; Knuuti, J; Koistinen, J; Naum, A; Nekolla, SG; Stolen, KQ; Sundell, J; Ylitalo, A1
Katz, SD; Lee, FA; Nystrom, K; Saldarriaga, C; Sedrakyan, A; Upadya, S; Verma, S1
Habet, KJ1
Anastasiou-Nana, MI; Kanakakis, J; Moon, T; Nanas, JN; Nanas, SN; Terrovitis, JV; Tsagalou, EP1
Sharma, M; Teerlink, JR1
Azar, R; Barsumau, J; Decaudin, B; Horrent, S; Odou, P; Vairon, MX; Wierre, L1
Doverspike, A; Hentosz, T; Huerbin, R; Mathier, MA; Nikolaidis, LA; Shannon, RP; Shen, YT; Trumble, D1
Buttrick, PM; Geenen, DL; Goldspink, PH; McKinney, RD; Montgomery, DE; Solaro, RJ; Urboniene, D; Walker, LA1
Ahluwalia, MS; Butany, J; El Demellawy, D; Graba, J; Nair, V; Rao, V; Ross, H1
Andrisin, TE; Aquilante, CL; Hamilton, KK; Humma, LM; Johnson, JA; Lewis, JF; Yarandi, HN1
Bendall, JK; Damy, T; Heymes, C; Loyer, X; Marotte, F; Marty, I; Milliez, P; Monceau, V; Ratajczak, P; Robidel, E; Samuel, JL1
Badagliacca, R; Fedele, F; Sciomer, S; Vizza, CD1
Feinberg, MS; Freimark, D; Hochberg, N; Matezky, S; Shechter, M1
Agrios, N; Anastasiou-Nana, MI; Christodoulou, K; Dalianis, A; Kanakakis, J; Nanas, JN; Papazoglou, PP; Terrovitis, JV; Tsagalou, EP; Tsolakis, E1
Papalia, U; Puddu, PE; Schiariti, M; Usta, C1
Barzilai, B; Gage, BF; Gleva, MJ; Katsiyiannis, WT; Lindsay, BD; Rogers, JG; Sanchez, JM; Waggoner, AD1
Bove, T; Crivellari, M; Landoni, G; Zangrillo, A1
Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Ntalianis, A; Papazoglou, P; Terrovitis, JV; Tsagalou, EP; Tsolakis, E1
Hausmann, H; Hennig, F; Hetzer, R; Lehmkuhl, HB; Potapov, EV; Sodian, R; Volk, HD; Wagner, FD1
Sackner-Bernstein, JD1
Andreadou, I; Androulakis, A; Avgeropoulou, C; Demopoulou, M; Kallikazaros, I; Markantonis-Kyroudis, S; Missovoulos, P1
Dean, AS; Gaughan, JP; Libonati, JR; Margulies, KB; Nicholas, JJ; Rubin, S1
Buttrick, PM; de Tombe, PP; Geenen, DL; Goldspink, PH; Montgomery, DE; Rundell, VL; Urboniene, D1
Bloem, LJ; Gill, RM; Higgins, MA; Ingwall, JS; Jin, N; Ryan, TP; Shen, W; Spindler, M1
Abraham, WT; Adams, KF; Berkowitz, RL; Cheng, ML; Costanzo, MR; Fonarow, GC; LeJemtel, TH; Wynne, J1
Dec, GW1
Mak, S; Newton, GE; Overgaard, CB1
Barretto, AC; Canaviera, R; Follador, W; Martins, ML; Oliveira, MT; Scipioni, A; Tsuji, RL1
Reingardiene, D1
Cittadini, A; Condorelli, G; Di Gianni, A; Di Rella, F; Iaccarino, G; Monti, MG; Peschle, C; Saccà, L; Sorriento, D; Strömer, H; Trimarco, B; Tsichlis, PN1
Bax, JJ; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, F; van Domburg, RT1
Gortney, JS; Porter, KB1
Burger, AJ1
Adams, KF; Gattis Stough, W; Gheorghiade, M; Hasselblad, V; Jaffe, AS; O'Connor, CM1
Bayram, M; De Luca, L; Gheorghiade, M; Massie, MB1
Barraud, D; Mebazaa, A; Welschbillig, S1
Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Papazoglou, PD; Terrovitis, JV; Toumanidis, S; Tsagalou, EP; Tsolakis, EJ1
Bax, JJ; Boersma, E; de Roos, A; Kaandorp, TA; Lamb, HJ; van der Wall, EE; Viergever, EP1
Hidaka, I; Kamiya, A; Kawada, T; Shimizu, S; Shishido, T; Sugimachi, M; Sunagawa, K; Uemura, K; Yoshizawa, M1
Ducharme, A; Guertin, MC; He, Y; Ibrahim, R; Lavoie, J; Racine, N; Rouleau, JL; Schiffrin, EL; Touyz, RM; White, M; Whittom, L; Yao, G1
Gerhard, T; Hartzema, AG; Winterstein, AG; Zineh, I1
Atar, D; Hodt, A; Steine, K1
Brodde, OE; Bruck, H; Leineweber, K1
Adamopoulos, S; Farmakis, D; Filippatos, GS; Gheorghiade, M; Iliodromitis, EK; Karatzas, D; Kremastinos, DT; Paraskevaidis, I; Parissis, JT; Tsiapras, D1
Hennersdorf, M; Müller, K; Peters, A; Strauer, BE; Zeus, T1
Arnold, LM; Carroll, NV; Crouch, MA; Oinonen, MJ1
Bangalore, S; Chaudhry, FA; Hematpour, K1
Brimioulle, S; Demester, JP; Fesler, P; Huez, S; Kerbaul, F; Naeije, R; Rondelet, B1
Kurien, S; Miller, WL; Warfield, KT; Wood, CM1
Deftereos, D; McKechnie, R; Norton, GR; Osadchii, OE; Woodiwiss, AJ1
George, A; Hauptman, PJ; Hoover, R; Mikolajczak, P; Mohr, CJ; Schnitzler, MA; Swindle, J1
Gotthardt, M; Granzier, H; Labeit, S; Molkentin, JD; Peng, J; Raddatz, K; Wu, Y1
Akilli, A; Akin, M; Duygu, H; Ergene, O; Nalbantgil, S; Nazli, C; Ozerkan, F; Zoghi, M1
Khoury, DS; Nagueh, SF; Thohan, V; Torre-Amione, G; Wang, J1
Cavusoglu, Y1
Barraud, D; Damy, T; Faivre, V; Gayat, E; Heymes, C; Mebazaa, A; Payen, D; Shah, AM; Welschbillig, S1
Erdem, A; Karadas, F; Tandogan, I; Yilmaz, MB1
Berg, AM; Mahle, WT; Snell, L1
Cohen-Solal, A; Kivikko, M; Kleber, FX; Mebazaa, A; Nieminen, MS; Packer, M; Padley, RJ; Pocock, SJ; Põder, P; Thakkar, R1
Aaronson, K; Frazier, OH; Mancini, D; Margulies, K; Maybaum, S; McRee, S; Miller, LW; Pagani, FD; Starling, RC; Torre-Amione, G; Xydas, S1
Farmakis, D; Nieminen, M; Parissis, JT1
Barr, M; Bourge, RC; Jessup, ML; Lilly-Hersley, J; Linde, P; Mancini, D; McCluskey, T; Mehra, MR; Radovancevic, B; Rayburn, B; Taylor, DO1
Kagaya, Y1
Iino, K; Ito, H1
Kajimoto, K; Kawana, M; Watanabe, H1
Bars, C; Dubois-Randé, JL; Elbaz, N; Guéret, P; Hamdaoui, B; Lellouche, N; Lim, P; Mitchell-Heggs, L; Roiron, C1
Barold, SS; Cutro, R; Dewhurst, R; Herweg, B; Ilercil, A; Krishnan, S; Weston, M1
Butler, J; Giamouzis, G; Giannakoulas, G1
Hata, K; Hirata, K; Inoue, N; Masai, H; Matsumoto, D; Matsumoto, H; Otake, H; Ozawa, T; Shinke, T; Shite, J; Takaoka, H; Watanabe, S; Yokoyama, M; Yoshikawa, R1
Akilli, A; Akin, M; Duygu, H; Ergene, O; Nalbantgil, S; Nazli, C; Ozerkan, F; Yildiz, A; Zoghi, M1
Azevedo, CH; Bacal, F; Bocchi, EA; Carneiro, RM; Chizzola, PR; Ferreira, SM; Issa, VS; Mangini, S1
Damman, K; Voors, AA1
Bax, JJ; Bleeker, GB; Holman, ER; Schalij, MJ; Sieders, A; van der Wall, EE; Ypenburg, C1
van der Wall, EE; Verwey, HF; Ypenburg, C1
Brügemann, J; de Jonge-Weber, AT; Rienstra, M; van den Broek, SA; van Veldhuisen, DJ; Zijlstra, F1
Bartunek, J; de Bruyne, B; Delrue, L; Goethals, M; Mullens, W; Vanderheyden, M; Verstreken, S; Wijns, W1
Chu, AL; Chun, J; Elsherif, L; Huang, MS; Kaufman, SJ; Li, RY; Mekany, MA; Ross, RS; Shai, SY; Yang, Y1
Komamura, K; Matsuo, H; Sasaki, T1
Alamgir, MF; Chattopadhyay, S; Clark, AL; Cleland, JG; Fraser, AG; Nikitin, NP1
Haritakis, CN; Nyktari, EG; Parthenakis, FI; Patrianakos, AP; Vardas, PE; Zacharis, EA1
Dalampiras, P; Kelepeshis, G; Sitafidis, G; Skoularigis, J; Triposkiadis, F1
Al-Hesayen, A; Parker, JD1
Du, J; Feng, HZ; Gobara, N; Hossain, MM; Huang, XP; Jean-Charles, PY; Jin, JP; Li, Y; Liu, J; Zhang, C1
Agha, SA; Butler, J; Georgiopoulou, V; Giamouzis, G; Giannakoulas, G; Kalogeropoulos, A; Karvounis, H; Tsarpalis, K1
Celik, T; Iyisoy, A; Kardesoglu, E; Yuksel, UC1
Roberts, R2
Carlier, J; Cremers, S; D'Orio, V; el Allaf, D1
Sharpe, DN1
Baumann, G; Permanetter, B; Wirtzfeld, A1
Klein, G; Schnelle, K; Wirtzfeld, A1
Shevchenko, VA1
Storstein, L; Taylor, SH1
Bodem, G; Ochs, HR1
Goldberg, LI; Rajfer, SI2
Brandt, D; Klein, W1
Artman, M; Graham, TP; Parrish, MD1
Doherty, JU; Hood, WB; Lee, VW; Liang, CS; Sherman, LG; Wellington, K1
Grom, E; Hauf, GF1
Cohn, JN2
Awan, NA; Beattie, JM; Evenson, MK; Mason, DT; Needham, KE1
Bernard, R; Jacobs, P; Renard, M; Vainsel, H1
Benjamin, GC1
Pachinger, O1
Brandt, D; Klein, W; Pristautz, H1
Bernard, R; Englert, M; Jacobs, P; Melot, C; Renard, M1
Hashimoto, K; Mori, T; Yabuuchi, Y; Yamashita, S1
Ye, JM1
Leier, CV; Unverferth, DV1
Chodera, A; Chodera-Otuszewska, R; Pieczyńska, A1
Bernard, R; Renard, M1
Hermiller, JB; Leier, CV; Leithe, ME; Magorien, RD; Unverferth, DV1
Jüngst, BK; Schranz, D; Stopfkuchen, H1
Ferraro, N; Martin, JL; Wilson, JR1
Cohn, JN; Levine, TB; Petein, M1
Bendersky, R; Chatterjee, K; Parmley, WW1
Boucher, R; David, A; Fortin, L; Gagnon, RM; Gilbert, S; Lemire, J; Morrisette, M; Present, S1
Applefeld, MM; Grove, WR; Linberg, SE; Newman, KA; Reed, WP; Roffman, DS; Sutton, FJ1
Brown, GP; Leier, CV; Magorien, RD; Unverferth, DV1
Hutton, I; Rae, AP; Tweddel, AC1
Kadota, K; Kambara, H; Kawai, C; Kawashita, K; Saimyoji, H1
Bödigheimer, K; Delius, W; Ischinger, T; Nowak, FG1
Forman, R; Frishman, WH; LeJemtel, TH; Maskin, CS; Sonnenblick, EH1
Altschuld, R; Kolibash, AJ; Leier, CV; Lewis, RP; Magorien, RD; Unverferth, DV1
Gürtler-Krawczyńska, E; Pałko, T; Pietrzyk, E1
Smith-Collins, A1
Gunnar, RM1
Ikram, H; Maslowski, AH; Nicholls, MG1
Andrews, V; Janicki, JS; Weber, KT1
Huss, P; Leier, CV; Lewis, RP; Unverferth, DV1
Bleifeld, W; Hanrath, P; Kupper, W; Waller, D1
Clemens, R; Emmrich, P; Jüngst, BK; Schranz, D; Stopfkuchen, H1
Chierchia, S; Crea, F; Distante, A; L'Abbate, A; Maseri, A; Moscarelli, E; Parodi, O; Pesola, A1
Bauer, R; Klein, G; Sauer, E; Sebening, H; Wirtzfeld, A1
Dirschinger, J; Rudolph, W1
Bortz, R; DiBianco, R; Fletcher, RD; Katz, RJ; Myerburg, RJ; Pozen, RG1
Frishman, WH; Klein, NA; LeJemtel, TH; Siskind, SJ; Sonnenblick, EH1
Doenecke, P; Schmengler, K1
Awan, NA; DeMaria, AN; Evenson, MK; Hermanovich, J; Joye, JA; Mason, DT; Needham, K1
Bendersky, R; Brundage, BH; Chatterjee, K; Parmley, WW; Ports, TA1
Kopman, EA1
Bodem, G; Spannbrucker, N; Vogel, F1
Alepuz Ferrer, R; Montero Benzo, R; Vicente Sánchez, JL1
Segal, BL1
Leier, CV; Magorien, RD; Unverferth, DV1
Blanford, M; Kates, RE; Leier, CV; Unverferth, DA1
Goldstein, RA; Passamani, ER; Roberts, R1
Baba, N; Croskery, R; Dick, MR; Kolibash, AJ; Leier, CV; Magorien, RD; Meacham, JA; Svirbely, JR; Unverferth, DV1
Leier, CV2
Awan, NA; Evenson, MK; Mason, DT; Needham, KE1
Mercadante, S; Simonetti, MT1
Adamopoulos, S; Bernardi, L; Coats, AJ; Piepoli, M; Sleight, P1
Berkland, D1
Giesen, G; Kersting, F; Kupp, M1
Marks, R1
Sherman, A1
Berger, R; Frey, B; Hülsmann, M; Ioannides, C; Pacher, R; Stanek, B; Wutte, M1
Beanlands, RS; Schwaiger, M1
Buser, PT; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, SY1
Kamijo, T; Kido, H; Miwa, AY; Nakamura, F; Sugimoto, T; Tomaru, T; Uchida, Y1
Iwase, M; Nagata, K; Sobue, T; Yokota, M1
Adamopoulos, S; Bernardi, L; Coats, A; Davies, M; Forfar, C; Piepoli, M; Pissimissis, E; Qiang, F; Sleight, P1
Barbarash, R; Beckham, V; Coulter, L; Davila-Roman, VG; Kurz, H; Morello, PJ; Rich, MW; Sperry, J; Spinner, L; Woods, WL1
Norris, RM1
Martin, C; Papazian, L; Perrin, G1
Lie, KI; van Zwieten, PA1
Gorrie, M; Nicholls, A1
Domínguez de Rozas, JM; Guindo Soldevila, J; Martínez Vílchez, R; Rodríguez Font, E1
da Silva, MA1
Arnal, JF; Bourdarias, JP; Chikli, F; Delorme, G; Dubourg, O; Dumas, C; Jondeau, G; Kamoun, L1
Berger, R; Globits, S; Heinz, G; Kreiner, G; Pacher, R; Presch, I; Radosztics, S; Rödler, S; Weber, H; Wutte, M1
Fedel, FJ; Kataoka, T; Keteyian, SJ; Levine, AB; Levine, TB; Marks, CR1
Hasenfuss, G; Holubarsch, C; Just, H; Pieske, B1
Ohizumi, Y1
Armstrong, PW; Grima, EA; Howard, RJ; Moe, GW; Seth, R1
Bonijoly, S; Favre, E; Marcon, JL1
Gheorghiade, M; Sy, J; Vitarelli, A1
Bashchinskiĭ, SE; Osipov, MA; Volkov, GV1
Alam, M; Goldstein, S; Kono, T; Rosman, H; Sabbah, HN; Shimoyama, H1
Bersin, RM; Chatterjee, K; de Marco, T; Henderson, GN; Khorrami, P; Klinski, C; Kwasman, M; Lau, D; Tanaka, K; Wolfe, C1
Scrima, DA1
Faggiano, P; Ghizzoni, G; Lombardi, C; Rusconi, C; Sorgato, A; Spedini, C1
Chang, WC; Chen, JH; Cheng, JT; Kwan, CM; Lin, LJ; Teng, JK; Tsai, LM1
Agostini, A; Angelucci, E; Cesaroni, P; Lucarelli, G; Mariotti, E; Sgarbi, E1
Bain, RJ; Davies, MK; Lawson, N; Qiang, FX; Townend, JN; Virk, SJ1
Gheorghiade, M; Goldstein, S; Kono, T; Levine, TB; Sabbah, HN1
Berton, C; Boujdaria, R; Graini, L; Richard, C; Teboul, JL1
Cannon, MA; Povlow, MJ1
Annane, D; Auzepy, P; Bellissant, E; Giudicelli, JF; Richard, C; Teboul, JL; Thuillez, C1
van der Giessen, WJ; van Woerkens, LJ; Verdouw, PD1
Szatmari, A; Terlouw, JF; Umans-Eckenhausen, MA; van den Anker, JN1
Jolobe, OM1
Caldicott, LD; Channer, KS; Hawley, K; Heppell, R; Woodmansey, PA1
Coddens, J; Delooft, T; Vandenbroucke, G1
Doi, Y; Hori, M; Kamada, T; Kondo, H; Mano, T; Masuyama, T; Nagano, R; Naito, J; Yamamoto, K1
Izumi, T; Kodama, M; Koyama, S; Shibata, A1
Christmann, G; Fleischer, F; Haussmann, R; Lange, R; Martin, E1
Hess, ML; Shipley, JB1
Manetti, A; Pipitone, S1
Ishihara, H; Kanda, H; Kato, R; Nagata, K; Sobue, T; Yokota, M1
Berder, V; Cherrier, F; Danchin, N; Feldmann, L; Juillière, Y; Perrin, O1
Barbe, F; Crozatier, B; Hittinger, L; Laplace, M; Su, JB1
Goldberg, D; Goldstein, S; Lesch, M; Levine, AB; Levine, TB; Narins, B1
Berger, R; Hülsmann, M; Pacher, R; Siegel, A; Stanek, B; Wutte, M1
Adamopoulos, S; Bemardi, L; Coats, AJ; Piepoli, M; Ponikowski, P; Radaelli, A; Sleight, P1
Clark, WA; Denes, P; Fernandez, RN; Heaney, L; Marius-Nunez, AL; Ranganini, A; Silber, E1
Berk, MR; DeMaria, AN; DeWood, MA; Karlsberg, RP; Lasher, KP1
Hogan, PM; Novotny, MJ1
Colucci, WS; Landzberg, JS; Newton, GE; Parker, AB; Parker, JD1
Counihan, PJ; Gorcsan, J; Kormos, RL; Mandarino, WA; Murali, S1
Campa, PP; Dawodu, AA; De Biase, L; Gentile, C; Lilla Della Monica, PL; Monti, F; Puddu, PE; Schiariti, M; Vaccaro, M1
Bedogni, F; Bottero, M; Centofante, P; Cera, A; Fortunato, A; La Vecchia, L; Ometto, R1
Assmann, G; Breithardt, G; Brisse, B; Deng, MC; Erren, M; Lütgen, A; Scheld, HH; Schmitz, W; Zimmermann, P1
Hanzawa, K; Kamiyama, Y; Murayama, K; Shiraishi, M; Warabi, K1
Berger, R; Daneschvar, H; Frey, B; Grimm, M; Hülsmann, M; Laufer, G; Pacher, R; Rödler, S; Siegel, A; Stanek, B1
Bareiss, P; Roul, G1
Erdmann, E1
Benoit, T; Gillain, D; Limet, R; Piérard, L; Rigo, P; Van Damme, H1
Kapoor, C; Mehra, MR; Smart, FW; Stapleton, DD; Ventura, HO; Zimmerman, D1
Benhalima, B; Chauvel, C; Cohen, A; Desert, I; Guyon, P; Valty, J1
Harjai, KJ; Lapeyre, YM; Mehra, MR; Murgo, JP; Smart, FW; Stapleton, DD; Ventura, HO1
Heyman, S; Ozdemir, S; Zucker, I1
Kaan, AF; Keogh, AM; Macdonald, PS; McCosker, CJ; Sindone, AP1
Bauce, B; Boffa, GM; Cacciavillani, L; Cannas, S; Grassi, G; Livi, U; Maddalena, F; Marzari, A1
Abraham, WT; Bristow, MR; Ferguson, DA; Lindenfeld, J; Lowes, BD; Scheffel, CA; White, M; Wolfel, EE1
Capomolla, S; Cobelli, F; Febo, O; Maestri, R; Opasich, C; Pozzoli, M; Riccardi, G; Salvucci, F; Sisti, M; Tavazzi, L1
Drew, BJ; Ide, B1
Dernellis, JM; Toutouzas, PK; Vyssoulis, GP; Zacharoulis, AA1
Matsuzaki, M; Nakamura, Y; Ohkusa, T; Ryoke, T; Tanaka, N1
Appleby, S; Johnson, RG; Kivilghn, SD; Krause, SM; Lynch, JJ; Prahalada, S; Shen, YT; Siegl, PK; Woltmann, RF1
Fujii, H; Ishizu, T; Kousogabe, Y; Kurasaka, N; Otani, S; Tanaka, T; Tokioka, H1
Asano, M; Maehara, J; Momose, K; Saitoh, C; Saitoh, M; Sato, S; Taguchi, K; Tanaka, H; Usuda, S1
Belardinelli, R; Georgiou, D; Purcaro, A1
Agliata, S; Bosimini, E; Cavagnino, A; Corrà, U; Giannuzzi, P; Sacco, A; Schweiger, K1
Maisel, A; Nuñez, S1
McCloskey, WW1
Bonser, RS; Camici, PG; Lorenzoni, R; Ordoubadi, F; Pagano, D; Townend, JN1
Chen, CK; Chen, CP; Chen, YT; Ho, HY; Hsueh, CW; Huang, DS; Huang, JL; Lee, WL; Ting, CT1
Berton, C; Lenique, F; Mercat, A; Richard, C; Teboul, JL1
Bental, T; Elis, A; Kimchi, O; Lishner, M; Ravid, M1
Anzai, T; Gao, M; Hammond, HK; Lai, NC1
Baumann, G; Iven, H; Kieback, AG; Stolzenburg, K1
Anthopoulos, L; Filippatos, G; Kappos, K; Kranidis, A1
Ambrosino, N; D'Aloia, A; Faggiano, P; Giordano, A; Gualeni, A; Pagani, M1
Cocozza, M; De Vecchis, R; Imperatore, F; Nocerino, L; Pucciarelli, G; Setaro, A; Torre, G1
Bermúdez-Cañete, R; Díez-Balda, JI; Domínguez, F; Gómez, R; Martínez, A; Ramos, A; Vellibre, D1
Crilley, JG; Dark, JH; Hall, JA1
Lauer, MS; Lytle, BW; Marwick, TH; Secknus, MA; Williams, J; Zuchowski, C1
Finocchi, G; Ometto, R; Vecchia, L; Vincenzi, M1
Junger, E; Liziczai, I; Nagy, L; Tarján, J1
Delehanty, J; Liang, CS; Odorisi, ML1
Berger, R; Bojic, A; Frey, B; Grimm, M; Hülsmann, M; Laufer, G; Locker, G; Pacher, R; Rödler, S; Stanek, B; Sturm, B1
Dukić, M; Gradinac, S; Hercog, D; Jovanović, I; Jovović, L; Kokai, G; Simeunović, S; Stajević, M1
Mutnick, AH; Souney, PF1
Boldt, J; Faust, K; Lang, J; Lehmann, A; Thaler, E; Werling, C1
Kaul, S; Lahiri, A; Senior, R1
Liu, L; Zhao, SP1
Adams, KF; Califf, RM; Gattis, WA; Gheorghiade, M; Grossman, SH; McKenna, WJ; McNulty, SE; O'Connor, CM; Swedberg, K; Uretsky, BF; Zannad, F1
Bax, JJ; Boersma, E; Cornel, JH; Elhendy, A; Fioretti, PM; Poldermans, D; Rambaldi, R; Roelandt, JR1
Silver, MA1
Latini, R; Maggioni, AP; Mauri, F; Nicolis, E; Oliva, F; Politi, A; Staszewsky, L1
Fujiwara, A; Hirota, Y; Kawamura, K; Kono, T; Morita, H; Nishina, T1
Frey, B; Hartter, E; Kos, T; Kubecova, L; Pacher, R; Spinar, J; Stanek, B; Vitovec, J; Wimmer, A; Yilmaz, N1
Drazner, MH; Solomon, MA; Thompson, B; Yancy, CW1
Cherng, WJ; Hung, MJ; Wang, CH1
Blankenship, JS1
Karas, SM; Kefalas, CG; Mentzikof, DG; Parissis, JT; Venetsanou, KF; Ziras, NG1
Bristow, MR; Lindenfeld, J; Lowes, BD1
Bonser, RS; Camici, PG; Pagano, D; Parums, DV; Townend, JN1
Mingrone, R; Opasich, C; Russo, A; Tavazzi, L; Zambelli, M1
Bristow, MR; Lowes, BD; Simon, MA; Tsvetkova, TO1
Borzak, S; Goldstein, S; Mishima, T; Sabbah, HN; Steinberg, MI; Tanimura, M1
Delle-Karth, G; Haumer, M; Heinz, G; Koller-Strametz, J; Koreny, M; Siostrzonek, P1
Hata, K; Kawai, H; Kijima, Y; Murata, T; Okubo, H; Shinke, T; Takaoka, H; Takeuchi, M; Yokoyama, M1
Armstrong, WF; Avelar, E; Grossman, PM; Nicklas, JM; Oral, H; Sachdev, V; Sherman, HL1
Duncan, KF; Newberry, JW; Rauch, ED; Stammers, AH; Willett, LD1
Lagioia, R; Napoli, V; Passantino, A; Ricci, A; Rizzon, P; Scrutinio, D1
Das, MK; Mahoney, DW; McCully, RB; Oh, JK; Pellikka, PA; Roger, VL; Seward, JB1
Bojic, A; Frey, B; Hartter, E; Locker, G; Pacher, R; Stanek, B; Woloszczuk, W1
Diehl, JL; Faisy, C; Guerot, E; Labrousse, J; Rezgui, N1
Cianfrone, N; De Rito, V; Fanelli, R; Fusilli, S; Lombardo, A; Loperfido, F; Natali, R; Russo, A; Siena, GP; Vigna, C1
Bommer, WJ; Dhond, MR; Donnell, K; Nguyen, T; Whitley, TB1
Moen, EK; Young, JB1
Agricola, E; Alfieri, O; La Canna, G1
Atsumi, H; Endoh, M; Nakada, S; Sakurai, K; Sugawara, H; Tomoike, H1
Dienesch, C; Haase, A; Leupold, A; Neubauer, S; Rommel, E; Ruff, J; Wiesmann, F1
Kahn, JH; Starling, MR; Supiano, MA1
Elliott, WG; Levine, AB; Levine, TB; Narins, B; Stomel, RJ1
Alexopoulos, GP; Anastasiou-Nana, MI; Kontoyannis, DA; Moulopoulos, SD; Nanas, JN; Stamatelopoulos, SF; Tsagalou, EP1
Cadariu, AR; Carolan, S; Longo, MD; Ramahi, TM; Rohlfs, K; Slade, M; Vallejo, E; Wackers, FJ1
Burnett, JC; Hahn, EL; Hart, CY; Meyer, DM; Redfield, MM1
Aronson, D; Burger, AJ; Elkayam, U; Ghali, J; Haught, H; Horton, DP; Neibaur, MT1
De la Peña-Almaguer, E; Desai, MY; Mannting, F1
Durand, JB; Kobrin, I; Nagueh, S; Pratt, C; Torre-Amione, G; Vooletich, MT1
Bache, RJ; Godinot, C; Gong, G; Ishibashi, Y; Liu, J; Murakami, Y; Ochiai, K; Prody, C; Wang, C; Zhang, J1
Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF1
Capomolla, S; Caporotondi, A; Cobelli, F; Febo, O; Gnemmi, M; Guazzotti, G; La Rovere, MT; Maestri, R; Mortara, A; Opasich, C; Pinna, GD; Vona, M1
Borghetti, V; Ceconi, C; Coletti, G; La Canna, G; Lorusso, R; Minzioni, G; Parrinello, G; Totaro, P1
Frantz, S; Kelly, RA; Paulus, WJ1
Albert, N; Haji, SA; Kelly, L; Knack, DL; Starling, RC; Yamani, MH; Young, JB1
Bristow, MR; Eichhorn, EJ; Gilbert, EM; Lowes, BD; Tsvetkova, T1
Van Besouw, J1
Elkayam, U; Ghali, JK; Horton, DP; Silver, MA1
Al-Hesayen, A; Azevedo, ER; Newton, GE; Parker, JD1
Gorski, LA1
Diakakis, GF; Filippou, OK; Kanakaraki, MK; Kanoupakis, EM; Parthenakis, FI; Skalidis, EI; Vardas, PE1
Anagnostopoulos, P; Chaudhry, PA; Emala, CW; Gupta, RC; Kass, DA; Mishima, T; Paolocci, N; Saavedra, WF; Sabbah, HN; Suzuki, G; Tunin, RS1
Kübler, W; Mäurer, W; Tillmanns, H1
Bredakis, J; Gunner, RM; Loeb, HS1
Bolen, JL; Harrison, DC; Stoner, JD1
Frishman, WH; LeJemtel, TH; Sonnenblick, EH1
Kates, RE; Leier, CV; Unverferth, DV1
Armstrong, PW1
Bolte, HD; Cyran, J2
Lundman, T; Rehnqvist, N1
Codecà, L; De Lorenzi, E; Pradella, A1
Bush, CA; Heban, PT; Huss, P; Leier, CV; Lewis, RP1
Cohn, JN; Franciosa, JA1
Jackson, PG; Jennings, K; Jewitt, D1
Bleifeld, W; Hanrath, P; Kupper, W; Mathey, D1
Kates, RE; Leier, CV1
Davidson, J; Delius, W; Himmler, C; Klein, G; Volger, E; Wirtzfeld, A1
Ambrosioni, E; Branzi, A; Capitanucci, P; Magnani, B; Picchio, F1
Ali, N; Andy, JJ; Curry, CL; Mehrotra, PP1
Bush, CA; Leier, CV; Webel, J1
Bardet, J; Boschat, J; Bourdarias, JP; Ferreira, A; Rigaud, M; Rocha, P1
Cohn, JN; Franciosa, JA; Mikulic, E1
Delius, W; Mathes, P; Sebening, H; Wirtzfeld, A1
Delius, W; Sebening, H; Wirtzfeld, A1
Anderson, FL; Bristow, MR; Hanson, G; Hershberger, RE; Kralios, AC; Port, JD; Reid, BB1
Bier, S; Burkhoff, D; de Tombe, PP; Gerstenblith, G; Harasawa, Y; Hunter, WC; Kass, DA; Wolff, MR1
Quaale, S1
Amano, M; Kanamori, T; Kinoshita, M; Shichiri, G; Takahashi, M1
Qi, WH1
Adnot, S; Benvenuti, C; Bourguignon, MH; Castaigne, A; Dubois-Randé, JL; Loisance, D; Merlet, P; Syrota, A; Valette, H1
Reynolds, GW; Richmond, A; Silke, B; Taylor, SH; Verma, SP1
Benvenuti, C; Bohuon, C; Carville, C; Castaigne, A; Comoy, E; Dubois-Randé, JL; Hittinger, L; Macquin-Mavier, I; Merlet, P1
Elis, A; Lishner, M; Ravid, M1
Sleight, P1
Cleland, JG; Frost, G; Good, J; Oakley, CM1
Bleifeld, W; Erlemeier, HH; Kupper, W2
Asanoi, H; Ishizaka, S; Sasayama, S2
Bossan, P; Drici, M; Ferrari, E; Gibelin, P; Morand, P1
Bubik, JS; Robison-Strane, SR1
Asanoi, H; Ishizaka, S; Kameyama, T; Sasayama, S2
Honda, H; Hoshi, N; Kikuchi, J; Koiwa, Y; Takagi, T; Takishima, T1
Annane, D; Bellissant, E; Depret, J; Richard, C; Teboul, JL; Thuillez, C1
Brown, G; Douglas, I; Herkes, R; O'Leary, M1
Araghi, A; Dietrich, KA; Dooley, F; Landau, SW; Mene, M; Sacher, HL; Sacher, ML1
Pickworth, KK1
Gerdesmeyer, L; Herrmann, G; Meissner, A; Simon, R1
Bittl, JA; Colucci, WS; Landzberg, JS; Mirsky, I; Parker, JD1
Baumann, G; Gerzer, R; Stangl, K; Weil, J1
Frey, MJ; Lanoce, V; Liang, BT; Manning, DR; Marzo, KP; Molinoff, PB; Wilson, JR1
Hilleman, DE; Mohiuddin, SM1
Hua, J; Uretsky, BF1
Fan, TM; Frantz, RP; Guthinger, L; Liang, CS; Sakamoto, S; Suematsu, M; Sullebarger, JT1
Asanoi, H; Fujita, M; Miyagi, Y; Nakajima, H; Sasayama, S1
Budzinski, D; Goldberg, AD; Jafri, SM; Levine, TB; Pilla, A; Reddy, BR1
Debets, JJ; Schoemaker, RG; Smits, JF; Struyker-Boudier, HA1
Costa, R; De Marino, V; Marino, A1
Keller, N; Larsen, J; Sykulski, R1
Boldt, J; Hempelmann, G1
Zeplin, HE1
Peters, P; Saborowski, F; Schneider, M1
Brichant, C; Cauwe, F; De Coster, P; Gonzalez, M; Installe, E; Lessire, H1
Hilger, HH; Höpp, HW; Klocke, RK; Kux, A; Mager, G1
Paccagnella, A; Simini, G; Valfré, C1
Gofman, AM; Ol'binskaia, LI; Poptsov, VN1
Guy, S; Silke, B1
Adamopoulos, S; Coats, AJ1
Binkley, PF; Hammer, DF; Leier, CV; Starling, RC1
Camous, JP; Drici, M; Gibelin, P; Lapalus, P; Morand, P; Sbirrazzuoli, V1
Arter, WJ; Field, MJ; Kiyingi, A; Lawrence, JR; Pawsey, CC; Yiannikas, J1
Bristow, MR; Gilbert, EM; Ginsburg, R; Hershberger, RE; Larrabee, P; Mealey, P; Murray, J; Port, JD; Volkman, K1
Fournier, P; Fraysse, JB; Grosgogeat, Y; Komajda, M; Landault, C; Lechat, P; Richaud, M1
Baumann, G; Felix, SB; Filcek, SA1
Lewis, RP1
van Zwieten, PA1
Buttrick, P; Geenen, D; Lahorra, M; Malhotra, A; Perla, C; Scheuer, J1
Littler, WA; Murray, RG; Tan, LB2
Hilger, HH; Höpp, HW; Klocke, RK; Kux, A; Mager, G; Volkmann, A1
Baumann, G; Cremer, G; Joder-Ohlenbusch, AM; Ningel, K; Vieweg, J1
Schoemaker, RG; Smits, JF1
Benvenuti, C; Cachera, JP; Castaigne, A; Deleuze, P; Dubois-Randé, JL; Duval-Moulin, AM; Lellouche, D; Loisance, D; Merlet, P; Saal, JP1
Annane, D; Bellissant, E; Richard, C; Teboul, JL; Thuillez, C1
Bounhoure, JP; Edouard, P; Fauvel, JM; Fourcade, J; Galinier, M; Massabuau, P; Puel, J; Rochiccioli, JP1
Besse, P; Coste, P; Durrieu, C; Le Goff, G; Rochoux, G1
Allal, J; Barraine, R; Bouton, S; Couetil, JP; Dreyfus, G; Farge, D; Ourbak, P; Pornin, M; Prevost, D; Sarkis, A1
Liu, ZQ; Ma, AQ; Yang, DY; Zhang, L1
Gunnar, RM; Stecy, P1
Applefeld, MM; Sohl, LL1
Marcus, RH; Mitha, A; Patel, J; Raw, K; Sareli, P1
Herrmann, V; Merkle, EJ; Miller, LW1
Follath, F; Ha, HR; Ritz, R; Schmidlin, O; Weiss, P1
Imburgia, M; Rich, MW1
Campbell, CA; Held, AC; Johnson, V; Lavine, SJ1
Chance, B; Ferraro, N; Mancini, DM; Schwartz, M; Seestedt, R; Wilson, JR1
De Backer, D; Kahn, RJ; Roman, A; Vincent, JL1
Demedts, M; Van den Brande, P; Van Mieghem, W1
Keren, G; LeJemtel, TH; Reis, D; Sonnenblick, EH1
Bayliss, J; Poole-Wilson, P; Thomas, L1
Hood, WB; Imai, N; Kawashima, S; Liang, CS; Stone, CK; Thomas, A1
Baumann, G; Ningel, K; Permanetter, B2
Gilfrich, HJ; Römer, A; Witzke-Gross, J1
Gans, SJ; Zwaveling, JH1
Katz, S; Keren, G; LeJemtel, TH; Sonnenblick, EH; Strom, J1
Kahn, RJ; Madhoun, P; Primo, G; Vincent, JL1
Carey, RA; Jacob, L1
Drexler, H; Just, H; Meinertz, T1
Aïtkaciali, F; Cupa, M; Fosse, JP; Fournier, JL; Hoang, P; Pourriat, JL1
Buser, PT; Camacho, SA; Higgins, CB; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, ST1
Bhatt-Mehta, V; Nahata, MC1
Bain, RJ; Littler, WA; Tan, LB1
Dieckelmann, A; Haan, J; Haupts, M; Kaliwoda, A; Rembs, E; Zumtobel, V1
Keren, G; Laniado, S; Lejemtel, TH; Sonnenblick, EH1
Banerjee, SP; Fan, TH; Kawashima, S; Liang, CS1
Colucci, WS; Denniss, AR; Gauthier, DF; Leatherman, GF; Ludmer, PL; Marsh, JD; Quigg, RJ1
Matoba, M1
Fukuzaki, H; Nakanishi, M; Yokota, Y1
Acar, J; Le Potier, J; Michel, PL; Sergent, J; Vahanian, A1
Braunwald, E; Colucci, WS; Wright, RF1
Kopia, GA; Ruffolo, RR1
Andersson, KE1
Ruffolo, RR; Shebuski, RJ; Smith, JM1
Dhainaut, JF1
Colucci, WS2
Sonoki, H; Sugimoto, T; Tomaru, T; Uchida, Y1
Cohn, JN; Goldenberg, IF; Levine, TB; Olivari, MT1
Reddy, PS; Uretsky, BF; Valdes, AM1
Hakki, A; Iskandrian, AS; Likoff, MJ; Ulrich, S1
Generalovich, T; Reddy, PS; Uretsky, BF; Valdes, AM; Verbalis, JG1
Jain, MC; Janicki, JS; Weber, KT1
Uretsky, BF1
Collard, P; Gonzalez, M; Installé, E; Jacquemart, JL; Pourbaix, S; Roulette, F; Tremouroux, J1
LeJemtel, TH; Mancini, DM; Sonnenblick, EH1
Kleinschmidt, R; Spannbrucker, N; Vogel, F1
Applefeld, MM; Roffman, DS1
Ruggie, N1
Bristow, MR; Fowler, MB; Hopkins, GL; Laser, JA; Minobe, W1
Halon, DA; Hardoff, R; Lewis, BS; Merdler, A; Rodeanu, ME; Saggie, Y1
Autenrieth, G1
Amin, DK; Brandon, G; Hulse, S; Shah, PK; Shellock, FG; Spangenberg, R; Swan, HJ1
Keren, G; LeJemtel, TH; Mancini, D; Sonnenblick, EH1
Crawford, MV; Schactman, M1
Marshall, LE; Thomas, RL; Watson, D1
Kolesar, JA; Lawless, CE; Reddy, PS; Uretsky, BF; Valdes, AM; Verbalis, JG1
Ruffolo, RR1
Hattori, R; Kawai, C; Sakaguchi, K; Susawa, T; Takatsu, Y; Yui, N; Yui, Y1
Drexler, H; Faude, F; Freudenberg, N; Just, H; Winterer, H; Wollschläger, H1
Anand, IS; Gurden, J; Harris, P; Poole-Wilson, PA; Wanless, RB1
Casanegra, P; Chamorro, G; Corbalán, R; Illanes, G; Jalil, J; Martínez, A1
Jaski, BE; Peters, C1
Kindler, M; Kramer, W; Kremer, P; Schlepper, M; Thormann, J1
Martínez Martínez, A; Salvati, A; Suárez, LD1
Baim, DS; Lanoue, AS; Monrad, ES; Smith, HS1
Braunwald, E; Colucci, WS; Fifer, MA; Jaski, BE; Wright, RF1
Riemenschneider, TA; Tiefenbrunn, LJ1
Mauro, LS; Mauro, VF1
Huth, R; Jüngst, BK; Schranz, D; Stopfkuchen, H1
Benotti, JR; Biddle, TL; Creager, MA; Faxon, DP; Firth, BG; Fitzpatrick, PG; Kershner, RP; Konstam, MA; Krebs, C; Walton, L1
Agmon, J; Davidson, E; Hellman, C; Lewin, RF; Sclarovsky, S; Strasberg, B; Zafrir, N1
Bache, RJ; Cohn, JN; Heppner, B; Petein, M; Pierpont, GL1
Iwasaki, T; Komasa, N; Mihata, S; Mori, S; Nishian, K; Tateishi, J; Yasutomi, N1
Applefeld, MM; Grove, WR; Newman, KA; Reed, WP; Roffman, DS; Sutton, FJ; Talesnick, BS1
Margolis, J; Puram, B; Puram, V1
Hagège, HH1
Colucci, WS; Gauthier, DF; Leatherman, GF; Ludmer, PL1
Baerman, JM; de Buitleir, M; DiCarlo, LA; Krol, RB; Morady, F; Schork, MA; Schurig, L; Sereika, SM1
Cornyn, J; Loge, D; Massie, BM; Podolin, RA; Topic, N1
Eichhorn, EJ; Konstam, MA; Martin, TT; Roberts, DJ; Salem, DN; Stransky, NB; Weiland, DS1
Aiba, S; Nakazawa, M; Ohta, H; Okuda, H; Takahashi, Y; Takao, A1
Bleifeld, W; Erlemeier, HH; Hamm, CW; Kupper, W1
Gage, J; LeJemtel, TH; Lucido, D; Rutman, H1
Hayakawa, H; Katoh, T; Koh, M; Munakata, K; Nejima, J; Seino, Y; Shimai, S; Takada, K; Takano, T; Tanaka, K1
Bates, ER; Dilworth, LR; Hodgson, JM; Kline, EM; Krell, MJ; Laufer, N; Pitt, B; Vogel, RA1
Seino, Y; Takano, T; Tanaka, K1
Geraets, DR1
Applefeld, MM; Hassan, E; Roffman, DS1
McGuirk, SM; Muir, WW1
Domenech, R; Goich, J; Thumala, A1
Beck, OA1
Ferraro, N; Fink, LI; Wilson, JR1
Applefeld, MM1
David, S; Zaks, JM1
Elert, O; Pomer, S; Sarai, K; Satter, P1
Greenberg, M; Grose, R; LeJemtel, TH; Strain, J1
Berger, M; McSherry, CK1
Alpert, JS; Benotti, JR; McCue, JE1
Janicki, JS; Maskin, CS; Weber, KT1
Fukuzaki, H; Hayakawa, M; Inoh, T; Kubo, M; Kumaki, T; Maehashi, N; Seo, T; Takarada, A; Toh, S; Yokota, Y1

Reviews

105 review(s) available for dobutamine and Cardiac Failure

ArticleYear
In search of the digitalis replacement.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship

1987
Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis.
    ESC heart failure, 2022, Volume: 9, Issue:3

    Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone

2022
Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
    Current problems in cardiology, 2023, Volume: 48, Issue:8

    Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Randomized Controlled Trials as Topic; Retrospective Studies; Shock, Cardiogenic

2023
Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure.
    Current heart failure reports, 2022, Volume: 19, Issue:5

    Topics: Cardiac Output, Low; Diuretics; Dobutamine; Heart Failure; Humans; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Water-Electrolyte Imbalance

2022
Comparison of milrinone with dobutamine in patients undergoing cardiac surgery: a systematic review and meta-analysis.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2023, Volume: 70, Issue:7

    Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone

2023
[The Role of Pharmacists in Home Medical Care of Patients with Heart Failure].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2020, Volume: 140, Issue:7

    Topics: Catecholamines; Chronic Disease; Dobutamine; Furosemide; Heart Failure; Home Care Services; Humans; Injections; Patient Care Team; Pharmacists; Professional Role

2020
An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.
    Expert review of cardiovascular therapy, 2021, Volume: 19, Issue:4

    Topics: Adrenergic beta-Antagonists; Cardiac Surgical Procedures; Cardiotonic Agents; Critical Care; Dobutamine; Heart Failure; Hemodynamics; Humans; Shock, Cardiogenic; Simendan

2021
Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis.
    Cardiology journal, 2021, Volume: 28, Issue:3

    Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan; Treatment Outcome

2021
Calcium and Heart Failure: How Did We Get Here and Where Are We Going?
    International journal of molecular sciences, 2021, Jul-09, Volume: 22, Issue:14

    Topics: Adenosine Triphosphatases; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Ca(2+) Mg(2+)-ATPase; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Sarcoplasmic Reticulum

2021
Left ventricular contractile reserve by stress echocardiography as a predictor of response to cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis.
    BMC cardiovascular disorders, 2017, 08-16, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Cardiac Resynchronization Therapy; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Odds Ratio; Predictive Value of Tests; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left

2017
Dobutamine echocardiography for assessment of viability in the current era.
    Current opinion in cardiology, 2019, Volume: 34, Issue:5

    Topics: Cardiotonic Agents; Dobutamine; Echocardiography; Echocardiography, Stress; Heart Failure; Humans; Myocardial Contraction; Myocardial Ischemia; Prognosis; Tissue Survival; Ventricular Dysfunction, Left

2019
Is there evidence favoring the use of beta-blockers and dobutamine in acute heart failure?
    Arquivos brasileiros de cardiologia, 2013, Volume: 100, Issue:2

    Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Heart Failure; Humans

2013
Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.
    Journal of Zhejiang University. Science. B, 2013, Volume: 14, Issue:5

    Topics: Arrhythmias, Cardiac; Cardiotonic Agents; Comorbidity; Critical Illness; Dobutamine; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Hypotension; Pyridazines; Randomized Controlled Trials as Topic; Risk Factors; Simendan; Survival Rate; Treatment Outcome

2013
[Possibilities of clinical echocardiography in patients with heart failure: some examples from clinical practice].
    Medicina clinica, 2014, Volume: 142 Suppl 1

    Topics: Acute Coronary Syndrome; Acute Disease; Aged; Arrhythmias, Cardiac; Counterpulsation; Diagnostic Errors; Dobutamine; Dyspnea; Echocardiography; Gastroenteritis; Heart Failure; Humans; Male; Middle Aged; Myocarditis; Norepinephrine; Point-of-Care Systems; Pulmonary Embolism; Radiography; Respiration, Artificial; Shock, Cardiogenic; Stroke Volume; Systole

2014
[Organ-protection therapy. A new therapeutic approach for acute heart failure?].
    Medicina clinica, 2014, Volume: 142 Suppl 1

    Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan

2014
Scorpion-related cardiomyopathy: Clinical characteristics, pathophysiology, and treatment.
    Clinical toxicology (Philadelphia, Pa.), 2015, Volume: 53, Issue:6

    Topics: Animals; Cardiomyopathies; Cardiotonic Agents; Combined Modality Therapy; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Oxygen Inhalation Therapy; Pulmonary Edema; Respiration, Artificial; Scorpion Stings; Scorpion Venoms; Scorpions; Time Factors; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure

2015
Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2015, Volume: 15, Issue:6

    Topics: Acute Disease; Cardiotonic Agents; Cohort Studies; Dobutamine; Heart Failure; Hospital Mortality; Humans; Natriuretic Peptide, Brain; Patient Readmission; Survival Analysis

2015
Long-term intravenous inotropes in low-output terminal heart failure?
    Clinical research in cardiology : official journal of the German Cardiac Society, 2016, Volume: 105, Issue:6

    Topics: Administration, Intravenous; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Chi-Square Distribution; Dobutamine; Drug Administration Schedule; Heart Failure; Heart Transplantation; Humans; Hydrazones; Milrinone; Odds Ratio; Practice Guidelines as Topic; Pyridazines; Risk Factors; Simendan; Time Factors; Treatment Outcome; Waiting Lists

2016
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?
    Heart failure reviews, 2009, Volume: 14, Issue:4

    Topics: Acute Disease; Animals; Cardiotonic Agents; Dobutamine; Etiocholanolone; Heart Failure; Hemodynamics; Humans; Pulmonary Wedge Pressure; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Potassium-Exchanging ATPase

2009
Therapy for acute heart failure syndromes.
    Current cardiology reports, 2009, Volume: 11, Issue:3

    Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Milrinone; Mineralocorticoid Receptor Antagonists; Morphine; Nitroprusside; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Analysis; Syndrome; Treatment Outcome

2009
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.
    Heart failure reviews, 2009, Volume: 14, Issue:4

    Topics: Acute Disease; Cardiotonic Agents; Digoxin; Dobutamine; Etiocholanolone; Exercise Test; Heart Failure; Hemodynamics; Hospitals, Group Practice; Humans; Hydrazones; Prognosis; Pyrazines; Pyridazines; Quinolines; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Treatment Outcome; Urea; Vasodilator Agents

2009
Pharmacotherapy for acute heart failure syndromes.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Jan-01, Volume: 68, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Heart Failure; Humans; Milrinone; Morphine; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Practice Guidelines as Topic; Vasodilator Agents

2011
The concept of ventricular reserve in heart failure and pulmonary hypertension: an old metric that brings us one step closer in our quest for prediction.
    Current opinion in cardiology, 2011, Volume: 26, Issue:2

    Topics: Coronary Artery Disease; Dobutamine; Exercise Test; Health Status Indicators; Heart Failure; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Myocardial Contraction; Prognosis; Stroke Volume; Tissue Survival; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left

2011
Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance.
    European heart journal, 2011, Volume: 32, Issue:7

    Topics: Cardiotonic Agents; Chronic Disease; Contrast Media; Coronary Artery Disease; Death, Sudden, Cardiac; Diagnosis, Differential; Dobutamine; Feasibility Studies; Heart Failure; Humans; Magnetic Resonance Angiography; Myocardial Infarction; Myocardial Ischemia; Patient Safety; Prognosis

2011
Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials.
    Intensive care medicine, 2012, Volume: 38, Issue:3

    Topics: Adult; Cardiotonic Agents; Databases, Bibliographic; Dobutamine; Heart Failure; Humans; Mortality; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome

2012
Beta blocker therapy, decompensated heart failure, and inotropic interactions: current perspectives.
    The Israel Medical Association journal : IMAJ, 2012, Volume: 14, Issue:3

    Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Heart Failure; Hospitalization; Humans; Hydrazones; Phosphodiesterase Inhibitors; Practice Guidelines as Topic; Pyridazines; Simendan

2012
[Combination therapy; dobutamine and milrinone].
    Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 9

    Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Milrinone; Myocardial Ischemia; Phosphodiesterase 3 Inhibitors

2011
[Are cardiac glycosides still needed in the treatment of cardiac insufficiency?].
    Deutsche medizinische Wochenschrift (1946), 2002, Oct-11, Volume: 127, Issue:41

    Topics: Cardiac Glycosides; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Dobutamine; Heart Failure; Humans; Multicenter Studies as Topic; Odds Ratio; Risk; Severity of Illness Index; Treatment Failure; Treatment Outcome

2002
[Cardiac insufficiency of ischemic origin].
    La Revue du praticien, 2002, Oct-01, Volume: 52, Issue:15

    Topics: Cardiotonic Agents; Dobutamine; Echocardiography; Heart Failure; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Thallium Radioisotopes; Tomography, Emission-Computed

2002
Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.
    American heart journal, 2003, Volume: 145, Issue:2 Suppl

    Topics: Aged; Diuretics; Dobutamine; Enalaprilat; Female; Heart Failure; Hemodynamics; Hospitalization; Humans; Hydrazones; Injections, Intravenous; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroprusside; Pulmonary Wedge Pressure; Pyridazines; Renal Agents; Simendan; Vasodilator Agents

2003
B-type natriuretic peptide: from bench to bedside.
    American heart journal, 2003, Volume: 145, Issue:2 Suppl

    Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Cardiotonic Agents; Diuretics; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Randomized Controlled Trials as Topic; Receptors, Atrial Natriuretic Factor; Vasodilator Agents

2003
[Inotropic agents in advanced and refractory heart failure].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2003, Volume: 4, Issue:1

    Topics: Cardiotonic Agents; Dobutamine; Dopamine; Drug Administration Schedule; Heart Failure; Humans; Hydrazones; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Treatment Failure; Treatment Outcome

2003
Role of nonglycosidic inotropic agents: indications, ethics, and limitations.
    The Medical clinics of North America, 2003, Volume: 87, Issue:2

    Topics: Adrenergic beta-Antagonists; Cardiac Glycosides; Cardiotonic Agents; Dobutamine; Ethics, Clinical; Heart Failure; Humans; Milrinone; Myocardial Infarction; Nitroprusside; Quality of Life; Sympathomimetics; Vasodilator Agents

2003
Intravenous vasodilator therapy in congestive heart failure.
    Drugs & aging, 2003, Volume: 20, Issue:7

    Topics: Dobutamine; Endothelin Receptor Antagonists; Heart Failure; Humans; Injections, Intravenous; Nitroglycerin; Phosphodiesterase Inhibitors; Thrombocytopenia; Vasodilator Agents

2003
Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure.
    The American journal of cardiology, 2003, Sep-01, Volume: 92, Issue:5

    Topics: Acute Disease; Age Distribution; Aged; Cardiotonic Agents; Dobutamine; Drug Costs; Female; Heart Failure; Hospital Costs; Humans; Life Expectancy; Male; Middle Aged; Models, Econometric; Monte Carlo Method; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Admission; Predictive Value of Tests; Sex Distribution; Survival Analysis; Treatment Outcome; United States; Value of Life

2003
The role of Ca++-sensitizers for the treatment of heart failure.
    Current opinion in critical care, 2003, Volume: 9, Issue:5

    Topics: Calcium; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Myocardial Ischemia; Pyridazines; Simendan

2003
[Inotropic therapy in heart failure: general aspects and clinical results].
    Medicina clinica, 2004, Feb-28, Volume: 122, Issue:7

    Topics: Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Heart Failure; Humans; Milrinone; Treatment Outcome

2004
A rational approach for the treatment of acute heart failure: current strategies and future options.
    Current opinion in cardiology, 2004, Volume: 19, Issue:3

    Topics: Acute Disease; Adenosine; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Drug Therapy; Endothelins; Forecasting; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Vasopressins

2004
[Echocardiography in aortic stenosis: new insights into challenging scenarios].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2004, Volume: 5, Issue:6

    Topics: Aged; Aortic Valve Stenosis; Cardiotonic Agents; Clinical Trials as Topic; Death, Sudden, Cardiac; Diagnosis, Differential; Disease Progression; Dobutamine; Echocardiography; Heart Failure; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Myocardial Contraction; Prognosis; Risk Factors; Severity of Illness Index; Time Factors; Ventricular Dysfunction, Left

2004
Management of diuretic-refractory, volume-overloaded patients with acutely decompensated heart failure.
    Current cardiology reports, 2005, Volume: 7, Issue:3

    Topics: Cardiotonic Agents; Diuretics; Dobutamine; Edema; Heart Failure; Hemofiltration; Humans; Patient Care Management; Renal Dialysis; Treatment Outcome; Vasodilator Agents

2005
[The novelty in the treatment of heart failure].
    Medicina (Kaunas, Lithuania), 2005, Volume: 41, Issue:7

    Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Multicenter Studies as Topic; Pyridazines; Randomized Controlled Trials as Topic; Retrospective Studies; Simendan; Vasodilator Agents

2005
Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
    The American journal of cardiology, 2005, Sep-19, Volume: 96, Issue:6A

    Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Dopamine; Heart Failure; Humans; Milrinone; Syndrome

2005
Randomized clinical trials with levosimendan.
    The American journal of cardiology, 2005, Sep-19, Volume: 96, Issue:6A

    Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Syndrome

2005
[Medical and ventilatory treatment of acute heart failure].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006, Mar-09, Volume: 126, Issue:6

    Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Continuous Positive Airway Pressure; Diuretics; Dobutamine; Furosemide; Heart Failure; Humans; Hydrazones; Isosorbide Dinitrate; Natriuretic Agents; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxygen Inhalation Therapy; Practice Guidelines as Topic; Pyridazines; Simendan; Vasodilator Agents

2006
Cardiac adrenoceptors: physiological and pathophysiological relevance.
    Journal of pharmacological sciences, 2006, Volume: 100, Issue:5

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Dose-Response Relationship, Drug; GTP-Binding Proteins; Heart; Heart Failure; Heart Rate; Myocardium; Physical Conditioning, Animal; Polymorphism, Genetic; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Terbutaline

2006
Dobutamine stress echocardiography: does it predict response to beta-blockers in patients with heart failure?
    Current heart failure reports, 2006, Volume: 3, Issue:2

    Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Dobutamine; Echocardiography, Stress; Heart Failure; Humans; Predictive Value of Tests

2006
The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:5

    Topics: Aged; Biological Availability; Calcium Channels; Cardiotonic Agents; Dobutamine; Half-Life; Heart Failure; Hospitalization; Humans; Hydrazones; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Tissue Distribution; Treatment Outcome

2007
Classical inotropes and new cardiac enhancers.
    Heart failure reviews, 2007, Volume: 12, Issue:2

    Topics: Algorithms; Cardiotonic Agents; Dobutamine; Dopamine; Heart Failure; Humans; Hydrazones; Milrinone; Practice Guidelines as Topic; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Treatment Outcome

2007
[Catecholamines--characteristics, mechanisms of action, pharmacokinetics, indications, contraindications, clinical trials, and side effects].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, May-28, Volume: 65 Suppl 5

    Topics: Acute Disease; Cardiotonic Agents; Catecholamines; Clinical Trials as Topic; Contraindications; Dobutamine; Dopamine; Heart Failure; Humans; Norepinephrine

2007
[Catecholamines use in patients with heart failure].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, May-28, Volume: 65 Suppl 5

    Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Epinephrine; Heart Failure; Humans; Norepinephrine

2007
[Combination therapy with PDE III inhibitor for heart failure].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, May-28, Volume: 65 Suppl 5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Chronic Disease; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Hydrazones; Milrinone; Phosphodiesterase Inhibitors; Pyridazines; Simendan

2007
The role of diuretics and inotropic therapy in failure associated with myocardial infarction.
    Archives internationales de physiologie et de biochimie, 1984, Volume: 92, Issue:4

    Topics: Acute Disease; Blood Pressure; Cardiac Complexes, Premature; Cardiotonic Agents; Chronic Disease; Digoxin; Diuretics; Dobutamine; Heart Failure; Hemodynamics; Humans; Isoproterenol; Myocardial Infarction

1984
Newer inotropic agents.
    Methods and findings in experimental and clinical pharmacology, 1984, Volume: 6, Issue:4

    Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Ethanolamines; Heart Failure; Humans; Practolol; Prenalterol; Receptors, Adrenergic, beta

1984
[Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
    Vrachebnoe delo, 1983, Issue:10

    Topics: Adrenergic beta-Agonists; Captopril; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Isoproterenol; Isosorbide Dinitrate; Nitroprusside; Nonachlazine; Phentolamine; Practolol; Prazosin; Prenalterol; Vasodilator Agents

1983
[Catecholamines in the therapy of chronic cardiac insufficiency].
    Wiener medizinische Wochenschrift (1946), 1982, Oct-15, Volume: 132, Issue:19

    Topics: Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Epinephrine; Heart Failure; Humans; Isoproterenol; Metaproterenol; Myocardial Contraction; Norepinephrine; Practolol; Prenalterol; Receptors, Adrenergic, alpha; Vasoconstriction; Vasodilation

1982
Congestive heart failure in childhood and adolescence: recognition and management.
    American heart journal, 1983, Volume: 105, Issue:3

    Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Electrocardiography; Endocarditis, Bacterial; Furosemide; Heart; Heart Defects, Congenital; Heart Diseases; Heart Failure; Humans; Hydralazine; Isoproterenol; Nitroprusside; Physical Examination; Radionuclide Imaging; Rheumatic Heart Disease

1983
[Currently used positive inotropic substances].
    Therapeutische Umschau. Revue therapeutique, 1984, Volume: 41, Issue:2

    Topics: Cardiotonic Agents; Chemical Phenomena; Chemistry; Coronary Disease; Dobutamine; Dopamine; Epinephrine; Heart Failure; Hemodynamics; Humans; Isoproterenol; Norepinephrine

1984
Assessment of vasodilatation in man.
    Bibliotheca cardiologica, 1984, Issue:38

    Topics: Arterioles; Blood Pressure; Dobutamine; Heart Failure; Humans; Microcirculation; Nitroprusside; Pressoreceptors; Regional Blood Flow; Vascular Resistance; Vasodilation

1984
Dobutamine in heart failure.
    European heart journal, 1982, Volume: 3 Suppl D

    Topics: Catecholamines; Digoxin; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Nitroprusside; Oxygen Consumption

1982
Vasodilator therapy of congestive heart failure.
    Advances in internal medicine, 1980, Volume: 26

    Topics: Aortic Valve Insufficiency; Captopril; Dobutamine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Mitral Valve Insufficiency; Nitroglycerin; Nitroprusside; Phentolamine; Physical Exertion; Piperazines; Prazosin; Quinazolines; Time Factors; Vasodilator Agents

1980
The role of vasodilating agents in the treatment of chronic heart failure.
    Angiology, 1980, Volume: 31, Issue:8

    Topics: Cardiac Output; Chronic Disease; Dobutamine; Heart Failure; Humans; Muscle Contraction; Nitroprusside; Phentolamine; Prazosin; Pulmonary Edema; Vascular Resistance; Vasodilator Agents

1980
Creative solutions: home dobutamine infusions.
    AACN clinical issues, 1995, Volume: 6, Issue:3

    Topics: Dobutamine; Heart Failure; Home Infusion Therapy; Humans; Patient Care Planning

1995
Critical care management of the heart failure patient in the home.
    Critical care nursing quarterly, 1995, Volume: 18, Issue:1

    Topics: Aged; Critical Care; Dobutamine; Heart Failure; Home Care Services; Humans; Male

1995
[Dopexamine: a new dopaminergic agonist].
    Annales francaises d'anesthesie et de reanimation, 1993, Volume: 12, Issue:3

    Topics: Adrenergic Agonists; Animals; Dobutamine; Dogs; Dopamine; Glomerular Filtration Rate; Heart; Heart Conduction System; Heart Failure; Hemodynamics; Humans; Natriuresis; Rats; Receptors, Dopamine; Shock, Septic; Splanchnic Circulation

1993
[Neurohormonal compensation processes in chronic heart failure: the effect of drugs].
    Nederlands tijdschrift voor geneeskunde, 1994, Jun-11, Volume: 138, Issue:24

    Topics: Adrenergic beta-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Deoxyepinephrine; Diuretics; Dobutamine; Heart Failure; Humans; Receptors, Cell Surface; Renin-Angiotensin System; Sympathetic Nervous System

1994
[Tendency of development on novel type of cardiotonic drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 1993, Volume: 51, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Amrinone; Animals; Calcium; Catechols; Dobutamine; Dopamine; Fatty Alcohols; Heart Failure; Humans; Pyridazines; Troponin

1993
[Intermittent infusions of dobutamine in the treatment of chronic cardiac failure in the terminal stage].
    Annales de cardiologie et d'angeiologie, 1993, Volume: 42, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged

1993
Nicardipine in heart failure: distinguishing its acute beneficial from its chronic effects.
    Minerva cardioangiologica, 1993, Volume: 41, Issue:11

    Topics: Acute Disease; Calcium Channel Blockers; Chronic Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Nicardipine; Renin-Angiotensin System; Time Factors

1993
[Application of non-glycoside inotropic agents in newborn infants].
    Tijdschrift voor kindergeneeskunde, 1993, Volume: 61, Issue:1

    Topics: Cardiotonic Agents; Dobutamine; Dopamine; Heart Failure; Humans; Infant, Newborn; Infant, Newborn, Diseases; Isoproterenol; Myocardial Contraction; Oxygen; Oxygen Consumption

1993
Inotropic therapy for the failing myocardium.
    Clinical cardiology, 1995, Volume: 18, Issue:11

    Topics: Adrenergic beta-Agonists; Cardiac Output; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Vasodilator Agents; Ventricular Dysfunction, Left

1995
[Terminal heart failure; therapeutic strategies. Drug therapy in cases of absence of possibility of heart transplantation: dobutamine therapy, aspects of compassion?].
    Archives des maladies du coeur et des vaisseaux, 1996, Volume: 89 Spec No 6

    Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Dobutamine; Heart Failure; Hemofiltration; Humans; Infusions, Intravenous; Phosphodiesterase Inhibitors; Quality of Life; Terminal Care; Vasodilator Agents

1996
Reversed ventilation-perfusion mismatch involving a pediatric patient in congestive heart failure.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:11

    Topics: Adolescent; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Lung; Male; Milrinone; Pulmonary Circulation; Pulmonary Ventilation; Pyridones; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Ventilation-Perfusion Ratio

1997
Use of intravenous inotropic therapy in the home.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, May-01, Volume: 55, Issue:9

    Topics: Amrinone; Cardiotonic Agents; Dobutamine; Heart Failure; Home Infusion Therapy; Humans; Infusions, Intravenous; Milrinone; Pyridones

1998
Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?
    European journal of heart failure, 2000, Volume: 2, Issue:1

    Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Critical Care; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Intensive Care Units; Phosphodiesterase Inhibitors

2000
Outpatient parenteral inotropic therapy for advanced heart failure.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2000, Volume: 19, Issue:8 Suppl

    Topics: Adrenergic beta-Agonists; Aged; Ambulatory Care; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Prognosis; Severity of Illness Index; Survival Rate; Treatment Outcome

2000
[Evaluation of hibernating myocardium in patients with heart insufficiency].
    Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2000, Volume: 1, Issue:10

    Topics: Cardiotonic Agents; Coronary Circulation; Dobutamine; Heart Failure; Heart Function Tests; Humans; Myocardial Contraction; Myocardial Revascularization; Myocardial Stunning; Prognosis; Tomography, Emission-Computed; Ultrasonography, Doppler; Ventricular Dysfunction, Left

2000
Cardiovascular phenotype characterization in mice by high resolution magnetic resonance imaging.
    Magma (New York, N.Y.), 2000, Volume: 11, Issue:1-2

    Topics: Adrenergic beta-Agonists; Animals; Cardiovascular Physiological Phenomena; Cardiovascular System; Disease Models, Animal; Dobutamine; Heart Failure; Humans; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Phenotype; Ventricular Function, Left

2000
[Anesthesia for heart transplantation].
    Revista espanola de anestesiologia y reanimacion, 2001, Volume: 48, Issue:10

    Topics: Anesthesia, General; Animals; Cardiovascular Agents; Combined Modality Therapy; Dobutamine; Forecasting; Heart Failure; Heart Transplantation; Heart-Assist Devices; Hemodynamics; Humans; Phosphodiesterase Inhibitors; Preanesthetic Medication; Preoperative Care; Swine; Tissue and Organ Procurement; Transplantation, Heterologous; Transplantation, Homologous

2001
Dobutamine: a new synthetic cardioactive sympathetic amine.
    The New England journal of medicine, 1979, Jan-04, Volume: 300, Issue:1

    Topics: Animals; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Myocardial Infarction; Sympathomimetics

1979
Exercise and the heart.
    Australian and New Zealand journal of medicine, 1992, Volume: 22, Issue:5 Suppl

    Topics: Blood Pressure; Dobutamine; Exercise Therapy; Heart Diseases; Heart Failure; Humans; Hypertension; Myocardial Infarction; Risk

1992
[Treatment of chronic heart insufficiency with dobutamine. Value and limitations].
    Presse medicale (Paris, France : 1983), 1992, Oct-24, Volume: 21, Issue:35

    Topics: Chronic Disease; Dobutamine; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous

1992
Outpatient dobutamine therapy: the rhyme and the riddle.
    Journal of clinical pharmacology, 1992, Volume: 32, Issue:2

    Topics: Ambulatory Care; Arrhythmias, Cardiac; Cardiomyopathies; Dobutamine; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Oxygen Consumption

1992
Long-term dobutamine therapy for refractory congestive heart failure.
    Clinical pharmacy, 1992, Volume: 11, Issue:7

    Topics: Dobutamine; Heart Failure; Humans

1992
Changing strategies in the management of chronic congestive heart failure.
    DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:12

    Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Phosphodiesterase Inhibitors; Receptors, Adrenergic, beta

1991
[Physiological bases and therapeutic uses of inodilator drugs].
    La Clinica terapeutica, 1991, Jan-31, Volume: 136, Issue:2

    Topics: Amrinone; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Sympathomimetics; Vasodilator Agents

1991
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
    Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83, Issue:2

    Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol

1990
Pharmacology of modalities of treatment.
    The Canadian journal of cardiology, 1990, Volume: 6 Suppl C

    Topics: Adrenergic beta-Antagonists; Digitalis Glycosides; Diuretics; Dobutamine; Heart Failure; Humans; Vasodilator Agents

1990
[Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
    Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83 Spec No 3

    Topics: Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Myocardial Contraction; Vasodilation

1990
Is intermittent dobutamine infusion useful in the treatment of patients with refractory congestive heart failure?
    Cardiovascular clinics, 1990, Volume: 21, Issue:1

    Topics: Dobutamine; Drug Administration Schedule; Heart Failure; Heart Ventricles; Humans; Infusions, Intravenous

1990
The role of novel inotropic agents in the treatment of heart failure.
    Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 9

    Topics: Amrinone; Animals; Cardiotonic Agents; Dobutamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Physical Exertion; Pyridazines; Pyridones; Time Factors

1986
The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
    Journal of clinical pharmacology, 1989, Volume: 29, Issue:3

    Topics: Benzazepines; Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine

1989
Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?
    Basic research in cardiology, 1989, Volume: 84 Suppl 1

    Topics: Adrenergic Agonists; Animals; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Nitroprusside

1989
Dopamine and dobutamine in pediatric therapy.
    Pharmacotherapy, 1989, Volume: 9, Issue:5

    Topics: Child; Child, Preschool; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn; Shock

1989
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
    The New England journal of medicine, 1986, Jan-30, Volume: 314, Issue:5

    Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Calcium; Cardiotonic Agents; Cyclic AMP; Dobutamine; Dopamine; Drug Tolerance; Glucagon; Heart Failure; Histamine; Humans; Levodopa; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Receptors, Adrenergic; Receptors, Adrenergic, beta; Stimulation, Chemical; Sympathomimetics; Theophylline; Xanthines

1986
Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure.
    The American journal of medicine, 1986, Feb-28, Volume: 80, Issue:2B

    Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; Guinea Pigs; Heart Failure; Heart Rate; Heart Ventricles; Humans; Isoproterenol; Metoprolol; Myocardial Contraction; Norepinephrine; Propranolol; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Cell Surface; Receptors, Glucagon; Receptors, Histamine H2

1986
Some new positive inotropic agents.
    Acta medica Scandinavica. Supplementum, 1986, Volume: 707

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Drug Tolerance; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practolol; Prenalterol; Pyridones

1986
Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Circulation, 1986, Volume: 73, Issue:3 Pt 2

    Topics: Administration, Oral; Animals; Cardiomyopathies; Cardiotonic Agents; Dobutamine; Dogs; Enoximone; Heart Failure; Heart Rate; Hemodynamics; Hormones; Humans; Imidazoles; Injections, Intravenous; Kinetics; Lactates; Myocardial Contraction; Time Factors; Vasodilation

1986
[Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
    Deutsche medizinische Wochenschrift (1946), 1985, Apr-12, Volume: 110, Issue:15

    Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Renal Circulation; Shock, Cardiogenic; Vascular Resistance; Vasodilation

1985
Digitalis and other positive catecholamine-like inotropic agents in the management of congestive heart failure.
    The American journal of medicine, 1986, Feb-28, Volume: 80, Issue:2B

    Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Glycosides; Cardiotonic Agents; Digitalis Glycosides; Digoxin; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Middle Aged; Myocardial Contraction; Random Allocation; Risk; Sodium-Potassium-Exchanging ATPase; Stroke Volume

1986
Congestive heart failure.
    The Medical clinics of North America, 1986, Volume: 70, Issue:4

    Topics: Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Milrinone; Nitrates; Nitroprusside; Prazosin; Pyridones; Sympathomimetics; Vasodilator Agents

1986
Review of intermittent dobutamine infusions for congestive cardiomyopathy.
    Pharmacotherapy, 1987, Volume: 7, Issue:2

    Topics: Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Outpatients

1987
The pharmacology of dobutamine.
    The American journal of the medical sciences, 1987, Volume: 294, Issue:4

    Topics: Dobutamine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction

1987
Persistent pulmonary hypertension of the newborn.
    American heart journal, 1986, Volume: 111, Issue:3

    Topics: Animals; Cardiomyopathies; Catheterization; Diagnosis, Differential; Disease Models, Animal; Dobutamine; Echocardiography; Heart Failure; Humans; Hyperventilation; Infant, Newborn; Muscle Development; Muscle, Smooth, Vascular; Persistent Fetal Circulation Syndrome; Positive-Pressure Respiration; Pulmonary Circulation; Tolazoline

1986
Use of intermittent dobutamine infusion in congestive heart failure.
    Drug intelligence & clinical pharmacy, 1986, Volume: 20, Issue:12

    Topics: Dobutamine; Heart Failure; Humans; Infusions, Intravenous

1986
[Pump failure syndrome].
    Revista medica de Chile, 1985, Volume: 113, Issue:4

    Topics: Cardiac Output; Catecholamines; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Nitroprusside

1985

Trials

137 trial(s) available for dobutamine and Cardiac Failure

ArticleYear
The use of peripherally inserted central catheter reduced the incidence of phlebitis in heart failure patients: A randomized trial.
    The journal of vascular access, 2023, Volume: 24, Issue:5

    Topics: Catheterization, Central Venous; Catheterization, Peripheral; Catheters, Indwelling; Central Venous Catheters; Dobutamine; Heart Failure; Humans; Incidence; Middle Aged; Phlebitis; Retrospective Studies

2023
Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial.
    Journal of the American Heart Association, 2018, 08-21, Volume: 7, Issue:16

    Topics: Aged; Cardio-Renal Syndrome; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamic Monitoring; Hemodynamics; Humans; Male; Middle Aged; p-Aminohippuric Acid; Renal Circulation; Renal Insufficiency; Renal Plasma Flow; Simendan

2018
Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2019, 09-20, Volume: 15, Issue:7

    Topics: Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Heart-Assist Devices; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Treatment Outcome

2019
Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levels.
    BMC cardiovascular disorders, 2014, Mar-04, Volume: 14

    Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Blood Pressure; Cardiotonic Agents; China; Dobutamine; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Natriuretic Peptide, Brain; Recombinant Proteins; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left

2014
Short-term add-on therapy with angiotensin receptor blocker for end-stage inotrope-dependent heart failure patients: B-type natriuretic peptide reduction in a randomized clinical trial.
    Clinics (Sao Paulo, Brazil), 2014, Volume: 69, Issue:5

    Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Cardiac Output, Low; Dobutamine; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Time Factors; Treatment Outcome

2014
Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Cardiology journal, 2015, Volume: 22, Issue:1

    Topics: Aged; Biomarkers; Cardiotonic Agents; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Pyridazines; Recovery of Function; Simendan; Stroke Volume; Systole; Time Factors; Treatment Outcome; Turkey; Ventricular Dysfunction, Left; Ventricular Function, Left

2015
Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2015, Volume: 16, Issue:9

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged

2015
Global myocardial contractile reserve assessed by high-dose dobutamine stress echocardiography predicts response to the cardiac resynchronization therapy.
    Echocardiography (Mount Kisco, N.Y.), 2015, Volume: 32, Issue:3

    Topics: Cardiac Resynchronization Therapy; Dobutamine; Echocardiography, Stress; Exercise Test; Female; Fractional Flow Reserve, Myocardial; Heart Failure; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left

2015
Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
    Circulation. Heart failure, 2015, Volume: 8, Issue:3

    Topics: Adrenergic beta-1 Receptor Agonists; Aged; Aged, 80 and over; Arterial Pressure; Diagnostic Techniques, Cardiovascular; Dobutamine; Female; Heart Failure; Humans; Hypertension, Pulmonary; Infusions, Parenteral; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Artery; Stroke Volume; Vasodilation; Ventricular Dysfunction, Right; Ventricular Function, Left; Ventricular Function, Right

2015
Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.
    Anatolian journal of cardiology, 2015, Volume: 15, Issue:8

    Topics: Adolescent; Adult; Aged; Biomarkers; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyridazines; Serum Albumin; Serum Albumin, Human; Simendan; Treatment Outcome; Turkey; Young Adult

2015
Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patients.
    International journal of cardiology, 2016, Jul-15, Volume: 215

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Dobutamine; Drug Therapy, Combination; Female; Finland; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Proportional Hazards Models; Pyridazines; Retrospective Studies; Simendan; Survival Analysis; Treatment Outcome

2016
Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Cardiovascular therapeutics, 2008,Fall, Volume: 26, Issue:3

    Topics: Adrenergic beta-Antagonists; Blood Pressure; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Propanolamines; Pyridazines; Simendan; Time Factors; Treatment Outcome

2008
Effects of levosimendan on left atrial functions in patients with ischemic heart failure.
    Clinical cardiology, 2008, Volume: 31, Issue:12

    Topics: Aged; Atrial Function, Left; Blood Pressure; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Myocardial Ischemia; Pyridazines; Simendan; Stroke Volume; Ventricular Function, Left; Ventricular Pressure

2008
Behavior of B-type natriuretic peptide during mechanical ventilation and spontaneous breathing after extubation.
    Minerva anestesiologica, 2009, Volume: 75, Issue:4

    Topics: Adult; Aged; Biomarkers; Cell Size; Critical Illness; Dobutamine; Dyspnea; Female; Heart Failure; Humans; Intensive Care Units; Male; Middle Aged; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Respiration, Artificial; Sensitivity and Specificity; Ventilator Weaning; Ventricular Dysfunction, Left; Water-Electrolyte Balance

2009
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.
    European journal of heart failure, 2009, Volume: 11, Issue:3

    Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Cause of Death; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Simendan; Stroke Volume; Survival Rate; Treatment Outcome

2009
Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure.
    Heart and vessels, 2009, Volume: 24, Issue:1

    Topics: Aged; Cardiotonic Agents; Diastole; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Simendan; Stroke Volume; Systole; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Right

2009
The costs of treating acute heart failure: an economic analysis of the SURVIVE trial.
    Journal of medical economics, 2008, Volume: 11, Issue:3

    Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Female; Health Expenditures; Heart Failure; Humans; Hydrazones; Length of Stay; Male; Middle Aged; Patient Admission; Pyridazines; Simendan

2008
Usefulness and limitation of dobutamine stress echocardiography to predict acute response to cardiac resynchronization therapy.
    Echocardiography (Mount Kisco, N.Y.), 2010, Volume: 27, Issue:1

    Topics: Cardiac Pacing, Artificial; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left

2010
Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
    The Canadian journal of cardiology, 2009, Volume: 25, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Atrial Function, Left; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan; Single-Blind Method; Treatment Outcome; Young Adult

2009
The effect of dobutamine without and with L-arginine on arterial compliance in heart failure patients.
    Echocardiography (Mount Kisco, N.Y.), 2009, Volume: 26, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Arginine; Brachial Artery; Dobutamine; Drug Therapy, Combination; Elastic Modulus; Elasticity Imaging Techniques; Female; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome; Vascular Resistance; Vasodilator Agents

2009
Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
    European journal of heart failure, 2010, Volume: 12, Issue:4

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Analysis of Variance; Antihypertensive Agents; Cardiotonic Agents; Confidence Intervals; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Myocardial Perfusion Imaging; Natriuretic Peptide, Brain; Odds Ratio; Perfusion; Pulmonary Wedge Pressure; Pyridazines; Simendan; Vasodilator Agents

2010
[Is it necessary to suspend betablockers in decompensated heart failure with low output?].
    Arquivos brasileiros de cardiologia, 2010, Volume: 95, Issue:4

    Topics: Adrenergic beta-Antagonists; Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Prospective Studies; Withholding Treatment

2010
[Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
    Zhonghua xin xue guan bing za zhi, 2010, Volume: 38, Issue:6

    Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Injections, Intravenous; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome

2010
Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure.
    Arquivos brasileiros de cardiologia, 2010, Volume: 95, Issue:6

    Topics: Aged; Cardiotonic Agents; Chi-Square Distribution; Dobutamine; Female; Heart Conduction System; Heart Failure; Humans; Hydrazones; Male; Muscle Contraction; Pyridazines; Simendan; Statistics, Nonparametric

2010
[Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2010, Volume: 38, Issue:5

    Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiotonic Agents; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Parenteral; Male; Middle Aged; Pyridazines; Risk Factors; Simendan; Tachycardia, Ventricular; Ventricular Premature Complexes

2010
Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial.
    Critical care medicine, 2011, Volume: 39, Issue:5

    Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiotonic Agents; Confidence Intervals; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Hospital Mortality; Humans; Hydrazones; Infusions, Intravenous; International Cooperation; Kaplan-Meier Estimate; Male; Middle Aged; Patient Discharge; Proportional Hazards Models; Pyridazines; Reference Values; Risk Assessment; Severity of Illness Index; Simendan; Survival Analysis; Treatment Outcome

2011
Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure.
    Circulation. Arrhythmia and electrophysiology, 2012, Volume: 5, Issue:1

    Topics: Cardiotonic Agents; Disease Progression; Dobutamine; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Prognosis; Prospective Studies; Tachycardia, Ventricular

2012
[The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2012, Volume: 12, Issue:1

    Topics: Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Prospective Studies; Pyridazines; Simendan; Treatment Outcome

2012
Acute effect of sildenafil on central hemodynamics in mechanically ventilated patients with WHO group III pulmonary hypertension and right ventricular failure necessitating administration of dobutamine.
    International journal of cardiology, 2013, Aug-10, Volume: 167, Issue:3

    Topics: Adrenergic beta-1 Receptor Agonists; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Purines; Respiration, Artificial; Sildenafil Citrate; Sulfones; Time Factors; Treatment Outcome; Ventricular Dysfunction, Right

2013
[Hemodynamic and efficacies of domestic levosimendan versus dobutamine in patients with acute decompensated heart failure].
    Zhonghua yi xue za zhi, 2012, Feb-28, Volume: 92, Issue:8

    Topics: Adolescent; Adult; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome; Young Adult

2012
[Comparison on efficacy and safety between domestic levosimendan versus dobutamine for patients with acute decompensated heart failure].
    Zhonghua xin xue guan bing za zhi, 2012, Volume: 40, Issue:2

    Topics: Aged; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome

2012
Effect of short-term infusive dobutamine therapy on thyroid hormone profile and hemodynamic parameters in patients with acute worsening heart failure and low-triiodothyronine syndrome.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2012, Volume: 60, Issue:6

    Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Euthyroid Sick Syndromes; Heart Failure; Hemodynamics; Humans; Thyroid Hormones; Time Factors; Triiodothyronine

2012
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Journal of the American College of Cardiology, 2002, Oct-02, Volume: 40, Issue:7

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Angiography; Severity of Illness Index; Time Factors; Treatment Outcome

2002
Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
    American heart journal, 2002, Volume: 144, Issue:6

    Topics: Aged; Cardiotonic Agents; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Tachycardia, Ventricular

2002
Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
    European journal of heart failure, 2003, Volume: 5, Issue:1

    Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Double-Blind Method; Europe; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Length of Stay; Life Expectancy; Male; Middle Aged; Patient Admission; Pyridazines; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Simendan; Survival Analysis; Treatment Outcome

2003
Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
    American heart journal, 2003, Volume: 145, Issue:2 Suppl

    Topics: Cardiotonic Agents; Disease Progression; Dobutamine; Double-Blind Method; Endpoint Determination; Heart Failure; Hospitalization; Humans; Multicenter Studies as Topic; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Selection; Pilot Projects; Randomized Controlled Trials as Topic; Troponin I; Troponin T

2003
Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
    American heart journal, 2003, Volume: 145, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Drug Costs; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Prospective Studies; Statistics as Topic

2003
Neurohumoral activation and ventricular arrhythmias in patients with decompensated congestive heart failure: role of endothelin.
    Pacing and clinical electrophysiology : PACE, 2003, Volume: 26, Issue:3

    Topics: Arrhythmias, Cardiac; Cardiotonic Agents; Cytokines; Dobutamine; Electrocardiography, Ambulatory; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Natriuretic Agents; Natriuretic Peptide, Brain; Neurotransmitter Agents; Ventricular Premature Complexes

2003
Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.
    Heart (British Cardiac Society), 2003, Volume: 89, Issue:6

    Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Cross-Over Studies; Dobutamine; Dopamine; Echocardiography, Stress; Heart Failure; Humans; Metoprolol; Middle Aged; Propanolamines; Single-Blind Method; Treatment Outcome

2003
Comparison of the effects of dobutamine and nesiritide (B-type natriuretic peptide) on ventricular ectopy in acutely decompensated ischemic versus nonischemic cardiomyopathy.
    The American journal of cardiology, 2003, Jun-01, Volume: 91, Issue:11

    Topics: Aged; Arrhythmias, Cardiac; Cardiomyopathies; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Agents; Natriuretic Peptide, Brain; Prospective Studies; Treatment Outcome; Ventricular Premature Complexes

2003
Therapeutic implications of contractile reserve elicited by dobutamine echocardiography in symptomatic, low-gradient aortic stenosis.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2003, Volume: 4, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Dobutamine; Echocardiography, Stress; Feasibility Studies; Female; Heart Failure; Humans; Male; Middle Aged; Mortality; Myocardial Contraction; Survival Analysis; Ventricular Dysfunction, Left

2003
Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study.
    Journal of medicine, 2002, Volume: 33, Issue:1-4

    Topics: Aged; Cardiotonic Agents; Cross-Over Studies; Dobutamine; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Pilot Projects; Quality of Life; Time Factors

2002
Dobutamine potentiates the peripheral chemoreflex in patients with congestive heart failure.
    Journal of cardiac failure, 2003, Volume: 9, Issue:5

    Topics: Adult; Aged; Chemoreceptor Cells; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hypoxia; Male; Middle Aged; Pulmonary Ventilation

2003
Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy.
    Cardiovascular ultrasound, 2003, Sep-25, Volume: 1

    Topics: Adrenergic beta-Antagonists; Chronic Disease; Dobutamine; Echocardiography; Enoximone; Exercise Test; Female; Heart Failure; Humans; Image Enhancement; Male; Middle Aged; Myocardial Infarction; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left

2003
Peripheral sympathetic control during dobutamine infusion: effects of aging and heart failure.
    Journal of the American College of Cardiology, 2003, Nov-05, Volume: 42, Issue:9

    Topics: Adrenergic beta-Agonists; Age Factors; Blood Pressure; Dobutamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Pressoreceptors; Sympathetic Nervous System; Vasodilation

2003
Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2003, Volume: 4 Suppl 2

    Topics: Adrenergic beta-Agonists; Calcium Channels, L-Type; Cardiac Output, Low; Cardiotonic Agents; Death, Sudden, Cardiac; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Morbidity; Myocardial Contraction; Pulmonary Wedge Pressure; Pyridazines; Risk Factors; Severity of Illness Index; Shock, Cardiogenic; Simendan; Stroke Volume; Survival Analysis; Time; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left

2003
Prognostic usefulness of echocardiographic dobutamine in younger (14 to 25 years) and older (40 to 55 years) patients with idiopathic dilated cardiomyopathy.
    The American journal of cardiology, 2004, Jan-15, Volume: 93, Issue:2

    Topics: Adolescent; Adult; Age Factors; Cardiomyopathy, Dilated; Cardiotonic Agents; Case-Control Studies; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Humans; Male; Middle Aged; Oxygen Consumption; Prognosis; Prospective Studies; Risk Factors

2004
Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
    Clinical cardiology, 2004, Volume: 27, Issue:1

    Topics: Aged; Ambulatory Care; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Hospice Care; Humans; Infusions, Intravenous; Male; Milrinone; Needs Assessment; New York; Palliative Care; Patient Acceptance of Health Care; Quality of Life; Terminally Ill

2004
Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study.
    Chest, 2004, Volume: 125, Issue:4

    Topics: Administration, Oral; Amiodarone; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Survival Rate; Vasodilator Agents

2004
Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    American heart journal, 2004, Volume: 148, Issue:5

    Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Sympathomimetics

2004
Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure.
    American heart journal, 2004, Volume: 148, Issue:5

    Topics: Adrenergic beta-Agonists; Adult; Aged; Brachial Artery; Dobutamine; Drug Therapy, Combination; Endothelium, Vascular; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Prospective Studies; Ultrasonography; Vasodilation; Vasodilator Agents

2004
Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
    The American journal of cardiology, 2004, Nov-15, Volume: 94, Issue:10

    Topics: Administration, Oral; Cardiac Output; Cardiotonic Agents; Diuretics; Dobutamine; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Pyridazines; Simendan

2004
Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2004, Volume: 5, Issue:9

    Topics: Aged; Chronic Disease; Confidence Intervals; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Probability; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Survival Analysis; Tachycardia, Ventricular; Treatment Outcome

2004
The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine.
    European journal of heart failure, 2005, Volume: 7, Issue:5

    Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Interleukin-6; Male; Malondialdehyde; Middle Aged; Natriuretic Peptide, Brain; Oxidative Stress; Pyridazines; Simendan; Time Factors; Tumor Necrosis Factor-alpha

2005
Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:6

    Topics: Ascorbic Acid; Blood Pressure; Cardiotonic Agents; Dobutamine; Drug Combinations; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Treatment Outcome; Ventricular Dysfunction, Left

2005
Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    International journal of cardiology, 2006, Apr-04, Volume: 108, Issue:2

    Topics: Administration, Oral; Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Remodeling

2006
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
    Clinical science (London, England : 1979), 2006, Volume: 110, Issue:4

    Topics: Biomarkers; C-Reactive Protein; Cardiotonic Agents; Case-Control Studies; Cell Adhesion Molecules; Chemokine CCL2; Colorimetry; Cytokines; Dinoprost; Disease Progression; Dobutamine; E-Selectin; Enzyme-Linked Immunosorbent Assay; Exercise Test; Female; Heart Failure; Humans; Inflammation; Interleukin-18; Interleukin-6; Male; Middle Aged; Milrinone; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Tyrosine

2006
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.
    Pharmacotherapy, 2006, Volume: 26, Issue:1

    Topics: Cardiotonic Agents; Cost-Benefit Analysis; Decision Trees; Dobutamine; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Models, Economic; Models, Statistical; Monte Carlo Method; Natriuretic Agents; Natriuretic Peptide, Brain

2006
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    The American journal of cardiology, 2006, Jul-01, Volume: 98, Issue:1

    Topics: Aged; Apoptosis; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography; Fas Ligand Protein; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Interleukin-6; Male; Membrane Glycoproteins; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Pulmonary Wedge Pressure; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Tumor Necrosis Factor-alpha; Tumor Necrosis Factors

2006
Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
    International journal of cardiology, 2008, Jan-11, Volume: 123, Issue:2

    Topics: Aged; Cardiotonic Agents; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Pyridazines; Simendan; Single-Blind Method

2008
Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures.
    Circulation, 2007, Mar-20, Volume: 115, Issue:11

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aminoglycosides; Animals; Cardiac Catheterization; Cardiotonic Agents; Diastole; Dobutamine; Dogs; Echocardiography, Doppler; Enediynes; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Mitral Valve; Models, Cardiovascular; Predictive Value of Tests; Propanolamines; Pulmonary Wedge Pressure; Ventricular Function, Left; Ventricular Pressure

2007
Improvement in Doppler alternans in patients with severe heart failure: Levosimendan versus dobutamin.
    International journal of cardiology, 2008, Mar-28, Volume: 125, Issue:1

    Topics: Adult; Aged; Cardiotonic Agents; Dobutamine; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Ventricular Function, Left

2008
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
    JAMA, 2007, May-02, Volume: 297, Issue:17

    Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Simendan; Survival Analysis

2007
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
    Circulation, 2007, May-15, Volume: 115, Issue:19

    Topics: Cardiovascular Agents; Combined Modality Therapy; Cytokines; Dobutamine; Exercise Test; Exercise Tolerance; Female; Fibrosis; Heart Failure; Heart Function Tests; Heart Transplantation; Heart-Assist Devices; Humans; Hypertrophy; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Prospective Studies; Single-Blind Method; Stroke Volume; Treatment Outcome; Ultrasonography

2007
Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
    American heart journal, 2007, Volume: 153, Issue:6

    Topics: Cardiotonic Agents; Dobutamine; Double-Blind Method; Echocardiography; Eligibility Determination; Heart Failure; Heart Transplantation; Humans; Infusions, Intravenous; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Selection; Preoperative Care; Research Design; Sample Size; Severity of Illness Index; Survival Rate; Treatment Outcome

2007
Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    The American journal of cardiology, 2007, Jul-01, Volume: 100, Issue:1

    Topics: Adult; Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Female; Follow-Up Studies; Heart Conduction System; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Severity of Illness Index; Treatment Outcome; Ventricular Dysfunction, Left

2007
Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
    International journal of clinical practice, 2008, Volume: 62, Issue:2

    Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome; Ventricular Function, Right

2008
Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine.
    Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:6

    Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hydrazones; Kidney; Male; Middle Aged; Pyridazines; Simendan; Urination

2007
Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure.
    Arquivos brasileiros de cardiologia, 2007, Volume: 89, Issue:4

    Topics: Biomarkers; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Female; Furosemide; Heart Failure; Humans; Hypokalemia; Hyponatremia; Male; Middle Aged; Potassium; Renal Insufficiency; Saline Solution, Hypertonic; Severity of Illness Index; Sodium; Time Factors; Treatment Outcome; Urea

2007
Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.
    Circulation, 1984, Volume: 69, Issue:1

    Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Oxygen Consumption; Physical Exertion

1984
Drug-induced conditioning in congestive heart failure.
    Circulation, 1982, Volume: 65, Issue:7

    Topics: Adult; Aged; Ambulatory Care; Cardiac Output; Catecholamines; Dobutamine; Drug Administration Schedule; Female; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Random Allocation; Time Factors

1982
Sympathetic stimulations by exercise-stress testing and by dobutamine infusion induce similar changes in heart rate variability in patients with chronic heart failure.
    Clinical science (London, England : 1979), 1995, Volume: 89, Issue:2

    Topics: Aged; Blood Pressure; Chronic Disease; Cross-Over Studies; Dobutamine; Exercise; Exercise Test; Heart Failure; Heart Rate; Humans; Middle Aged; Reproducibility of Results; Sympathetic Nervous System

1995
Preliminary evidence for the mechanism underlying the development of tolerance to prazosin in congestive heart failure: the alpha-agonistic properties of dobutamine unmasked by prazosin treatment.
    Journal of cardiovascular pharmacology, 1993, Volume: 21, Issue:4

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prazosin; Up-Regulation; Vasodilator Agents

1993
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program.
    Pacing and clinical electrophysiology : PACE, 1995, Volume: 18, Issue:1 Pt 2

    Topics: Alprostadil; Angiotensin-Converting Enzyme Inhibitors; Death, Sudden, Cardiac; Digoxin; Dobutamine; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Life Tables; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome

1995
Changes in myocardial oxygen consumption and efficiency with heart failure therapy measured by 11C acetate PET.
    The Canadian journal of cardiology, 1995, Volume: 11, Issue:4

    Topics: Acetates; Animals; Carbon Radioisotopes; Cardiomyopathy, Dilated; Dobutamine; Heart Failure; Humans; Myocardium; Nitroprusside; Oxygen Consumption; Tomography, Emission-Computed

1995
Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure.
    Journal of the American College of Cardiology, 1995, Volume: 25, Issue:2

    Topics: Administration, Oral; Blood Flow Velocity; Cardiac Catheterization; Coronary Circulation; Diastole; Dobutamine; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isoquinolines; Male; Middle Aged; Phosphodiesterase Inhibitors; Tetrahydroisoquinolines; Ventricular Function, Left

1995
Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure.
    Lancet (London, England), 1995, Feb-11, Volume: 345, Issue:8946

    Topics: Aged; Dobutamine; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Lymphocytes; Male; Middle Aged; Norepinephrine; Receptors, Adrenergic, beta; Up-Regulation; Vascular Resistance

1995
A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
    Journal of the American Geriatrics Society, 1995, Volume: 43, Issue:3

    Topics: Aged; Aged, 80 and over; Amrinone; Analysis of Variance; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Prospective Studies; Treatment Outcome; Ventricular Function, Left

1995
[The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Revista espanola de cardiologia, 1994, Volume: 47, Issue:10

    Topics: Adult; Aged; Analysis of Variance; Dobutamine; Dopamine; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Nitroprusside; Phosphodiesterase Inhibitors; Pyridones

1994
Oral enoximone as a substitute for intravenous catecholamine support in end-stage congestive heart failure.
    European heart journal, 1994, Volume: 15, Issue:2

    Topics: Administration, Oral; Aged; Cardiac Output, Low; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged

1994
Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
    Critical care medicine, 1994, Volume: 22, Issue:7

    Topics: Alprostadil; Analysis of Variance; Chronic Disease; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Single-Blind Method; Time Factors

1994
[An outpatient study by stress echocardiography with dobutamine of myocardial function in patients with congestive heart failure (the first trial in Russia of the use of the dobutamine-echocardiography test)].
    Terapevticheskii arkhiv, 1993, Volume: 65, Issue:12

    Topics: Adult; Aged; Ambulatory Care; Dobutamine; Echocardiography, Doppler; Exercise Test; Heart; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Moscow; Myocardial Contraction

1993
Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial.
    European heart journal, 1993, Volume: 14, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Cardiac Output; Dobutamine; Double-Blind Method; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left

1993
Effects of dobutamine and/or nitroprusside on the pulmonary circulation in patients with pulmonary hypertension secondary to end-stage heart failure.
    Journal of cardiothoracic and vascular anesthesia, 1993, Volume: 7, Issue:3

    Topics: Blood Pressure; Cardiac Catheterization; Cardiac Output, Low; Dobutamine; Drug Combinations; Electrocardiography; Heart Failure; Heart Rate; Heart Transplantation; Humans; Hypertension, Pulmonary; Middle Aged; Nitroprusside; Pulmonary Artery; Pulmonary Circulation; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Ventricular Function, Right

1993
A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
    American heart journal, 1996, Volume: 132, Issue:2 Pt 1

    Topics: Cardiotonic Agents; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Middle Aged; Oxygen Consumption; Prospective Studies; Quinolones; Vascular Resistance; Vasodilator Agents; Ventricular Function, Left

1996
Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
    International journal of cardiology, 1995, Nov-10, Volume: 52, Issue:1

    Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Premedication; Prognosis; Prospective Studies; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Right

1995
Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
    Clinical cardiology, 1996, Volume: 19, Issue:1

    Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Echocardiography; Electrocardiography, Ambulatory; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Myocardial Infarction; Pyridones; Treatment Outcome

1996
Interleukin-6 correlates with hemodynamic impairment during dobutamine administration in chronic heart failure.
    International journal of cardiology, 1996, Dec-06, Volume: 57, Issue:2

    Topics: Adult; Chronic Disease; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Interleukin-6; Male; Middle Aged; Pilot Projects; Prognosis; Sensitivity and Specificity; Severity of Illness Index; Stroke Volume; Vascular Resistance

1996
Safety and clinical utility of long-term intravenous milrinone in advanced heart failure.
    The American journal of cardiology, 1997, Jul-01, Volume: 80, Issue:1

    Topics: Adult; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hypotension; Injections, Intravenous; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Prospective Studies; Pyridones; Survival Rate; Tachycardia, Supraventricular; Tachycardia, Ventricular; Thrombocytopenia; Treatment Outcome

1997
Low dose dobutamine echocardiography predicts improvement in functional capacity after exercise training in patients with ischemic cardiomyopathy: prognostic implication.
    Journal of the American College of Cardiology, 1998, Volume: 31, Issue:5

    Topics: Adult; Aged; Cardiotonic Agents; Dobutamine; Exercise Test; Exercise Therapy; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Stunning; Oxygen Consumption; Predictive Value of Tests; Prognosis; Ultrasonography; Ventricular Dysfunction, Left

1998
Dopamine and dobutamine have different effects on heart rate variability in patients with congestive heart failure.
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1998, Volume: 61, Issue:4

    Topics: Aged; Aged, 80 and over; Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Sympathomimetics

1998
Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.
    Clinical pharmacology and therapeutics, 1998, Volume: 63, Issue:6

    Topics: Adrenergic beta-Agonists; Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Humans; Injections, Intravenous; Male; Myocardial Ischemia; Severity of Illness Index; Survival Analysis; Treatment Outcome

1998
Saterinone, dobutamine, and sodium nitroprusside: comparison of cardiovascular profiles in patients with congestive heart failure.
    Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:4

    Topics: Adult; Aged; Antihypertensive Agents; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroprusside; Oxygen Consumption; Phosphodiesterase Inhibitors; Piperazines; Pyridones

1998
Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:4

    Topics: Alprostadil; Ambulatory Care; Antihypertensive Agents; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Disease Progression; Dobutamine; Epoprostenol; Female; Heart Failure; Heart Transplantation; Hospitalization; Humans; Infusions, Intravenous; Lung; Male; Middle Aged; Pilot Projects; Prospective Studies; Pulmonary Wedge Pressure; Risk Factors; Treatment Outcome; Vascular Resistance; Vasodilator Agents

1999
The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.
    International journal of cardiology, 1999, Apr-30, Volume: 69, Issue:1

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Tumor Necrosis Factor-alpha

1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).
    American heart journal, 1999, Volume: 138, Issue:1 Pt 1

    Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Risk; Severity of Illness Index; Survival Analysis; Treatment Outcome

1999
Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
    American heart journal, 1999, Volume: 138, Issue:2 Pt 1

    Topics: Adult; Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Treatment Outcome

1999
Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Japanese heart journal, 1999, Volume: 40, Issue:3

    Topics: Alprostadil; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Dobutamine; Endothelins; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prospective Studies; Renal Circulation; Vasodilator Agents

1999
Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
    Acta anaesthesiologica Scandinavica, 2000, Volume: 44, Issue:4

    Topics: Aged; Cardiotonic Agents; Catecholamines; Critical Illness; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Prospective Studies

2000
Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy.
    Circulation, 2000, Apr-25, Volume: 101, Issue:16

    Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Volume; Cardiomyopathy, Dilated; Diastole; Dobutamine; Energy Metabolism; Enzyme Inhibitors; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Oxygen Consumption; Pulmonary Wedge Pressure; Systole

2000
Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
    Chest, 2000, Volume: 117, Issue:6

    Topics: Adult; Aged; Alprostadil; Ambulatory Care; Cardiotonic Agents; Dobutamine; Endothelin-1; Endothelins; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Long-Term Care; Male; Middle Aged; Prognosis; Prospective Studies; Protein Precursors; Survival Rate; Vascular Resistance; Vasodilator Agents

2000
Effect of diabetes mellitus on heart rate variability in patients with congestive heart failure.
    Pacing and clinical electrophysiology : PACE, 2001, Volume: 24, Issue:1

    Topics: Atrial Natriuretic Factor; Cardiotonic Agents; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Signal Processing, Computer-Assisted

2001
Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure.
    Chest, 2001, Volume: 119, Issue:4

    Topics: Administration, Oral; Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Creatinine; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pulmonary Wedge Pressure; Sodium; Stroke Volume; Survival Rate

2001
Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy.
    The American journal of cardiology, 2001, Jul-01, Volume: 88, Issue:1

    Topics: Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Natriuretic Peptide, Brain; Statistics, Nonparametric; Tachycardia, Ventricular; Treatment Outcome

2001
A pilot safety trial of prolonged (48 h) infusion of the dual endothelin-receptor antagonist tezosentan in patients with advanced heart failure.
    Chest, 2001, Volume: 120, Issue:2

    Topics: Acute Disease; Aged; Dobutamine; Double-Blind Method; Drug Tolerance; Echocardiography, Doppler; Endothelin Receptor Antagonists; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Pyridines; Safety; Tetrazoles

2001
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.
    Journal of the American College of Cardiology, 2002, Mar-06, Volume: 39, Issue:5

    Topics: Acute Disease; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Cardiotonic Agents; Dobutamine; Female; Health Care Costs; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Readmission; Prospective Studies; Survival Rate; Time Factors; Treatment Outcome

2002
Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
    Circulation, 1977, Volume: 55, Issue:2

    Topics: Aged; Blood Gas Analysis; Blood Pressure; Cardiac Output; Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Drug Evaluation; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Pulmonary Circulation; Vascular Resistance

1977
Comparison of dobutamine and dopamine in treatment of severe heart failure.
    British heart journal, 1977, Volume: 39, Issue:5

    Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Drug Evaluation; Heart Failure; Hemodynamics; Humans

1977
[Combined infusion of nitroprusside and dobutamine in the treatment of severe congestive heart failure (author's transl)].
    Klinische Wochenschrift, 1979, Sep-03, Volume: 57, Issue:17

    Topics: Adult; Catecholamines; Coronary Disease; Dobutamine; Drug Synergism; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Humans; Infusions, Parenteral; Male; Middle Aged; Nitroprusside

1979
[Dopamine and dobutamine in the treatment of severe cardiac failure (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1978, Dec-01, Volume: 103, Issue:48

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Dopamine; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Oxygen Consumption; Pulmonary Circulation; Pulmonary Edema; Stroke Volume

1978
Modulation of inotropic therapy by venodilation in acute heart failure: a randomised comparison of four inotropic agents, alone and combined with isosorbide dinitrate.
    Journal of cardiovascular pharmacology, 1992, Volume: 19, Issue:1

    Topics: Adult; Aged; Amrinone; Cardiotonic Agents; Digoxin; Dobutamine; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Prenalterol; Prospective Studies; Single-Blind Method; Vasodilation

1992
The renal effects of dopamine and dobutamine in stable chronic heart failure.
    Postgraduate medical journal, 1992, Volume: 68 Suppl 2

    Topics: Aged; Chronic Disease; Diuresis; Dobutamine; Dopamine; Drug Interactions; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Kidney; Male; Middle Aged; Single-Blind Method

1992
Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.
    Cardiovascular drugs and therapy, 1992, Volume: 6, Issue:4

    Topics: Adult; Aged; Blood Pressure; Body Weight; Dobutamine; Drug Tolerance; Exercise Test; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Oxygen; Physical Exertion; Random Allocation

1992
Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure.
    Journal of cardiovascular pharmacology, 1990, Volume: 15, Issue:1

    Topics: Adult; Aged; Blood Pressure; Bucladesine; Cardiac Output; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Vascular Resistance

1990
[Hemodynamic effects of enoximone--comparative studies of heart surgery patients].
    Zeitschrift fur Kardiologie, 1991, Volume: 80 Suppl 4

    Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Drug Therapy, Combination; Enoximone; Epinephrine; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusion Pumps; Myocardial Contraction; Phosphodiesterase Inhibitors; Postoperative Complications

1991
[The effect of enoximone and catecholamines on renal function after open heart surgery].
    Zeitschrift fur Kardiologie, 1991, Volume: 80 Suppl 4

    Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Diuresis; Dobutamine; Enoximone; Heart Failure; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Imidazoles; Kidney Function Tests; Middle Aged; Myocardial Contraction; Phosphodiesterase Inhibitors; Postoperative Complications; Prospective Studies; Vascular Resistance

1991
[The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Zeitschrift fur Kardiologie, 1991, Volume: 80 Suppl 4

    Topics: Aged; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors

1991
Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    American heart journal, 1991, Volume: 121, Issue:6 Pt 2

    Topics: Adult; Aged; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pulmonary Wedge Pressure; Pyridones; Receptors, Adrenergic, beta; Stroke Volume; Time Factors

1991
Metolazone in treatment of severe refractory congestive cardiac failure.
    Lancet (London, England), 1990, Jan-06, Volume: 335, Issue:8680

    Topics: Aged; Aged, 80 and over; Body Weight; Clinical Trials as Topic; Diuresis; Diuretics; Dobutamine; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Male; Metolazone; Middle Aged; Prognosis

1990
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
    Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83, Issue:2

    Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol

1990
Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure.
    International journal of cardiology, 1991, Volume: 30, Issue:2

    Topics: Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Vasodilator Agents

1991
Piroximone, dobutamine and nitroprusside: comparative effects on haemodynamics in patients with congestive heart failure.
    European heart journal, 1991, Volume: 12, Issue:4

    Topics: Adult; Aged; Analysis of Variance; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside; Random Allocation

1991
[Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83 Spec No 3

    Topics: Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged

1990
[Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
    Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83 Spec No 3

    Topics: Adult; Aged; Angiography, Digital Subtraction; Cardiomyopathy, Dilated; Cardiotonic Agents; Cineangiography; Dobutamine; Enoximone; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Vasodilation

1990
[Enoximone in the hemodynamic evaluation before heart transplantation. A new test].
    Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83 Spec No 3

    Topics: Adult; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside

1990
Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.
    The American journal of cardiology, 1990, Nov-01, Volume: 66, Issue:15

    Topics: Adult; Amrinone; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Water-Electrolyte Balance

1990
Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Journal of cardiovascular pharmacology, 1989, Volume: 13, Issue:5

    Topics: Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Nitroprusside; Pulmonary Circulation; Pyridazines; Receptors, Adrenergic, beta; Stroke Volume; Time Factors; Vascular Resistance; Vasodilator Agents

1989
Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Journal of cardiovascular pharmacology, 1989, Volume: 14 Suppl 2

    Topics: Adult; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Chronic Disease; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Myocardial Contraction; Nitroprusside; Pulmonary Artery; Pulmonary Wedge Pressure; Pyridazines; Receptors, Adrenergic, beta; Stroke Volume; Time Factors; Vascular Resistance

1989
Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
    The American journal of cardiology, 1987, Aug-14, Volume: 60, Issue:5

    Topics: Aged; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Enoximone; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside

1987
[Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
    Deutsche medizinische Wochenschrift (1946), 1985, Apr-12, Volume: 110, Issue:15

    Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Renal Circulation; Shock, Cardiogenic; Vascular Resistance; Vasodilation

1985
Hemodynamic effect of oral TA-064 after dobutamine in congestive heart failure.
    Japanese circulation journal, 1987, Volume: 51, Issue:6

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors

1987
[Clinical effects of the infusion of dobutamine and amrinone in patients with refractory cardiac insufficiency].
    Revista medica de Chile, 1987, Volume: 115, Issue:12

    Topics: Aged; Aged, 80 and over; Amrinone; Body Weight; Clinical Trials as Topic; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged

1987
An analytical method to separate inotropic and vasodilatory drug effects in patients with heart failure.
    Cardiovascular research, 1987, Volume: 21, Issue:9

    Topics: Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Felodipine; Female; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Male; Middle Aged; Nitrendipine; Vasodilator Agents

1987
Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
    Circulation, 1986, Volume: 73, Issue:3 Pt 2

    Topics: Clinical Trials as Topic; Dobutamine; Ferricyanides; Heart Failure; Hemodynamics; Humans; Milrinone; Myocardial Contraction; Nitroprusside; Oxygen Consumption; Pyridones

1986
Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Circulation, 1986, Volume: 73, Issue:3 Pt 2

    Topics: Aged; Blood Pressure; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Myocardial Contraction; Nitroprusside; Norepinephrine; Pyridones; Stimulation, Chemical; Vascular Resistance; Vasodilation

1986
Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
    The American journal of cardiology, 1987, Jun-01, Volume: 59, Issue:15

    Topics: Cardiomyopathy, Dilated; Coronary Disease; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Milrinone; Pyridones

1987
Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    The American journal of cardiology, 1987, Dec-01, Volume: 60, Issue:16

    Topics: Adult; Aged; Cardiomyopathy, Dilated; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Pyridones; Systole

1987

Other Studies

496 other study(ies) available for dobutamine and Cardiac Failure

ArticleYear
Identification of a Hydroxypyrimidinone Compound (
    Journal of medicinal chemistry, 2021, 12-23, Volume: 64, Issue:24

    Topics: Animals; Apelin Receptors; Dogs; Drug Discovery; Heart Failure; Humans; Pyrimidinones; Rats; Structure-Activity Relationship

2021
Renal Hemodynamics and Renin-Angiotensin-Aldosterone System Profiles in Patients With Heart Failure.
    Journal of cardiac failure, 2022, Volume: 28, Issue:3

    Topics: Aldosterone; Biomarkers; Dobutamine; Heart Failure; Hemodynamics; Humans; Nitroprusside; Renin; Renin-Angiotensin System

2022
Incidence and Predictors of Eosinophilic Myocardial Hypersensitivity in Patients Receiving Home Dobutamine.
    Journal of cardiovascular pharmacology, 2022, 10-01, Volume: 80, Issue:4

    Topics: Adult; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Milrinone; Myocardium

2022
Prognostic Role of Cardiac Power in a Large Cohort of Patients with Normal Ejection Fraction Referred for Dobutamine Stress Echocardiography.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2022, Volume: 35, Issue:11

    Topics: Aged; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Stroke Volume; Ventricular Function, Left

2022
Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
    Journal of cardiac failure, 2022, Volume: 28, Issue:12

    Topics: Adrenergic beta-Antagonists; Adult; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Retrospective Studies

2022
Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone.
    The American journal of cardiology, 2022, 12-01, Volume: 184

    Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Retrospective Studies; Stroke Volume; Ventricular Function, Left

2022
[Comparative assessment of the effects of dobutamine and levosimendan on right ventricular ejection fraction in patients with biventricular heart failure].
    Kardiologiia, 2023, Feb-28, Volume: 63, Issue:2

    Topics: Cardiovascular Agents; Cross-Sectional Studies; Dobutamine; Heart Failure; Humans; Prospective Studies; Simendan; Stroke Volume; Ventricular Function, Left; Ventricular Function, Right

2023
Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
    ESC heart failure, 2023, Volume: 10, Issue:4

    Topics: Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone; Retrospective Studies; Shock, Cardiogenic

2023
Preoperative Levosimendan Administration in Heart Transplant Patients with Severe Hepatic and Renal Impairment: A Retrospective Study.
    The heart surgery forum, 2023, Aug-14, Volume: 26, Issue:4

    Topics: Dobutamine; Dopamine; Heart Failure; Heart Transplantation; Humans; Renal Insufficiency; Retrospective Studies; Simendan

2023
Successful echocardiography-guided medical management of severe early post-implant right ventricular failure in a patient with left ventricular assist device support: a case report.
    Journal of cardiothoracic surgery, 2023, Oct-04, Volume: 18, Issue:1

    Topics: Adolescent; Dobutamine; Echocardiography; Female; Heart Failure; Heart-Assist Devices; Humans; Milrinone; Retrospective Studies

2023
Myocardial Energetics in Heart Failure With Preserved Ejection Fraction.
    Circulation. Heart failure, 2019, Volume: 12, Issue:10

    Topics: Adrenergic beta-1 Receptor Agonists; Aged; Case-Control Studies; Coronary Circulation; Dobutamine; Echocardiography, Stress; Energy Metabolism; Female; Heart Failure; Humans; Male; Microcirculation; Middle Aged; Myocardium; Oxygen Consumption; Positron-Emission Tomography; Prospective Studies; Stroke Volume; Ventricular Function, Left

2019
Combined Therapy With Dobutamine and Omecamtiv Mecarbil in Pigs With Ischemic Acute Heart Failure Is Attributed to the Effect of Dobutamine.
    Journal of cardiovascular pharmacology and therapeutics, 2020, Volume: 25, Issue:3

    Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Energy Metabolism; Heart Failure; Male; Myocardial Contraction; Myocardial Ischemia; Oxygen Consumption; Sus scrofa; Urea; Ventricular Function, Left

2020
Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
    Journal of cardiovascular pharmacology, 2020, Volume: 75, Issue:5

    Topics: Aged; Cardiotonic Agents; Cause of Death; Disease Progression; Dobutamine; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Milrinone; Recovery of Function; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left

2020
Levosimendan with other inotropes or vasopressors: Should you combine them?
    The American journal of emergency medicine, 2020, Volume: 38, Issue:12

    Topics: Acute Disease; Aged; Aged, 80 and over; Arterial Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Hospital Mortality; Humans; Hypotension; Length of Stay; Male; Middle Aged; Norepinephrine; Simendan; Tachycardia, Supraventricular; Treatment Outcome; Vasoconstrictor Agents

2020
Feasibility and value of two-dimensional volumetric stress echocardiography.
    Minerva cardiology and angiology, 2022, Volume: 70, Issue:2

    Topics: Aged; Dobutamine; Echocardiography; Echocardiography, Stress; Feasibility Studies; Heart Failure; Humans; Male; Middle Aged

2022
COVID-19 infection in left ventricular assist device patients.
    Journal of cardiac surgery, 2020, Volume: 35, Issue:11

    Topics: Aged; Cardiotonic Agents; COVID-19; Dobutamine; Furosemide; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Simendan; Ventricular Dysfunction, Right

2020
Comparison of cardiac output estimates by echocardiography and bioreactance at rest and peak dobutamine stress test in heart failure patients with preserved ejection fraction.
    Echocardiography (Mount Kisco, N.Y.), 2020, Volume: 37, Issue:10

    Topics: Cardiac Output; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Stroke Volume; Ventricular Function, Left

2020
Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era.
    American journal of therapeutics, 2020, Oct-01, Volume: 28, Issue:6

    Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Outpatients; Retrospective Studies

2020
Application of dopamine combined with dobutamine in children with pneumonia and heart failure.
    Pakistan journal of pharmaceutical sciences, 2020, Volume: 33, Issue:3(Special)

    Topics: Adrenergic beta-1 Receptor Agonists; Age Factors; Cardiotonic Agents; Case-Control Studies; Child, Preschool; Dobutamine; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Female; Heart Failure; Humans; Infant; Length of Stay; Male; Pneumonia; Recovery of Function; Time Factors; Treatment Outcome

2020
Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
    Pharmacotherapy, 2017, Volume: 37, Issue:6

    Topics: Acute Disease; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Milrinone; Mortality; Retrospective Studies

2017
Is the mechanism of re-expansion pulmonary oedema in a heart-lung interaction?
    BMJ case reports, 2017, Jul-18, Volume: 2017

    Topics: Aged; Blood Pressure; Cardiotonic Agents; Dobutamine; Drainage; Echocardiography; Heart; Heart Failure; Heart Ventricles; Humans; Hypertension, Pulmonary; Lung; Male; Mitral Valve Insufficiency; Pleural Effusion; Pulmonary Edema; Respiratory Insufficiency; Stroke Volume; Ventricular Function, Left

2017
Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2017, Volume: 36, Issue:9

    Topics: Acute Disease; Aged; Cardio-Renal Syndrome; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Incidence; Male; Middle Aged; Pyridazines; Retrospective Studies; Simendan

2017
Successful Withdrawal from Dobutamine by Canagliflozin in a Diabetic Patient with Stage D Heart Failure.
    International heart journal, 2017, Dec-12, Volume: 58, Issue:6

    Topics: Aged; Canagliflozin; Cardiotonic Agents; Diabetes Complications; Dobutamine; Female; Heart Failure; Humans; Hypoglycemic Agents

2017
Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.
    ESC heart failure, 2018, Volume: 5, Issue:4

    Topics: Aged; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Home Care Services; Humans; Infusions, Intravenous; Male; Palliative Care; Quality of Life; Retrospective Studies; Stroke Volume; Treatment Outcome

2018
Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality.
    Critical care (London, England), 2018, Feb-26, Volume: 22, Issue:1

    Topics: Aged; Aged, 80 and over; Cardiac Surgical Procedures; Cardiotonic Agents; Cohort Studies; Denmark; Dobutamine; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Milrinone; Prospective Studies; Retrospective Studies

2018
Stability of dobutamine in continuous ambulatory delivery devices.
    Journal of clinical pharmacy and therapeutics, 2018, Volume: 43, Issue:4

    Topics: Dobutamine; Drug Delivery Systems; Drug Packaging; Drug Stability; Heart Failure; Humans; Infusion Pumps; Temperature

2018
Remote Left Ventricular Hemodynamic Monitoring Using a Novel Intracardiac Sensor.
    Circulation. Cardiovascular interventions, 2018, Volume: 11, Issue:5

    Topics: Animals; Cardiac Catheterization; Cardiac Pacing, Artificial; Disease Models, Animal; Dobutamine; Dogs; Echocardiography; Equipment Design; Heart Failure; Hemodynamics; Male; Miniaturization; Predictive Value of Tests; Remote Sensing Technology; Reproducibility of Results; Time Factors; Transducers, Pressure; Vasopressins; Ventricular Function, Left

2018
Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
    Pediatric cardiology, 2018, Volume: 39, Issue:7

    Topics: Adolescent; Adult; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Infant; Infusions, Intravenous; Male; Milrinone; Retrospective Studies; Simendan; Survival Rate; Treatment Outcome; Young Adult

2018
Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition.
    Circulation, 2018, 10-30, Volume: 138, Issue:18

    Topics: Animals; Calcium; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dogs; Heart Failure; Heart Rate; Hemodynamics; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Rabbits; Receptors, Adrenergic, beta-2; Signal Transduction

2018
Treatments targeting inotropy.
    European heart journal, 2019, 11-21, Volume: 40, Issue:44

    Topics: Acute Disease; Animals; Antioxidants; Calcium; Cardiotonic Agents; Case-Control Studies; Catecholamines; Clinical Trials as Topic; Diastole; Dobutamine; Dogs; Energy Metabolism; Excitation Contraction Coupling; Heart Failure; Humans; Mitochondria; Models, Animal; Myocardial Contraction; Nitrogen Oxides; Oxidation-Reduction; Phosphodiesterase Inhibitors; Placebos; Receptors, Adrenergic; Sarcomeres; Shock, Cardiogenic; Simendan; Swine; Systole; Urea

2019
Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co-treatment in pigs with acute ischemic heart failure.
    Physiological reports, 2018, Volume: 6, Issue:19

    Topics: Animals; Cardiotonic Agents; Cardiovascular Agents; Diastole; Dobutamine; Drug Therapy, Combination; Heart Failure; Ivabradine; Male; Myocardial Ischemia; Swine; Treatment Outcome; Urea

2018
Drop-off in positivity rate of stress echocardiography based on regional wall motion abnormalities over the last three decades.
    The international journal of cardiovascular imaging, 2019, Volume: 35, Issue:4

    Topics: Adrenergic beta-1 Receptor Agonists; Aged; Coronary Artery Disease; Dipyridamole; Dobutamine; Echocardiography, Stress; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Time Factors; Vasodilator Agents; Ventricular Function, Left

2019
Echocardiography for prediction of 6-month and late response to cardiac resynchronization therapy: implementation of stress echocardiography and comparative assessment along with widely used dyssynchrony indices.
    The international journal of cardiovascular imaging, 2019, Volume: 35, Issue:2

    Topics: Adrenergic beta-1 Receptor Agonists; Aged; Cardiac Resynchronization Therapy; Dobutamine; Echocardiography, Doppler, Color; Echocardiography, Stress; Female; Heart Failure; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Recovery of Function; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Function, Right

2019
Fenestration in the Fontan circulation as a strategy for chronic cardioprotection.
    Heart (British Cardiac Society), 2019, Volume: 105, Issue:16

    Topics: Adrenergic beta-1 Receptor Agonists; Child; Child, Preschool; Dobutamine; Echocardiography; Echocardiography, Stress; Female; Fontan Procedure; Heart Defects, Congenital; Heart Failure; Heart Rate; Hemodynamics; Humans; Hyperemia; Male; Myocardial Contraction

2019
The value of a simplified approach to end-systolic volume measurement for assessment of left ventricular contractile reserve during stress-echocardiography.
    The international journal of cardiovascular imaging, 2019, Volume: 35, Issue:6

    Topics: Adrenergic beta-1 Receptor Agonists; Aged; Coronary Artery Disease; Dipyridamole; Dobutamine; Echocardiography, Stress; Feasibility Studies; Female; Heart Failure; Humans; Italy; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Stroke Volume; Systole; Vasodilator Agents; Ventricular Function, Left

2019
Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol.
    Arquivos brasileiros de cardiologia, 2019, 06-06, Volume: 112, Issue:5

    Topics: Adult; Aged; Cardiotonic Agents; Clinical Protocols; Critical Care; Dobutamine; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Milrinone; Patient Discharge; Retrospective Studies; Treatment Outcome

2019
Ventricular dyssynchrony; it is a dynamic phenomenon.
    Journal of cardiology, 2013, Volume: 61, Issue:4

    Topics: Cardiac Resynchronization Therapy; Clinical Trials as Topic; Dobutamine; Echocardiography; Exercise Test; Heart Failure; Humans; Prognosis; Ventricular Dysfunction, Left; Ventricular Function, Left

2013
Low-dose dobutamine induces left ventricular mechanical dyssynchrony in patients with dilated cardiomyopathy and a narrow QRS: a study using real-time three-dimensional echocardiography.
    Journal of cardiology, 2013, Volume: 61, Issue:4

    Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Echocardiography, Three-Dimensional; Electrocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Ventricular Dysfunction, Left

2013
Right ventricular-pulmonary arterial coupling in patients after repair of tetralogy of Fallot.
    The Journal of thoracic and cardiovascular surgery, 2013, Volume: 146, Issue:6

    Topics: Adolescent; Cardiac Catheterization; Cardiac Surgical Procedures; Cardiotonic Agents; Child; Compliance; Dobutamine; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Myocardial Contraction; Predictive Value of Tests; Pulmonary Artery; Tetralogy of Fallot; Treatment Outcome; Vascular Stiffness; Ventricular Dysfunction, Right; Ventricular Function, Right; Young Adult

2013
Left ventricular assist device implantation in heart failure patients with a left ventricular thrombus.
    Transplantation proceedings, 2013, Volume: 45, Issue:3

    Topics: Dobutamine; Dopamine; Heart Failure; Heart-Assist Devices; Humans; Thrombosis; Ventricular Dysfunction, Left

2013
Characteristics of patients with advanced heart failure having eosinophilic infiltration of the myocardium in the recent era.
    International heart journal, 2013, Volume: 54, Issue:3

    Topics: Biopsy; Dobutamine; Eosinophils; Heart Failure; Heart Transplantation; Humans; Milrinone; Myocarditis; Myocardium; Prognosis; Retrospective Studies; Survival Analysis; Survival Rate

2013
An autonomic link between inhaled diesel exhaust and impaired cardiac performance: insight from treadmill and dobutamine challenges in heart failure-prone rats.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 135, Issue:2

    Topics: Animals; Dobutamine; Electrocardiography; Heart Failure; Male; Rats; Rats, Inbred SHR; Vehicle Emissions; Walking

2013
Usefulness of a surface cooling device (Arctic Sun®) for therapeutic hypothermia following cardiac arrest.
    Journal of cardiology, 2014, Volume: 63, Issue:1

    Topics: Aged; Body Temperature; Cardiotonic Agents; Dobutamine; Female; Heart Arrest; Heart Failure; Humans; Hypothermia, Induced; Infusions, Intravenous; Male; Middle Aged

2014
The effect of the renin-angiotensin-aldosterone system inhibition on myocardial function in early and late phases of dilated cardiomyopathy in Tgaq*44 mice.
    Kardiologia polska, 2013, Volume: 71, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Canrenone; Cardiovascular Agents; Dobutamine; Heart Failure; Mice; Mice, Transgenic; Models, Animal; Perindopril; Renin-Angiotensin System

2013
Can we do better than dobutamine?
    Circulation research, 2013, Aug-02, Volume: 113, Issue:4

    Topics: Arrhythmias, Cardiac; Cardiac Output; Cardiotonic Agents; Dobutamine; Drug Discovery; Heart Failure; Humans; Myocardial Contraction; Risk Factors; Treatment Outcome

2013
Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure.
    Cell metabolism, 2013, Aug-06, Volume: 18, Issue:2

    Topics: Acetylation; Animals; Cardiotonic Agents; Dobutamine; Electron Transport Complex I; Female; Heart Failure; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Mitochondrial Diseases; Myocardium; NAD; Oxidative Stress; Pregnancy; Reactive Oxygen Species; Sirtuin 3

2013
Levosimendan: a retrospective single-center case series.
    Journal of critical care, 2013, Volume: 28, Issue:6

    Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Hospital Mortality; Humans; Hydrazones; Intensive Care Units; Male; Milrinone; Norepinephrine; Pyridazines; Retrospective Studies; Simendan; Sympathomimetics; Treatment Outcome

2013
Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
    Journal of cardiology, 2014, Volume: 63, Issue:6

    Topics: Acute Disease; Aged; Cardiotonic Agents; Disease Progression; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Hydrazones; Infusions, Intravenous; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neutrophils; Predictive Value of Tests; Pyridazines; Retrospective Studies; Simendan

2014
Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis.
    European journal of heart failure, 2014, Volume: 16, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Echocardiography; Enoximone; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Prognosis; Propanolamines; Retrospective Studies; Survival Rate; Ventilator Weaning

2014
Regional myocardial contractile reserve assessed by strain echocardiography and the response to cardiac resynchronization therapy.
    Cardiology journal, 2014, Volume: 21, Issue:5

    Topics: Cardiac Resynchronization Therapy; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Prospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function, Left

2014
[Takotsubo cardiomyopathy in an adolescent girl].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2014, Volume: 21, Issue:5

    Topics: Adolescent; Cerebellum; Dobutamine; Echocardiography; Female; Heart Failure; Heart Failure, Systolic; Hematoma; Humans; Intracranial Arteriovenous Malformations; Prognosis; Rupture, Spontaneous; Takotsubo Cardiomyopathy

2014
Expression of uncoupling protein-2 remains increased within hibernating myocardium despite successful coronary artery bypass grafting at 4 wk post-revascularization.
    The Journal of surgical research, 2015, Volume: 193, Issue:1

    Topics: Animals; Cardiac Imaging Techniques; Cardiotonic Agents; Cell Respiration; Chronic Disease; Coronary Artery Bypass; Coronary Circulation; Disease Models, Animal; Dobutamine; Echocardiography, Doppler; Heart Failure; Ion Channels; Mitochondria; Mitochondrial Proteins; Myocardial Stunning; Oxidative Stress; Swine; Tomography, X-Ray Computed; Uncoupling Protein 2

2015
Dobutamine-induced fever and isolated eosinophilic myocarditis in a 66-year-old male awaiting heart transplantation: a case report.
    Transplantation proceedings, 2014, Volume: 46, Issue:7

    Topics: Aged; Cardiotonic Agents; Dobutamine; Eosinophilia; Fever; Heart Failure; Heart Transplantation; Humans; Male; Myocarditis; Waiting Lists

2014
Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Respiratory research, 2015, Feb-03, Volume: 16

    Topics: Administration, Inhalation; Animals; Arterial Pressure; Cardiotonic Agents; Disease Models, Animal; Disease Progression; Dobutamine; Energy Metabolism; Heart Failure; Hexokinase; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; L-Lactate Dehydrogenase; Male; Mitochondria, Heart; Monocrotaline; Oxygen; Oxygen Consumption; Protoporphyrins; Pulmonary Artery; Rats, Wistar; Ventricular Dysfunction, Right; Ventricular Function, Right

2015
Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study.
    American journal of physiology. Heart and circulatory physiology, 2015, Jun-15, Volume: 308, Issue:12

    Topics: Animals; Area Under Curve; Cardiac Catheterization; Disease Models, Animal; Dobutamine; Echocardiography, Doppler; Echocardiography, Stress; Exercise Tolerance; Feasibility Studies; Head-Down Tilt; Heart Failure; Hemodynamics; Male; Obesity; Oxygen Consumption; Phenylephrine; Predictive Value of Tests; Rats, Inbred WKY; Rats, Zucker; Reproducibility of Results; ROC Curve; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Pressure

2015
Reversible Cardiomyopathy After Epirubicin Administration.
    International heart journal, 2015, Volume: 56, Issue:4

    Topics: Aged; Antibiotics, Antineoplastic; Atrial Natriuretic Factor; Breast Neoplasms; Cardiomyopathies; Cardiotonic Agents; Diuretics; Dobutamine; Echocardiography; Electrocardiography; Epirubicin; Female; Heart Failure; Heart Ventricles; Humans; Magnetic Resonance Imaging, Cine; Respiration, Artificial; Severity of Illness Index; Treatment Outcome

2015
Urocortin 2 protects heart and kidney structure and function in an ovine model of acute decompensated heart failure: Comparison with dobutamine.
    International journal of cardiology, 2015, Oct-15, Volume: 197

    Topics: Adrenergic beta-1 Receptor Agonists; Animals; Biomarkers; Collagen; Disease Models, Animal; Dobutamine; Female; Gene Expression; Heart; Heart Failure; Kidney; Kidney Diseases; Real-Time Polymerase Chain Reaction; Sheep; Transforming Growth Factor beta1; Urocortins

2015
Management of catecholamine-induced stunned myocardium--a case report.
    Journal of clinical anesthesia, 2015, Volume: 27, Issue:6

    Topics: Blood Pressure; Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Female; Fluid Therapy; Heart Failure; Humans; Intraoperative Complications; Middle Aged; Milrinone; Myocardial Stunning; Neurosurgical Procedures; Norepinephrine; Subarachnoid Hemorrhage; Vasodilator Agents

2015
Na+-induced Ca2+ influx through reverse mode of Na+-Ca2+ exchanger in mouse ventricular cardiomyocyte.
    Oncotarget, 2015, Sep-15, Volume: 6, Issue:27

    Topics: Action Potentials; Animals; Calcium; Dobutamine; Dose-Response Relationship, Drug; Electrophysiology; Heart; Heart Failure; Heart Ventricles; Male; Mice; Myocytes, Cardiac; Patch-Clamp Techniques; Receptors, Adrenergic, beta; Sodium-Calcium Exchanger; Thiourea

2015
Hemodynamic and neurochemical determinates of renal function in chronic heart failure.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2016, Jan-15, Volume: 310, Issue:2

    Topics: Aged; Aged, 80 and over; Arterial Pressure; Atrial Function, Right; Atrial Pressure; Cardiac Catheterization; Case-Control Studies; Chronic Disease; Dobutamine; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Models, Cardiovascular; Nitroprusside; Renal Plasma Flow; Sympathetic Nervous System; Sympathomimetics; Vasodilator Agents; Ventricular Function, Left

2016
Temporal Development of Autonomic Dysfunction in Heart Failure: Effects of Age in an Ovine Rapid-pacing Model.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2016, Volume: 71, Issue:12

    Topics: Acetylcholine; Adrenergic beta-Antagonists; Age Factors; Animals; Autonomic Nervous System; Biomarkers; Cardiac Pacing, Artificial; Disease Models, Animal; Dobutamine; Echocardiography; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Female; Heart Failure; Heart Rate; Hemodynamics; Norepinephrine; Sheep, Domestic; Time Factors

2016
Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.
    The American journal of cardiology, 2016, Mar-15, Volume: 117, Issue:6

    Topics: Administration, Intravenous; Adult; Aged; Alabama; Atrial Fibrillation; Bacteremia; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Female; Follow-Up Studies; Heart Arrest; Heart Conduction System; Heart Failure; Home Care Services; Hospitals, University; Humans; Male; Middle Aged; Milrinone; Pacemaker, Artificial; Patient Readmission; Retrospective Studies; Tachycardia, Ventricular; Treatment Outcome

2016
Citric Acid Cycle Metabolites Predict the Severity of Myocardial Stunning and Mortality in Newborn Pigs.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2016, Volume: 17, Issue:12

    Topics: Animals; Biomarkers; Cardiotonic Agents; Chromatography, Liquid; Citric Acid Cycle; Dobutamine; Drug Therapy, Combination; Epinephrine; Female; Heart Failure; Microdialysis; Milrinone; Myocardial Stunning; Random Allocation; Severity of Illness Index; Sodium Chloride; Spectrometry, Mass, Electrospray Ionization; Swine; Tandem Mass Spectrometry; Treatment Outcome

2016
Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.
    European heart journal, 2017, 02-01, Volume: 38, Issue:5

    Topics: Adrenergic beta-1 Receptor Agonists; Adult; Animals; Blood Glucose; Cardiomyopathies; Dobutamine; Female; Heart Failure; Humans; Isoproterenol; Male; Mice, Knockout; MicroRNAs; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Peripartum Period; Puerperal Disorders; Purine Nucleotides; Random Allocation; Reactive Oxygen Species; Receptor, ErbB-4; STAT3 Transcription Factor; Ventricular Dysfunction, Left

2017
Prediction of functional capacity by low-dose dobutamine stress echocardiography in chronic heart failure.
    Minerva cardioangiologica, 2008, Volume: 56, Issue:3

    Topics: Adrenergic beta-Agonists; Aged; Chronic Disease; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Prospective Studies; Respiratory Function Tests; Ventricular Dysfunction, Left

2008
Inotropic agents improve the peripheral microcirculation of patients with end-stage chronic heart failure.
    Journal of cardiac failure, 2008, Volume: 14, Issue:5

    Topics: Adrenergic beta-Agonists; Brachial Artery; Cardiotonic Agents; Case-Control Studies; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Microcirculation; Middle Aged; Muscle, Skeletal; Myocardial Reperfusion; Oxygen Consumption; Prognosis; Prospective Studies; Pyridazines; Simendan; Spectroscopy, Near-Infrared; Vasodilator Agents

2008
Decompensated heart failure in the emergency department of a cardiology hospital.
    Arquivos brasileiros de cardiologia, 2008, Volume: 90, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Brazil; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Dopamine; Emergency Service, Hospital; Epidemiologic Methods; Female; Heart Failure; Hospitalization; Humans; Infant; Infant, Newborn; Length of Stay; Male; Middle Aged; Young Adult

2008
Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 295, Issue:2

    Topics: Adenylyl Cyclases; Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Colforsin; Dobutamine; ErbB Receptors; Female; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Mutation; Myocardial Contraction; Myocytes, Cardiac; Phenotype; Phosphorylation; Receptor, ErbB-2; Signal Transduction; Time Factors; Ventricular Dysfunction, Left

2008
Effect of glucose-insulin-potassium in severe acute heart failure after brain death.
    Critical care medicine, 2008, Volume: 36, Issue:10

    Topics: Adult; Brain Death; Confidence Intervals; Dobutamine; Drug Therapy, Combination; Echocardiography, Doppler; Echocardiography, Transesophageal; Female; Follow-Up Studies; Glucose; Heart Failure; Heart Rate; Heart Transplantation; Humans; Infusions, Intravenous; Insulin; Male; Middle Aged; Organ Preservation; Potassium; Probability; Prospective Studies; Risk Factors; Severity of Illness Index; Stroke Volume; Tissue Donors; Treatment Outcome; Ventricular Remodeling

2008
A comparison of central and mixed venous oxygen saturation in circulatory failure.
    Journal of cardiothoracic and vascular anesthesia, 2010, Volume: 24, Issue:3

    Topics: Aged; Cardiac Output; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Female; Heart Failure; Heart Function Tests; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Norepinephrine; Oxygen; Respiration, Artificial; ROC Curve; Sample Size; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents

2010
Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
    The American journal of cardiology, 2008, Nov-01, Volume: 102, Issue:9

    Topics: Aged; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Heart Ventricles; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Severity of Illness Index; Simendan; Stroke Volume

2008
Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
    Neuromuscular disorders : NMD, 2008, Volume: 18, Issue:12

    Topics: Adolescent; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Humans; Infusions, Intravenous; Male; Muscular Dystrophy, Duchenne; Time Factors

2008
A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 295, Issue:6

    Topics: Acetylcholine; Animals; Apoptosis; Blood Glucose; Capillaries; Coronary Circulation; Dietary Fats; Disease Models, Animal; Dobutamine; Fibrosis; Heart Failure; Hemodynamics; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Risk Factors; Time Factors; Ultrasonography; Vasodilation; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling

2008
Levosimendan: from basic science to clinical practice.
    Heart failure reviews, 2009, Volume: 14, Issue:4

    Topics: Animals; Cardiotonic Agents; Coronary Circulation; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Kidney; Myocardial Contraction; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Quality of Life; Simendan; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Right

2009
Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:2

    Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan; Survival Rate; Treatment Outcome

2009
Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echocardiography.
    European journal of heart failure, 2009, Volume: 11, Issue:5

    Topics: Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Contraction; Prospective Studies; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling

2009
Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Journal of the American College of Cardiology, 2009, Jun-23, Volume: 53, Issue:25

    Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Randomized Controlled Trials as Topic; Retrospective Studies; Simendan

2009
Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2009, Volume: 98, Issue:8

    Topics: Acute Disease; Benzazepines; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Tachycardia, Sinus; Treatment Outcome

2009
Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice.
    Critical care (London, England), 2009, Volume: 13, Issue:3

    Topics: Animals; Arginine Vasopressin; Cardiotonic Agents; Dobutamine; Heart Failure; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Shock; Stroke Volume; Survival Analysis; Vasoconstrictor Agents; Ventricular Dysfunction, Left

2009
Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction.
    JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:7

    Topics: Adrenergic beta-Agonists; Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Vessels; Dobutamine; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Microvessels; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardium; Necrosis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Thrombolytic Therapy; Time Factors; Treatment Outcome

2009
Variation on a theme: CMR as the "one-stop shop" for risk stratification after infarction?
    JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:7

    Topics: Adrenergic beta-Agonists; Angioplasty, Balloon, Coronary; Coronary Vessels; Dobutamine; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Microvessels; Myocardial Contraction; Myocardial Infarction; Myocardium; Necrosis; Predictive Value of Tests; Prognosis; Recurrence; Risk Assessment; Risk Factors; Thrombolytic Therapy; Time Factors; Treatment Outcome

2009
Selective activation of PI3Kalpha/Akt/GSK-3beta signalling and cardiac compensatory hypertrophy during recovery from heart failure.
    European journal of heart failure, 2009, Volume: 11, Issue:8

    Topics: Analysis of Variance; Animals; Dobutamine; Dogs; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; Hemodynamics; Hypertrophy, Left Ventricular; Longitudinal Studies; Male; Models, Animal; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction

2009
Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2009, Aug-03, Volume: 11

    Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Angina, Unstable; Cardiovascular Diseases; Dobutamine; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Observer Variation; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Ventricular Dysfunction, Left

2009
Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
    Annals of emergency medicine, 2009, Volume: 54, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Overdose; Heart Failure; Hemodynamics; Hydrazones; Propranolol; Pyridazines; Random Allocation; Simendan; Survival Analysis; Swine

2009
Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Circulation. Heart failure, 2009, Volume: 2, Issue:4

    Topics: Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Retrospective Studies; Severity of Illness Index; Treatment Outcome

2009
Should we use outpatient dobutamine or milrinone?
    Circulation. Heart failure, 2009, Volume: 2, Issue:4

    Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Injections, Intravenous; Milrinone; Outpatients; Treatment Outcome

2009
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.
    The European respiratory journal, 2010, Volume: 35, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aged; Blood Pressure; C-Reactive Protein; Cardiotonic Agents; Creatinine; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Hypertension, Pulmonary; Intensive Care Units; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Sodium; Survival Analysis; Vasoconstrictor Agents; Young Adult

2010
Pressure-volume relationship during dobutamine stress echocardiography predicts exercise tolerance in patients with congestive heart failure.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2010, Volume: 23, Issue:1

    Topics: Aged; Blood Pressure; Dobutamine; Echocardiography; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Stroke Volume; Vasodilator Agents

2010
Prognostic value of dobutamine stress echocardiography in diabetic patients.
    The international journal of cardiovascular imaging, 2010, Volume: 26, Issue:5

    Topics: Aged; Cardiotonic Agents; Chi-Square Distribution; Comorbidity; Coronary Disease; Diabetic Angiopathies; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Myocardial Infarction; Predictive Value of Tests; Prognosis; Rest; Risk Factors; Statistics, Nonparametric; Survival Analysis

2010
Is levosimendan better than dobutamine in acute heart failure in patients on beta-blockade treatment? What is the evidence?
    European journal of heart failure, 2010, Volume: 12, Issue:4

    Topics: Acute Disease; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan

2010
[Angiotensin II receptor blocker add-on therapy for low cardiac output in decompensated heart failure].
    Arquivos brasileiros de cardiologia, 2010, Volume: 94, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Dobutamine; Drug Therapy, Combination; Epidemiologic Methods; Female; Heart Failure; Humans; Kidney; Male; Middle Aged; Stroke Volume

2010
Rotating inotrope therapy in a pediatric population with decompensated heart failure.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2011, Volume: 12, Issue:1

    Topics: Adolescent; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Hydrazones; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Milrinone; Pyridazines; Retrospective Studies; Simendan; Treatment Outcome

2011
The myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:2

    Topics: Adrenergic beta-Agonists; Animals; Cardiac Output; Dietary Fats; Disease Models, Animal; Dobutamine; Energy Metabolism; Fatty Acids; Gene Expression Profiling; Gene Expression Regulation; Heart Failure; Male; Myocardial Contraction; Myocardial Infarction; Oligonucleotide Array Sequence Analysis; Rats; Rats, Wistar; Recovery of Function; Signal Transduction; Stress, Physiological; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure

2010
Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events?
    Current heart failure reports, 2010, Volume: 7, Issue:3

    Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Dobutamine; Etiocholanolone; Genetic Therapy; Heart Failure; Humans; Hydrazones; Pyridazines; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Sodium-Potassium-Exchanging ATPase; Urea

2010
Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy.
    European journal of heart failure, 2010, Volume: 12, Issue:11

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Dobutamine; Heart Failure; Hemodynamics; Metoprolol; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, Inbred Strains; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophy, Duchenne; Papillary Muscles

2010
Correspondence concerning the article: is levosimendan better than dobutamine in acute heart failure in patients on beta blockade treatment? What is the evidence?
    European journal of heart failure, 2010, Volume: 12, Issue:8

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan

2010
How to treat acute decompensated heart failure in the 'beta-blocker era'?
    European journal of heart failure, 2010, Volume: 12, Issue:8

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan; Vasodilator Agents

2010
Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock.
    Translational research : the journal of laboratory and clinical medicine, 2010, Volume: 156, Issue:5

    Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Male; Norepinephrine; Orchiectomy; Shock, Cardiogenic; Swine; Vasodilator Agents; Vasopressins; Ventricular Function, Left

2010
Automated drug delivery system for the management of hemodynamics and cardiac energetic in acute heart failure.
    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2010, Volume: 2010

    Topics: Acute Disease; Animals; Automation; Bradycardia; Cardiac Output; Computer Simulation; Dextrans; Dobutamine; Dogs; Drug Delivery Systems; Embolization, Therapeutic; Heart Failure; Heart Function Tests; Heart Rate; Hemodynamics; Nitroprusside; Systole; Time Factors

2010
Dobutamine-induced changes of left atrial two-dimensional deformation predict clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensated chronic heart failure.
    International journal of cardiology, 2012, May-17, Volume: 157, Issue:1

    Topics: Aged; Atrial Function, Left; Biomarkers; Chronic Disease; Dobutamine; Echocardiography; Echocardiography, Stress; Female; Forecasting; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Pyridazines; Simendan; Treatment Outcome

2012
Impaired left ventricular stroke volume reserve during clinical dobutamine stress predicts future episodes of pulmonary edema.
    Journal of the American College of Cardiology, 2011, Feb-15, Volume: 57, Issue:7

    Topics: Aged; Atropine; Dobutamine; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pulmonary Edema; Risk Factors; Stroke Volume

2011
Long-term prognostic value of dobutamine stress CMR.
    JACC. Cardiovascular imaging, 2011, Volume: 4, Issue:2

    Topics: Aged; Chi-Square Distribution; Coronary Artery Disease; Disease-Free Survival; Dobutamine; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Ventricular Function, Left

2011
Dobutamine stress CMR: can we predict outcome?
    JACC. Cardiovascular imaging, 2011, Volume: 4, Issue:2

    Topics: Coronary Artery Disease; Disease-Free Survival; Dobutamine; Heart Failure; Humans; Magnetic Resonance Imaging; Myocardial Contraction; Myocardial Infarction; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Ventricular Function, Left

2011
Altered microRNA expression associated with reduced catecholamine sensitivity in patients with chronic heart failure.
    Journal of cardiology, 2011, Volume: 57, Issue:3

    Topics: Cardiac Catheterization; Cardiomyopathy, Dilated; Catecholamines; Chronic Disease; Dobutamine; Female; Gene Expression Regulation; Heart Failure; Humans; Male; Microarray Analysis; MicroRNAs; Middle Aged; Myocardial Contraction; Myocardium; Norepinephrine; Receptors, Adrenergic; Ventricular Function

2011
[Treatment of heart failure patients with inotropic drugs: beyond traditional agents].
    Giornale italiano di cardiologia (2006), 2010, Volume: 11, Issue:10 Suppl 1

    Topics: Adrenergic beta-1 Receptor Agonists; Cardiotonic Agents; Dobutamine; Guidelines as Topic; Heart Failure; Hydrazones; Meta-Analysis as Topic; Phosphodiesterase Inhibitors; Pyridazines; Retrospective Studies; Risk Assessment; Simendan

2010
Cardiomyopathy in α-kinase 3 (ALPK3)-deficient mice.
    Veterinary pathology, 2012, Volume: 49, Issue:1

    Topics: Animals; Cardiomyopathies; Diastole; Dobutamine; Female; Heart; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Mice; Mice, Knockout; Muscle Proteins; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Phosphotransferases; Sequence Deletion; Stroke Volume; Systole

2012
Usefulness of low-dose dobutamine echocardiography to predict response and outcome in patients undergoing cardiac resynchronization therapy.
    The American journal of cardiology, 2011, Jul-15, Volume: 108, Issue:2

    Topics: Adrenergic beta-1 Receptor Agonists; Aged; Cardiac Pacing, Artificial; Defibrillators, Implantable; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Hospitalization; Humans; Male; Myocardial Ischemia; Pacemaker, Artificial; Prospective Studies; Stroke Volume; Systole; Ventricular Dysfunction, Left

2011
MR perfusion-weighted imaging may help in differentiating between nonenhancing gliomas and nonneoplastic lesions in the cervicomedullary junction.
    Journal of magnetic resonance imaging : JMRI, 2011, Volume: 34, Issue:1

    Topics: Animals; Aorta; Brain Neoplasms; Cardiac Output; Dobutamine; Glioma; Heart Failure; Heart Ventricles; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Perfusion; Swine

2011
Cost-effectiveness of levosimendan in patients with acute heart failure.
    Journal of cardiovascular pharmacology, 2011, Volume: 58, Issue:4

    Topics: Acute Disease; Aged; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Patient Readmission; Pyridazines; Retrospective Studies; Simendan; Survival Rate

2011
Hospital in the home.
    Australian family physician, 2011, Volume: 40, Issue:4

    Topics: Australia; Cardiotonic Agents; Dobutamine; Heart Failure; Home Care Services; Humans; Infusions, Intravenous; Milrinone; Palliative Care

2011
Beta-blockers and dobutamine in heart failure: a safe combination?
    Arquivos brasileiros de cardiologia, 2011, Volume: 96, Issue:6

    Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Male; Withholding Treatment

2011
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: a cardiac MR study.
    International journal of cardiology, 2013, Jun-20, Volume: 166, Issue:2

    Topics: Aged; Dobutamine; Exercise Test; Female; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Ischemia; Stroke Volume

2013
[Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
    Vojnosanitetski pregled, 2011, Volume: 68, Issue:11

    Topics: Acute Disease; Adolescent; Cardiotonic Agents; Child, Preschool; Dobutamine; Heart Failure; Humans; Hydrazones; Male; Milrinone; Pyridazines; Simendan

2011
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved.
    The Journal of clinical investigation, 2012, Volume: 122, Issue:1

    Topics: Adenosine Triphosphate; Animals; Creatine Kinase, MM Form; Disease Models, Animal; Dobutamine; Energy Metabolism; Gene Expression; Heart Failure; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Contraction; Perfusion; Recombinant Proteins

2012
Heart failure syndrome due to dobutamine stress echocardiography: Tako-Tsubo induced-cardiomiopathy.
    Panminerva medica, 2012, Volume: 54, Issue:1

    Topics: Adrenergic beta-1 Receptor Agonists; Dobutamine; Echocardiography, Stress; Electrocardiography; Female; Heart Failure; Humans; Middle Aged; Myocardial Ischemia; Takotsubo Cardiomyopathy

2012
Heart failure secondary to dilated cardiomyopathy: a role for emergency physician bedside ultrasonography.
    Pediatric emergency care, 2012, Volume: 28, Issue:2

    Topics: Abdominal Pain; Acute Disease; Cardiomyopathy, Dilated; Child, Preschool; Diagnostic Errors; Dobutamine; Dopamine; Dyspnea; Echocardiography; Edema; Electrocardiography; Emergency Service, Hospital; Female; Gastroenteritis; Gastrointestinal Hemorrhage; Heart Failure; Heart Transplantation; Humans; Point-of-Care Systems; Vomiting

2012
Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.
    Journal of cardiology, 2012, Volume: 59, Issue:3

    Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Female; Follow-Up Studies; Heart Failure; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Outpatients; Pyridones; Severity of Illness Index; Survival Rate; Systole; Treatment Outcome

2012
[Occurrence of severe cardiac alterations in Amanita proxima poisoning: two original observations].
    Annales francaises d'anesthesie et de reanimation, 2012, Volume: 31, Issue:5

    Topics: Adrenergic beta-Agonists; Adult; Amanita; Diuretics; Dobutamine; Electrocardiography; Female; Furosemide; Heart Failure; Hemodiafiltration; Hemodynamics; Humans; Long QT Syndrome; Male; Middle Aged; Mushroom Poisoning; Nausea; Resuscitation; Shock, Cardiogenic; Ultrasonography; Ventricular Dysfunction, Left

2012
Stroke volume-to-wall stress ratio as a load-adjusted and stiffness-adjusted indicator of ventricular systolic performance in chronic loading.
    Journal of applied physiology (Bethesda, Md. : 1985), 2012, Oct-15, Volume: 113, Issue:8

    Topics: Animals; Arteries; Body Weight; Dobutamine; Echocardiography; Heart; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Male; Pressure; Rats; Rats, Sprague-Dawley; Stroke; Stroke Volume; Systole; Ventricular Function, Left

2012
Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure.
    European heart journal, 2013, Volume: 34, Issue:10

    Topics: Acute Disease; Aged; Alkaline Phosphatase; Cardiotonic Agents; Cholestasis; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Liver Diseases; Liver Function Tests; Male; Prognosis; Prospective Studies; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Transaminases

2013
Characterization of the cardiac response to a low and high dose of dobutamine in the mouse model of dilated cardiomyopathy by MRI in vivo.
    Journal of magnetic resonance imaging : JMRI, 2013, Volume: 37, Issue:3

    Topics: Adrenergic beta-1 Receptor Agonists; Animals; Cardiomyopathy, Dilated; Disease Models, Animal; Dobutamine; Electrocardiography; Heart; Heart Failure; Heart Rate; Magnetic Resonance Imaging; Mice; Myocardium; Receptors, Adrenergic, beta; Software; Ventricular Function, Left

2013
Economic evaluation of levosimendan versus dobutamine for the treatment of acute heart failure in Italy.
    Advances in therapy, 2012, Volume: 29, Issue:12

    Topics: Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Heart Failure; Hospitalization; Humans; Hydrazones; Pyridazines; Retrospective Studies; Rome; Simendan; Treatment Outcome

2012
Oxygen costs of left ventricular contractility for dobutamine and Ca(2+) in normal rat hearts and the cost for dobutamine in Ca(2+) overload-induced failing hearts.
    The Japanese journal of physiology, 2002, Volume: 52, Issue:2

    Topics: Animals; Calcium Chloride; Cardiotonic Agents; Dobutamine; Heart Failure; Male; Myocardial Contraction; Myocardial Stunning; Myocardium; Oxygen Consumption; Rats; Rats, Wistar; Ventricular Function, Left

2002
Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure.
    Circulation research, 2002, Aug-23, Volume: 91, Issue:4

    Topics: Acetanilides; Animals; Cardiotonic Agents; Chronic Disease; Coronary Circulation; Disease Models, Animal; Dobutamine; Dogs; Drug Administration Schedule; Fatty Acids, Nonesterified; Glucose; Heart; Heart Failure; Heart Rate; Lactic Acid; Myocardium; Oxygen Consumption; Piperazines; Ranolazine; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left

2002
[How is catecholamine therapy carried out in heart failure?].
    Deutsche medizinische Wochenschrift (1946), 2002, Oct-04, Volume: 127, Issue:40

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Catecholamines; Chronic Disease; Dobutamine; Drug Therapy, Combination; Epinephrine; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Treatment Outcome

2002
Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 283, Issue:5

    Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Blood Pressure; Cardiotonic Agents; Desipramine; Dobutamine; Dogs; Heart Failure; Immunohistochemistry; Myocardial Contraction; Myocardium; Neuropeptide Y; Norepinephrine; Organ Size; Presynaptic Terminals; Receptors, Adrenergic, beta; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Ventricular Dysfunction, Right

2002
Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:2

    Topics: Animals; Azetidines; Cardiotonic Agents; Chronic Disease; Coronary Circulation; Cyclic AMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Failure; Heart Rate; Male; Myocardial Contraction; Myocardium; Oxygen Consumption; Sodium Channel Agonists; Ventricular Function, Left

2002
Incidence and risk calculation of inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anaesthesia record-keeping system.
    British journal of anaesthesia, 2002, Volume: 89, Issue:3

    Topics: Aged; Anesthesia; Cardiopulmonary Bypass; Cardiotonic Agents; Dobutamine; Enoximone; Epinephrine; Female; Heart Failure; Humans; Male; Medical Records Systems, Computerized; Middle Aged; Myocardial Infarction; Preoperative Care; Retrospective Studies; Risk Factors; Time Factors

2002
Successful resuscitation of serious bupivacaine intoxication in a patient with pre-existing heart failure.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2003, Volume: 50, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Anesthetics, Local; Bupivacaine; Clonidine; Dobutamine; Female; Heart Failure; Humans; Injections, Intravenous; Middle Aged; Resuscitation

2003
Disparate force-frequency effects of pimobendan and dobutamine in conscious dogs with tachycardia-induced cardiomyopathy.
    Journal of cardiac failure, 2002, Volume: 8, Issue:6

    Topics: Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Cardiotonic Agents; Dobutamine; Dogs; Heart Failure; Heart Rate; Myocardial Contraction; Pyridazines; Stimulation, Chemical; Stroke Volume; Tachycardia; Ventricular Pressure

2002
Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability.
    European journal of heart failure, 2003, Volume: 5, Issue:1

    Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures; Cell Survival; Chronic Disease; Coronary Artery Disease; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardium; Postoperative Complications; Prognosis; Severity of Illness Index; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left

2003
A bridge for the 21st century in heart transplantation?
    American heart journal, 2003, Volume: 145, Issue:2

    Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Heart Transplantation; Humans; Milrinone; Prospective Studies; Randomized Controlled Trials as Topic

2003
Prognostic value of dobutamine stress echocardiography in patients with diabetes.
    Diabetes care, 2003, Volume: 26, Issue:4

    Topics: Adrenergic beta-Agonists; Coronary Disease; Diabetic Angiopathies; Disease-Free Survival; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Hypercholesterolemia; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Survival Analysis; Time Factors; Treatment Outcome

2003
Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2003, Volume: 22, Issue:4

    Topics: Adult; Aged; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Electric Countershock; Female; Heart Failure; Heart Transplantation; Home Care Services; Humans; Male; Middle Aged; Milrinone; Outcome Assessment, Health Care; Retrospective Studies; Severity of Illness Index; Waiting Lists

2003
Dobutamine for patients with end-stage heart failure in a hospice program?
    Journal of palliative medicine, 2003, Volume: 6, Issue:1

    Topics: Aged; Cardiotonic Agents; Dobutamine; Heart Failure; Hospice Care; Humans; Male; Palliative Care; Treatment Outcome; United States

2003
Sustained use of nesiritide to aid in bridging to heart transplant.
    Clinical cardiology, 2003, Volume: 26, Issue:5

    Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Preoperative Care; Time Factors; Treatment Outcome; Waiting Lists

2003
The cul-de-sac at the end of the road.
    Journal of cardiac failure, 2003, Volume: 9, Issue:3

    Topics: Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Palliative Care

2003
Hemodynamic effects of a new inotropic compound, PST-2744, in dogs with chronic ischemic heart failure.
    Journal of cardiovascular pharmacology, 2003, Volume: 42, Issue:2

    Topics: Animals; Cardiotonic Agents; Dobutamine; Dogs; Etiocholanolone; Heart Failure; Hemodynamics; Ventricular Dysfunction, Left

2003
Hypercontractile heart failure caused by catecholamine therapy in premature neonates.
    Acta paediatrica (Oslo, Norway : 1992), 2003, Volume: 92, Issue:7

    Topics: Adrenergic Agonists; Adrenergic beta-Agonists; Dobutamine; Drug Therapy, Combination; Epinephrine; Female; Heart Failure; Heart Rate; Humans; Hypertrophy, Left Ventricular; Hypotension; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Myocardial Contraction; Norepinephrine; Ultrasonography

2003
Nesiritide in acute heart failure.
    Lancet (London, England), 2003, Sep-20, Volume: 362, Issue:9388

    Topics: Acute Disease; Cardiac Output, Low; Clinical Trials as Topic; Comorbidity; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Treatment Outcome

2003
Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure.
    American journal of physiology. Heart and circulatory physiology, 2004, Volume: 286, Issue:2

    Topics: Ascorbic Acid; Cardiotonic Agents; Dobutamine; Female; Heart; Heart Failure; History, Early Modern 1451-1600; Humans; Male; Middle Aged; Myocardial Contraction; Oxidation-Reduction; Reference Values; Ventricular Dysfunction, Left

2004
Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST).
    Circulation, 2003, Nov-11, Volume: 108, Issue:19

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Dobutamine; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Propanolamines; Prospective Studies; Radionuclide Imaging; Stroke Volume; Ventricular Function, Left

2003
Preliminary clinical experience with the repetitive administration of levosimendan in patients with end-stage heart failure.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2003, Volume: 4 Suppl 2

    Topics: Adolescent; Adult; Aged; Biomarkers; Blood Pressure; Calcium Channels, L-Type; Cardiac Output, Low; Cardiotonic Agents; Diastole; Dobutamine; Dopamine; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Greece; Heart Failure; Heart Ventricles; Hematocrit; Hemoglobins; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Potassium; Pyridazines; Severity of Illness Index; Simendan; Stimulation, Chemical; Survival Analysis; Systole; Treatment Outcome; Ventricular Dysfunction, Left

2003
Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.
    Circulation, 2004, Feb-24, Volume: 109, Issue:7

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Signaling; Calcium-Transporting ATPases; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Dogs; Drug Evaluation, Preclinical; Heart Failure; Myocardial Contraction; Norepinephrine; Phosphorylation; Protein Processing, Post-Translational; Receptors, Adrenergic, beta; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Tachycardia, Ventricular; Tacrolimus Binding Proteins; Tetrazoles; Valine; Valsartan; Ventricular Remodeling

2004
The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Journal of the American College of Cardiology, 2004, Mar-17, Volume: 43, Issue:6

    Topics: Carbon Radioisotopes; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Coronary Circulation; Dobutamine; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Regional Blood Flow; Stroke Volume; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left

2004
Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:4

    Topics: Adult; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Dopamine; Empirical Research; Female; Health Care Costs; Heart Failure; Heart Transplantation; Home Infusion Therapy; Humans; Longitudinal Studies; Male; Middle Aged; Milrinone; Survival Rate; Waiting Lists

2004
To infuse or not?
    Chest, 2004, Volume: 125, Issue:4

    Topics: Aged; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infusions, Intravenous

2004
Dobutamine-induced myoclonia in severe renal failure.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:5

    Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Myoclonus

2004
Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure).
    European journal of heart failure, 2004, Volume: 6, Issue:4

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Catecholamines; Coronary Circulation; Disease Models, Animal; Dobutamine; Dogs; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Heart Ventricles; Male; Models, Cardiovascular; Myocardial Contraction; Norepinephrine; Oxygen Consumption; Severity of Illness Index; Stroke Volume; Vasodilation

2004
Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure.
    Circulation research, 2004, Aug-20, Volume: 95, Issue:4

    Topics: Actin Cytoskeleton; Animals; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Disease Progression; Dobutamine; Drug Resistance; Enzyme Induction; Heart Failure; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Myosin Heavy Chains; Myosin Light Chains; Osteopontin; Phosphorylation; Protein Kinase C; Protein Kinase C-epsilon; Protein Processing, Post-Translational; Recombinant Fusion Proteins; RNA, Messenger; Sialoglycoproteins

2004
Hypersensitivity myocarditis complicating hypertrophic cardiomyopathy heart.
    The Canadian journal of cardiology, 2004, Volume: 20, Issue:9

    Topics: Adrenergic beta-Agonists; Cardiomyopathy, Hypertrophic; Dobutamine; Drug Hypersensitivity; Echocardiography; Female; Heart Failure; Humans; Middle Aged; Mitral Valve Insufficiency; Myocarditis; Myocardium; Stroke Volume; Ventricular Dysfunction, Left

2004
Influence of gender and race on hemodynamic response to dobutamine during dobutamine stress echocardiography.
    The American journal of cardiology, 2004, Aug-15, Volume: 94, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Stress; Electrocardiography; Ethnicity; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Mathematical Computing; Middle Aged; Prospective Studies; Reference Values

2004
Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
    Circulation, 2004, Oct-19, Volume: 110, Issue:16

    Topics: Adrenergic beta-Agonists; Animals; Autocrine Communication; Caveolin 3; Caveolins; Dobutamine; Enzyme Induction; Heart Failure; Isoproterenol; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Ryanodine Receptor Calcium Release Channel; Sarcolemma; Ventricular Dysfunction, Left

2004
Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failure.
    The American journal of cardiology, 2005, Jan-15, Volume: 95, Issue:2

    Topics: Case-Control Studies; Defibrillators, Implantable; Dobutamine; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Ventricular Dysfunction, Left

2005
Heart failure after Caesarean section for twin delivery.
    European journal of anaesthesiology, 2004, Volume: 21, Issue:12

    Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Cardiotonic Agents; Catheterization, Swan-Ganz; Cesarean Section; Diagnosis, Differential; Digoxin; Diuretics; Dobutamine; Electrocardiography; Female; Furosemide; Heart Failure; Humans; Hydralazine; Intubation, Intratracheal; Nitroprusside; Pulmonary Edema; Twins; Vasodilator Agents

2004
Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
    The American journal of cardiology, 2005, Mar-15, Volume: 95, Issue:6

    Topics: Adult; Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Multivariate Analysis; Pyridazines; Radionuclide Ventriculography; Risk; Simendan; Survival Rate

2005
Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2005, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Dobutamine; Dopamine; Drug Administration Schedule; Drug Therapy, Combination; E-Selectin; Enoximone; Epidemiologic Methods; Epinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptides; Nerve Tissue Proteins; Norepinephrine; Peptide Fragments; Prognosis; Shock, Cardiogenic

2005
Impaired vasoreactivity in end-stage heart failure patients on intravenous inotropic support.
    Journal of cardiac failure, 2005, Volume: 11, Issue:5

    Topics: Blood Flow Velocity; Brachial Artery; Cardiac Catheterization; Cardiotonic Agents; Dobutamine; Echocardiography; Exercise Test; Follow-Up Studies; Forearm; Heart Failure; Humans; Injections, Intravenous; Isometric Contraction; Male; Middle Aged; Milrinone; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler; Vasoconstriction; Ventricular Function, Right

2005
Protein kinase C epsilon induces systolic cardiac failure marked by exhausted inotropic reserve and intact Frank-Starling mechanism.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:5

    Topics: Actin Cytoskeleton; Adenosine Triphosphatases; Animals; Animals, Genetically Modified; Cardiotonic Agents; Dobutamine; Electrophoresis, Polyacrylamide Gel; Heart Failure; Mice; Myocardial Contraction; Myocardium; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Sarcomeres; Systole; Ultrasonography

2005
The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system.
    Journal of molecular and cellular cardiology, 2005, Volume: 39, Issue:3

    Topics: Animals; Blotting, Western; Cardiac Pacing, Artificial; Cardiotonic Agents; Creatine; Creatine Kinase; Creatine Kinase, BB Form; Creatine Kinase, MM Form; Dobutamine; Dogs; Dose-Response Relationship, Drug; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Isoenzymes; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors

2005
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Journal of the American College of Cardiology, 2005, Jul-05, Volume: 46, Issue:1

    Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Retrospective Studies

2005
Acute decompensated heart failure: the shrinking role of inotropic therapy.
    Journal of the American College of Cardiology, 2005, Jul-05, Volume: 46, Issue:1

    Topics: Acute Disease; Cardiovascular Agents; Dobutamine; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Treatment Outcome

2005
[Cost analysis of the treatment of acute decompensated heart failure. Levosimendan versus dobutamine].
    Arquivos brasileiros de cardiologia, 2005, Volume: 85, Issue:1

    Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Health Care Costs; Heart Failure; Hospital Costs; Humans; Hydrazones; Length of Stay; Pyridazines; Simendan

2005
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling.
    Gene therapy, 2006, Volume: 13, Issue:1

    Topics: Adenoviridae; Adrenergic beta-Agonists; Animals; Calcium; Calcium-Transporting ATPases; Dobutamine; Echocardiography; Genetic Therapy; Genetic Vectors; Heart Failure; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxygen Consumption; Perfusion; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Transduction, Genetic

2006
Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy.
    The American journal of cardiology, 2005, Aug-15, Volume: 96, Issue:4

    Topics: Blood Pressure; Cardiotonic Agents; Death, Sudden, Cardiac; Dobutamine; Echocardiography, Stress; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Netherlands; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Survival Rate

2005
Risk of death with nesiritide.
    JAMA, 2005, Aug-24, Volume: 294, Issue:8

    Topics: Adrenergic beta-Antagonists; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain

2005
Risk of death with nesiritide.
    JAMA, 2005, Aug-24, Volume: 294, Issue:8

    Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Research Design

2005
The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).
    The American journal of cardiology, 2005, Sep-19, Volume: 96, Issue:6A

    Topics: Adrenergic beta-Agonists; Aged; Biomarkers; Dobutamine; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Agents; Natriuretic Peptide, Brain; Pilot Projects; Predictive Value of Tests; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Troponin I; Troponin T

2005
Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance.
    Heart (British Cardiac Society), 2005, Volume: 91, Issue:11

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Dobutamine; Feasibility Studies; Heart Failure; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Myocardial Ischemia; Propanolamines; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left

2005
Automated drug delivery system to control systemic arterial pressure, cardiac output, and left heart filling pressure in acute decompensated heart failure.
    Journal of applied physiology (Bethesda, Md. : 1985), 2006, Volume: 100, Issue:4

    Topics: Animals; Antihypertensive Agents; Atrial Function, Left; Automation; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; Drug Delivery Systems; Drug Therapy, Combination; Furosemide; Heart Failure; Infusions, Intravenous; Models, Cardiovascular; Nitroprusside

2006
[Therapy of acute decompensated heart failure with levosimendan].
    Medizinische Klinik (Munich, Germany : 1983), 2006, Mar-22, Volume: 101 Suppl 1

    Topics: Adult; Aged; Calcium Channel Agonists; Cardiotonic Agents; Conscious Sedation; Critical Care; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Norepinephrine; Pyridazines; Shock, Cardiogenic; Simendan

2006
Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Pharmacotherapy, 2006, Volume: 26, Issue:8

    Topics: Acute Disease; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Health Care Costs; Heart Failure; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Odds Ratio; Patient Readmission; Regression Analysis; Retrospective Studies; Treatment Outcome

2006
Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
    Critical care medicine, 2006, Volume: 34, Issue:11

    Topics: Animals; Cardiotonic Agents; Dobutamine; Dogs; Heart Failure; Hydrazones; Hypertension, Pulmonary; Prospective Studies; Pulmonary Artery; Pulmonary Circulation; Pyridazines; Random Allocation; Simendan; Ventricular Dysfunction, Right

2006
Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    The American journal of cardiology, 2006, Dec-15, Volume: 98, Issue:12

    Topics: Aged; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Kidney; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Survival Rate; Urine

2006
Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:4

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; Apoptosis; Cardiomyopathy, Dilated; Dobutamine; Down-Regulation; Heart Failure; Male; Myocardial Contraction; Myocardium; Norepinephrine; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Systole; Ventricular Dysfunction, Left

2007
Chronic inotropic therapy in end-stage heart failure.
    American heart journal, 2006, Volume: 152, Issue:6

    Topics: Aged; Cardiotonic Agents; Dobutamine; Drug Administration Schedule; Drug Costs; Female; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Male; Medicare; Middle Aged; Milrinone; Severity of Illness Index; Time Factors

2006
Cardiac hypertrophy and reduced contractility in hearts deficient in the titin kinase region.
    Circulation, 2007, Feb-13, Volume: 115, Issue:6

    Topics: Animals; Calcium; Cardiomegaly; Connectin; Dobutamine; Heart Failure; Mice; Mice, Knockout; Muscle Proteins; Myocardial Contraction; Protein Kinase C; Protein Kinases; Signal Transduction; Tamoxifen; Tripartite Motif Proteins; Ubiquitin-Protein Ligases

2007
Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Critical care medicine, 2007, Volume: 35, Issue:5

    Topics: Animals; Cardiotonic Agents; Diastole; Disease Models, Animal; Dobutamine; Heart Failure; Hydrazones; Lipopolysaccharides; Milrinone; Pyridazines; Rabbits; Sepsis; Simendan; Systole; Ventricular Function, Left

2007
Home inotropic therapy in children.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2007, Volume: 26, Issue:5

    Topics: Adolescent; Cardiotonic Agents; Child; Dobutamine; Female; Health Care Costs; Heart Failure; Heart Transplantation; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Time Factors; Treatment Outcome; Waiting Lists

2007
Importance of contractile reserve for CRT.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2007, Volume: 9, Issue:9

    Topics: Aged; Cardiac Pacing, Artificial; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Ischemia; Male; Middle Aged; Myocardial Contraction; Pacemaker, Artificial; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2007
A struggle to SURVIVE: to abandon or not to abandon levosimendan?
    Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:5

    Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; Pyridazines; Simendan; Survival Rate; Treatment Outcome

2007
Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
    American heart journal, 2007, Volume: 154, Issue:4

    Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Cardiac Catheterization; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Reactive Oxygen Species; Thermodilution; Ventricular Function, Left

2007
Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Editorial to: "Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et al."
    Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:6

    Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Glomerular Filtration Rate; Heart Failure; Humans; Hydrazones; Kidney; Pyridazines; Simendan

2007
Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy.
    American heart journal, 2007, Volume: 154, Issue:6

    Topics: Cardiac Pacing, Artificial; Dobutamine; Echocardiography; Heart Failure; Humans; Myocardial Contraction; Regression Analysis; Sensitivity and Specificity; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling

2007
[Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner].
    Nederlands tijdschrift voor geneeskunde, 2007, Nov-03, Volume: 151, Issue:44

    Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Health Care Costs; Heart Failure; Home Infusion Therapy; Humans; Nursing; Quality of Life

2007
[Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
    Nederlands tijdschrift voor geneeskunde, 2007, Nov-03, Volume: 151, Issue:44

    Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Female; Health Care Costs; Heart Failure; Heart Transplantation; Hemodynamics; Home Infusion Therapy; Humans; Male; Middle Aged; Nursing; Quality of Life; Retrospective Studies; Treatment Outcome; Waiting Lists

2007
Endomyocardial upregulation of beta1 adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy.
    Journal of cardiac failure, 2008, Volume: 14, Issue:2

    Topics: Aged; Cardiac Output, Low; Cardiac Pacing, Artificial; Dobutamine; Endocardium; Exercise Tolerance; Female; Gene Expression; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Muscle Contraction; Myocardial Contraction; Myocardium; Receptors, Adrenergic; Stroke Volume; Ventricular Function, Left

2008
Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification.
    Circulation research, 2008, May-09, Volume: 102, Issue:9

    Topics: Adrenergic beta-Agonists; Animals; Calcinosis; Calcium-Binding Proteins; Cardiomyopathies; Cell Adhesion Molecules; Core Binding Factor Alpha 1 Subunit; Decorin; Disease Models, Animal; Dobutamine; Dystrophin; Extracellular Matrix Proteins; Female; Fibrosis; Heart Failure; Integrin beta1; Isoproterenol; Male; Matrix Gla Protein; Mice; Mice, Inbred mdx; Mice, Knockout; Myocytes, Cardiac; Necrosis; Phenotype; Pregnancy; Proteoglycans; RNA, Messenger; Severity of Illness Index; Time Factors; Up-Regulation; Ventricular Function

2008
Comparison of the initial hospitalization costs between the patients treated with dobutamine and the patients treated with amrinone for acute decompensated heart failure in a Japanese institute.
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2008, Volume: 11 Suppl 1

    Topics: Aged; Amrinone; Cardiotonic Agents; Chi-Square Distribution; Cost-Benefit Analysis; Dobutamine; Drug Costs; Economics, Pharmaceutical; Female; Heart Failure; Hospital Costs; Humans; Japan; Length of Stay; Male; Statistics, Nonparametric

2008
The effect of pharmacological stress on intraventricular dyssynchrony in left ventricular systolic dysfunction.
    European journal of heart failure, 2008, Volume: 10, Issue:4

    Topics: Aged; Cardiac Pacing, Artificial; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Doppler, Color; Echocardiography, Stress; Electrocardiography; Female; Heart Failure; Heart Ventricles; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Stroke Volume; Systole; Ventricular Dysfunction, Left; Ventricular Function, Left

2008
NT-proBNP response to dobutamine stress echocardiography predicts left ventricular contractile reserve in dilated cardiomyopathy.
    European journal of heart failure, 2008, Volume: 10, Issue:5

    Topics: Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Natriuretic Peptide, Brain; Peptide Fragments

2008
Hemodynamic effects of dobutamine in patients with an exacerbation of chronic systolic heart failure treated with low doses of carvedilol.
    International journal of clinical pharmacology and therapeutics, 2008, Volume: 46, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Stroke Volume

2008
The effects of dobutamine on renal sympathetic activity in human heart failure.
    Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:5

    Topics: Adrenergic beta-Agonists; Dobutamine; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Renal Plasma Flow; Sympathetic Nervous System

2008
Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:6

    Topics: Age Factors; Animals; Cardiac Output; Cardiomyopathy, Restrictive; Cardiotonic Agents; Cell Size; Diastole; Disease Progression; Dobutamine; Echocardiography, Doppler; Genotype; Heart Failure; Heart Rate; Mice; Mice, Transgenic; Mutation; Myocardial Contraction; Phenotype; Troponin I

2008
Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach.
    International journal of cardiology, 2008, Aug-01, Volume: 128, Issue:1

    Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Pyridazines; Simendan; Time Factors

2008
The prolonged lowering effect of levosimendan on brain natriuretic peptide levels in patients with decompansated heart failure: clinical implications.
    International journal of cardiology, 2008, Aug-01, Volume: 128, Issue:1

    Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Pyridazines; Simendan; Time Factors

2008
Combined haemodynamic effects of low doses of dopamine and dobutamine in patients with acute infarction and cardiac failure.
    Archives internationales de physiologie et de biochimie, 1984, Volume: 92, Issue:4

    Topics: Acute Disease; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Dopamine; Drug Therapy, Combination; Electroencephalography; Heart Failure; Heart Rate; Hemodynamics; Humans; Kidney; Myocardial Infarction; Pulmonary Circulation; Vascular Resistance

1984
Possible value of H2-receptor agonists for treatment of catecholamine-insensitive congestive heart failure.
    Pharmacology & therapeutics, 1984, Volume: 24, Issue:2

    Topics: Adenylyl Cyclases; Adult; Aged; Catecholamines; Dihydroalprenolol; Dobutamine; Female; Heart Failure; Heart Valve Diseases; Hemodynamics; Humans; Imidazoles; Impromidine; Male; Middle Aged; Myocardial Contraction; Receptors, Adrenergic, beta; Receptors, Histamine; Receptors, Histamine H2

1984
[Therapy of heart failure with beta adrenoceptor agonists].
    MMW, Munchener medizinische Wochenschrift, 1983, Apr-08, Volume: 125, Issue:14

    Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Heart Failure; Humans; Practolol; Prenalterol

1983
New and old inotropic drugs: controversies and challenges, Oslo, Norway, May 21-22, 1982: reflections on inotropic drugs: a personal commentary.
    Clinical cardiology, 1984, Volume: 7, Issue:2

    Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Dopamine; Heart Failure; Humans; Kinetics; Myocardial Contraction

1984
[Alternatives to digitalis therapy?].
    Deutsche medizinische Wochenschrift (1946), 1981, May-01, Volume: 106, Issue:18

    Topics: Albuterol; Captopril; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Teprotide

1981
Sympathomimetic amines: potential clinical applications in ischemic heart disease.
    American heart journal, 1982, Volume: 103, Issue:4 Pt 2

    Topics: Animals; Coronary Disease; Deoxyepinephrine; Dobutamine; Dogs; Dopamine; Heart Failure; Humans; Levodopa; Myocardial Contraction; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Sympathomimetics

1982
Effect of combined nitroglycerin and dobutamine infusion in left ventricular dysfunction.
    American heart journal, 1983, Volume: 106, Issue:1 Pt 1

    Topics: Catecholamines; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin

1983
Dobutamine effects on blood gases and hemodynamics in acute myocardial infarction with heart failure.
    Acta cardiologica, 1984, Volume: 39, Issue:2

    Topics: Aged; Carbon Dioxide; Cardiac Output; Catecholamines; Dobutamine; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen; Pulmonary Circulation; Pulmonary Wedge Pressure

1984
Cardiogenic pulmonary edema.
    American family physician, 1984, Volume: 30, Issue:5

    Topics: Aminophylline; Cardiovascular Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Morphine; Nitroglycerin; Nitroprusside; Pulmonary Edema; Verapamil

1984
[Diagnostic possibilities and therapy in the acute phase of myocardial infarct].
    Wiener medizinische Wochenschrift (1946), 1984, Dec-31, Volume: 134, Issue:23-24

    Topics: Digitalis Glycosides; Diuretics; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Nitroglycerin; Nitroprusside; Norepinephrine; Prognosis; Vasodilator Agents

1984
[Catecholamines in internal medicine emergencies].
    Wiener medizinische Wochenschrift (1946), 1984, Jul-31, Volume: 134, Issue:13-14

    Topics: Acute Disease; Catecholamines; Coronary Disease; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Oxygen Consumption; Shock, Cardiogenic; Shock, Septic

1984
Hemodynamic effects of dobutamine in patients below and over 65 years, with left heart failure secondary to an acute myocardial infarction.
    Gerontology, 1984, Volume: 30, Issue:6

    Topics: Age Factors; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Stroke Volume; Vascular Resistance

1984
Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
    Arzneimittel-Forschung, 1984, Volume: 34, Issue:3A

    Topics: Administration, Oral; Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiotonic Agents; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Injections, Intravenous; Male; Myocardial Contraction; Pyrazines; Quinolines

1984
[Combined medication of nitroprusside and dopamine or dobutamine in acute heart failure].
    Zhonghua xin xue guan bing za zhi, 1984, Volume: 12, Issue:4

    Topics: Acute Disease; Adult; Aged; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Humans; Male; Middle Aged; Nitroprusside

1984
Drugs five years later. Dobutamine.
    Annals of internal medicine, 1983, Volume: 99, Issue:4

    Topics: Animals; Cardiac Output; Catecholamines; Coronary Disease; Dobutamine; Dogs; Dopamine; Heart Failure; Heart Rate; Heart Ventricles; Humans; Myocardial Contraction; Myocardial Infarction; Stroke Volume

1983
[Dopamine and dobutamine as circulatory drugs].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1983, Nov-28, Volume: 38, Issue:48

    Topics: Catecholamines; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Vasodilator Agents

1983
[Heart failure and acute myocardial infarct. Current treatment].
    Bulletin et memoires de l'Academie royale de medecine de Belgique, 1983, Volume: 138, Issue:11

    Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Imidazoles; Labetalol; Myocardial Infarction; Phentolamine; Vasodilator Agents

1983
Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 228, Issue:2

    Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Time Factors; Vascular Resistance

1984
[Dobutamine in childhood].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1984, Volume: 132, Issue:1

    Topics: Adolescent; Age Factors; Blood Pressure; Catecholamines; Child; Child, Preschool; Dobutamine; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn

1984
Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine.
    The American journal of cardiology, 1984, May-01, Volume: 53, Issue:9

    Topics: Blood Flow Velocity; Cardiac Output; Catecholamines; Dobutamine; Exercise Test; Heart; Heart Failure; Hemodynamics; Humans; Lactates; Leg; Muscles; Oxygen Consumption

1984
Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
    Journal of the American College of Cardiology, 1984, Volume: 4, Issue:2

    Topics: Adult; Blood Pressure; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Myocardial Contraction; Pulmonary Artery; Pulmonary Wedge Pressure; Stimulation, Chemical; Vascular Resistance

1984
Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure.
    Chest, 1980, Volume: 78, Issue:5

    Topics: Adult; Aged; Cardiac Output; Catecholamines; Dobutamine; Drug Synergism; Heart Failure; Hemodynamics; Humans; Middle Aged; Nitroglycerin; Pulmonary Wedge Pressure

1980
Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure.
    The American journal of cardiology, 1983, Volume: 51, Issue:3

    Topics: Catecholamines; Catheterization; Dobutamine; Drug Tolerance; Female; Heart Failure; Humans; Infusions, Parenteral; Male; Middle Aged; Outpatient Clinics, Hospital; Quality of Life; Stroke Volume; Time Factors

1983
Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure.
    Journal of the American College of Cardiology, 1983, Volume: 1, Issue:2 Pt 1

    Topics: Adult; Catecholamines; Coronary Circulation; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Stimulation, Chemical; Vasodilation

1983
The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Herz, 1983, Volume: 8, Issue:1

    Topics: Catecholamines; Dobutamine; Dopamine; Ethanolamines; Heart Failure; Hemodynamics; Humans; Practolol; Prenalterol

1983
Radiocardiographic assessment of dobutamine and isosorbide dinitrate therapy in patients with mitral stenosis and pulmonary congestion.
    Japanese circulation journal, 1983, Volume: 47, Issue:3

    Topics: Adult; Aged; Blood Pressure; Blood Volume; Cardiac Output; Catecholamines; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Mitral Valve Stenosis; Pulmonary Edema

1983
[Positive inotropic effects of doxaminol in congestive heart failure].
    Zeitschrift fur Kardiologie, 1983, Volume: 72, Issue:1

    Topics: Aged; Chemical Phenomena; Chemistry; Dibenzoxepins; Dobutamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Sympathomimetics; Thermodilution

1983
Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure.
    The American journal of cardiology, 1983, Jan-01, Volume: 51, Issue:1

    Topics: Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Oxygen Consumption; Pulmonary Wedge Pressure; Stroke Volume

1983
The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy.
    American heart journal, 1983, Volume: 106, Issue:1 Pt 1

    Topics: Adenosine Triphosphate; Adult; Aged; Blood Urea Nitrogen; Catecholamines; Coronary Circulation; Creatine; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardium; Sodium

1983
[Noninvasive monitoring of stroke volume during intravenous infusion of dobutamine].
    Kardiologia polska, 1983, Volume: 26, Issue:1

    Topics: Adult; Cardiac Output; Catecholamines; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Infusions, Parenteral; Male; Middle Aged; Monitoring, Physiologic; Plethysmography, Impedance; Stroke Volume

1983
Dobutamine: a new inotropic agent.
    Nursing, 1980, Volume: 10, Issue:3

    Topics: Adult; Catecholamines; Digoxin; Dobutamine; Female; Heart Failure; Humans; Myocardial Infarction

1980
Haemodynamic effects of dobutamine in patients with congestive heart failure receiving captopril.
    British heart journal, 1981, Volume: 46, Issue:5

    Topics: Aged; Captopril; Cardiac Output; Catecholamines; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardium; Oxygen Consumption; Proline

1981
Cardiotonic agents in the management of chronic cardiac failure.
    American heart journal, 1982, Volume: 103, Issue:4 Pt 2

    Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Ethanolamines; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Kidney Function Tests; Male; Middle Aged; Oxygen Consumption

1982
Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery disease.
    European heart journal, 1982, Volume: 3, Issue:1

    Topics: Adult; Aged; Catecholamines; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption

1982
Hemodynamic effects of dobutamine in children with cardiovascular failure.
    European journal of pediatrics, 1982, Volume: 139, Issue:1

    Topics: Adolescent; Blood Pressure; Cardiac Output; Catecholamines; Child; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Infant; Infant, Newborn; Pulmonary Artery; Stroke Volume; Vascular Resistance

1982
[Hemodynamic effects of dobutamine in patients with severe low-output heart failure (author's transl)].
    Giornale italiano di cardiologia, 1980, Volume: 10, Issue:9

    Topics: Adult; Aged; Cardiac Output, Low; Cardiomyopathy, Hypertrophic; Catecholamines; Coronary Disease; Dobutamine; Heart Failure; Hemodynamics; Humans; Middle Aged

1980
The comparison of the effects of AR-L 115 BS and dobutamine in patients with severe cardiac failure.
    Arzneimittel-Forschung, 1981, Volume: 31, Issue:1a

    Topics: Blood Pressure; Cardiotonic Agents; Catecholamines; Dobutamine; Female; Heart Failure; Heart Rate; Humans; Imidazoles; Male

1981
[Standard therapy of acute myocardial infarction.--II. Management of hemodynamic complications. (author's transl)].
    Herz, 1981, Volume: 6, Issue:1

    Topics: Analgesics; Atropine; Digoxin; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Rupture; Hemodynamics; Humans; Hypertension; Hypotension; Myocardial Infarction; Propranolol; Shock, Cardiogenic; Vasodilator Agents

1981
Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease.
    Circulation, 1981, Volume: 63, Issue:6

    Topics: Adult; Aged; Catecholamines; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Hemodynamics; Humans; Lactates; Male; Middle Aged; Myocardium; Radionuclide Imaging

1981
Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
    The American journal of cardiology, 1981, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Aged; Aminopyridines; Amrinone; Cardiac Output; Catecholamines; Chronic Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Time Factors

1981
[Catecholamines in the treatment of therapy-refractory heart insufficiency].
    ZFA. Zeitschrift fur Allgemeinmedizin, 1981, Jul-10, Volume: 57, Issue:19

    Topics: Catecholamines; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans

1981
Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
    American heart journal, 1981, Volume: 102, Issue:3 Pt 2

    Topics: Administration, Oral; Adult; Cardiotonic Agents; Dobutamine; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Heart Failure; Hemodynamics; Humans; Time Factors; Vasodilator Agents

1981
Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics.
    The American journal of cardiology, 1981, Volume: 48, Issue:3

    Topics: Aged; Catecholamines; Coronary Circulation; Coronary Disease; Dobutamine; Female; Heart Failure; Humans; Lactates; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Pulmonary Wedge Pressure; Stroke Volume

1981
Ventricular failure.
    Archives of internal medicine, 1981, Volume: 141, Issue:11

    Topics: Dobutamine; Heart Failure; Heart Ventricles; Humans; Intra-Aortic Balloon Pumping

1981
[Sympathomimetics in intensive medicine].
    Deutsche medizinische Wochenschrift (1946), 1981, Oct-16, Volume: 106, Issue:42

    Topics: Anaphylaxis; Critical Care; Dobutamine; Dopamine; Epinephrine; Heart Failure; Humans; Isoproterenol; Metaproterenol; Norepinephrine; Resuscitation; Sympathomimetics

1981
[Dobutamine in low cardiac output syndrome. Haemodynamic study (author's transl)].
    Revista espanola de anestesiologia y reanimacion, 1981, Volume: 28, Issue:5

    Topics: Adult; Cardiac Output, Low; Catecholamines; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Isoproterenol; Male; Postoperative Complications

1981
New approaches to therapy of acute heart failure.
    American family physician, 1980, Volume: 21, Issue:2

    Topics: Antihypertensive Agents; Dobutamine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Oxygen Inhalation Therapy; Prazosin

1980
Drug regimens for congestive heart failure.
    Geriatrics, 1980, Volume: 35, Issue:7

    Topics: Cardiac Glycosides; Cardiotonic Agents; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Vasodilator Agents

1980
Tolerance to dobutamine after a 72 hour continuous infusion.
    The American journal of medicine, 1980, Volume: 69, Issue:2

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Drug Tolerance; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Systole; Time Factors

1980
A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure.
    The New England journal of medicine, 1980, Oct-09, Volume: 303, Issue:15

    Topics: Aged; Blood Pressure; Catecholamines; Digoxin; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Vascular Resistance

1980
Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
    The Journal of pharmacology and experimental therapeutics, 1980, Volume: 215, Issue:2

    Topics: Catecholamines; Coronary Circulation; Dobutamine; Heart Failure; Humans; Mitochondria, Heart

1980
New catecholamines in clinical cardiovascular medicine.
    Kardiologia polska, 1980, Volume: 23, Issue:9

    Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Catecholamines; Dobutamine; Heart Diseases; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Myocardium; Oxygen Consumption

1980
Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.
    The American journal of cardiology, 1981, Volume: 47, Issue:3

    Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Ethanolamines; Female; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume; Vascular Resistance

1981
Dobutamine as palliative drug in home-care advanced cancer patients.
    Journal of pain and symptom management, 1994, Volume: 9, Issue:7

    Topics: Dobutamine; Female; Heart Failure; Home Care Services; Humans; Middle Aged; Neoplasms; Palliative Care

1994
Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure.
    Lancet (London, England), 1995, Apr-08, Volume: 345, Issue:8954

    Topics: Dobutamine; Heart Failure; Heart Rate; Humans; Receptors, Adrenergic, beta

1995
Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.
    Cardiovascular drugs and therapy, 1995, Volume: 9, Issue:1

    Topics: Amrinone; Animals; Blood Pressure; Bucladesine; Calcium; Cardiomyopathies; Cardiotonic Agents; Cricetinae; Digoxin; Disease Models, Animal; Dobutamine; Energy Metabolism; Heart Failure; Isoproterenol; Magnetic Resonance Spectroscopy; Mesocricetus; Myocardial Contraction; Oxygen Consumption; Phosphates; Phosphorylation

1995
The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure.
    Japanese journal of pharmacology, 1994, Volume: 65, Issue:3

    Topics: Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Disease Models, Animal; Dobutamine; Dogs; Dose-Response Relationship, Drug; Female; Heart; Heart Failure; Heart Rate; Infusions, Intravenous; Injections, Intra-Arterial; Male; Methoxamine; Myocardium; Nitroglycerin; Propranolol; Structure-Activity Relationship; Vascular Resistance; Ventricular Function, Left

1994
Digoxin in chronic heart failure.
    Lancet (London, England), 1995, Apr-01, Volume: 345, Issue:8953

    Topics: Digoxin; Dobutamine; Exercise Tolerance; Heart Failure; Humans

1995
Long-term dobutamine in heart failure.
    Postgraduate medical journal, 1994, Volume: 70, Issue:825

    Topics: Dobutamine; Drug Administration Schedule; Heart Failure; Home Care Services; Humans; Male; Middle Aged

1994
[Dobutamine pulse therapy in patients with severe heart failure. Is it a beneficial measure?].
    Arquivos brasileiros de cardiologia, 1994, Volume: 62, Issue:4

    Topics: Dobutamine; Heart Failure; Humans; Infusions, Intravenous

1994
Exercise training in a patient with congestive heart failure on continuous dobutamine.
    Medicine and science in sports and exercise, 1994, Volume: 26, Issue:6

    Topics: Dobutamine; Exercise Test; Exercise Therapy; Exercise Tolerance; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Oxygen Consumption; Physical Endurance

1994
[Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
    Zeitschrift fur Kardiologie, 1994, Volume: 83 Suppl 2

    Topics: Aged; Cardiac Output, Low; Cohort Studies; Coronary Disease; Critical Care; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Stroke Volume; Vasodilation

1994
Left ventricular remodelling and disparate changes in contractility and relaxation during the development of and recovery from experimental heart failure.
    Cardiovascular research, 1994, Volume: 28, Issue:1

    Topics: Animals; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Dobutamine; Dogs; Electrocardiography; Heart; Heart Failure; Heart Rate; Male; Myocardial Contraction; Stroke Volume; Ventricular Function, Left

1994
Divergent effects of intravenous dobutamine and nitroprusside on left atrial contribution to ventricular filling in dogs with chronic heart failure.
    American heart journal, 1994, Volume: 127, Issue:4 Pt 1

    Topics: Animals; Chronic Disease; Coronary Angiography; Diastole; Dobutamine; Dogs; Echocardiography, Doppler; Heart Atria; Heart Failure; Hemodynamics; Infusions, Intravenous; Nitroprusside; Ventricular Function, Left

1994
Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate.
    Journal of the American College of Cardiology, 1994, Volume: 23, Issue:7

    Topics: Dichloroacetic Acid; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Myocardium; Oxygen Consumption; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvate Dehydrogenase Complex

1994
Managing dobutamine infusions.
    Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, 1993, Volume: 2, Issue:6

    Topics: Dobutamine; Drug Monitoring; Heart Failure; Humans; Infusions, Intravenous; Nursing Assessment; Patient Care Planning

1993
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
    Cardiology, 1993, Volume: 83, Issue:1-2

    Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echocardiography, Doppler; Forced Expiratory Volume; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Nitroprusside; Vasodilator Agents; Vital Capacity

1993
Down-regulation of beta-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure.
    European heart journal, 1993, Volume: 14, Issue:10

    Topics: Adult; Aged; Dobutamine; Down-Regulation; Epinephrine; Female; Heart Failure; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Male; Middle Aged; Norepinephrine; Receptors, Adrenergic, beta; Ventricular Function, Left

1993
Cardiac study by dobutamine stress echocardiography in thalassemic patients.
    Bone marrow transplantation, 1993, Volume: 12 Suppl 1

    Topics: Adolescent; Adult; beta-Thalassemia; Chelation Therapy; Child; Combined Modality Therapy; Deferoxamine; Diastole; Dobutamine; Echocardiography; Female; Heart Failure; Hemosiderosis; Humans; Iron; Male; Transfusion Reaction

1993
Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure.
    European heart journal, 1993, Volume: 14, Issue:2

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Dobutamine; Exercise; Female; Heart Failure; Hemodynamics; Humans; Isoquinolines; Lymphocytes; Male; Middle Aged; Quinapril; Receptors, Adrenergic, beta; Tetrahydroisoquinolines; Up-Regulation

1993
Hemodynamic response of a canine model of chronic heart failure to intravenous dobutamine, nitroprusside, enalaprilat, and digoxin.
    Cardiovascular drugs and therapy, 1993, Volume: 7, Issue:3

    Topics: Animals; Blood Pressure; Cardiac Output; Digoxin; Disease Models, Animal; Dobutamine; Dogs; Enalaprilat; Heart Failure; Heart Rate; Hemodynamics; Nitroprusside; Stroke Volume; Vascular Resistance; Ventricular Function, Left

1993
Cardiac index vs oxygen-derived parameters for rational use of dobutamine in patients with congestive heart failure.
    Chest, 1993, Volume: 103, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiac Output; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Humans; Lactates; Male; Middle Aged; Oxygen; Oxygen Consumption

1993
Long-term dobutamine therapy.
    Clinical pharmacy, 1993, Volume: 12, Issue:1

    Topics: Dobutamine; Heart Failure; Humans; Time Factors

1993
Arterial hemodynamics and cardiac effects of enoximone, dobutamine, and their combination in severe heart failure.
    American heart journal, 1993, Volume: 125, Issue:3

    Topics: Adult; Aged; Cardiac Catheterization; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged

1993
Cardiovascular effects of dopamine and dobutamine in conscious pigs with chronic heart failure.
    Critical care medicine, 1993, Volume: 21, Issue:3

    Topics: Animals; Chronic Disease; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Male; Prospective Studies; Swine; Ventricular Function, Left

1993
The renal effects of dopamine and dobutamine in stable chronic heart failure.
    Postgraduate medical journal, 1993, Volume: 69, Issue:808

    Topics: Dobutamine; Dopamine; Heart Failure; Humans; Kidney

1993
Degree of external force to the left ventricle determines hemodynamic response to nitroprusside in failing hearts: comparison with the response to dobutamine.
    Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:4

    Topics: Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; Heart Failure; Microspheres; Nitroprusside; Pressure; Random Allocation; Vasodilator Agents; Ventricular Function, Left

1995
Experimental rat model representing both acute and chronic heart failure related to autoimmune myocarditis.
    Cardiovascular drugs and therapy, 1995, Volume: 9, Issue:5

    Topics: Acute Disease; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Autoimmune Diseases; Blood Pressure; Body Weight; Chronic Disease; Disease Models, Animal; Dobutamine; Electrocardiography; Heart; Heart Failure; Male; Myocarditis; Myocardium; Myosins; Organ Size; Rats; Rats, Inbred Lew; Staining and Labeling; Ventricular Function, Left

1995
[Anesthesiologic management in cardiomyoplasty].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 1995, Volume: 30, Issue:8

    Topics: Adult; Aged; Anesthesia, General; Anti-Arrhythmia Agents; Cardiomyoplasty; Cardiotonic Agents; Dobutamine; Electrocardiography; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Lidocaine; Male; Middle Aged; Monitoring, Intraoperative; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation

1995
[Treatment of heart failure in children].
    Giornale italiano di cardiologia, 1995, Volume: 25, Issue:11

    Topics: Adult; Age Factors; Cardiotonic Agents; Child; Diuretics; Dobutamine; Dopamine; Heart Defects, Congenital; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn; Phosphodiesterase Inhibitors; Vasodilator Agents

1995
Regional alterations of left ventricular contraction and inotropic reserve in conscious dogs with heart failure.
    Cardiovascular research, 1995, Volume: 30, Issue:6

    Topics: Analysis of Variance; Animals; Cardiac Pacing, Artificial; Dobutamine; Dogs; Heart Failure; Myocardial Contraction; Stimulation, Chemical; Ventricular Dysfunction, Left

1995
Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1996, Volume: 15, Issue:3

    Topics: Adult; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Enalapril; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Survival Rate; Treatment Outcome; Waiting Lists

1996
Effect of prostaglandin E1 infusion on kidney function in patients with severe heart failure.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1996, Volume: 15, Issue:3

    Topics: Alprostadil; Creatinine; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Kidney; Kidney Function Tests; Male; Middle Aged; Retrospective Studies; Vasodilator Agents

1996
Reproducibility of heart rate variability indices during exercise stress testing and inotrope infusion in chronic heart failure patients.
    Clinical science (London, England : 1979), 1996, Volume: 91 Suppl

    Topics: Aged; Chronic Disease; Dobutamine; Electrocardiography; Exercise Test; Heart Failure; Heart Rate; Humans; Middle Aged; Reproducibility of Results; Signal Processing, Computer-Assisted; Sympathomimetics

1996
Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure.
    American heart journal, 1996, Volume: 132, Issue:4

    Topics: Ambulatory Care; Amrinone; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Drug Administration Schedule; Emergency Service, Hospital; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Milrinone; Patient Admission; Patient Education as Topic; Pyridones; Time Factors

1996
Inotropic interventions in the assessment of myocardial failure associated with taurine deficiency in domestic cats.
    Advances in experimental medicine and biology, 1996, Volume: 403

    Topics: Animals; Blood Pressure; Cats; Dobutamine; Echocardiography; Female; Food, Fortified; Heart; Heart Failure; In Vitro Techniques; Male; Myocardial Contraction; Taurine; Ventricular Function, Left

1996
Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle.
    The Journal of clinical investigation, 1996, Dec-15, Volume: 98, Issue:12

    Topics: Acetylcholine; Adrenergic beta-Agonists; Atropine; Catheterization; Dobutamine; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Receptors, Muscarinic

1996
Right ventricular performance and contractile reserve in patients with severe heart failure. Assessment by pressure-area relations and association with outcome.
    Circulation, 1996, Dec-15, Volume: 94, Issue:12

    Topics: Adult; Cardiac Output; Cardiotonic Agents; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Pulmonary Artery; Pulmonary Wedge Pressure; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Right

1996
[Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
    Cardiologia (Rome, Italy), 1995, Volume: 40, Issue:12 Suppl 1

    Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cyclooxygenase Inhibitors; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Dobutamine; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Heart Failure; Humans; Nitrates; Phosphodiesterase Inhibitors; Vasodilator Agents

1995
[Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    Giornale italiano di cardiologia, 1996, Volume: 26, Issue:8

    Topics: Aged; Atrial Natriuretic Factor; Dobutamine; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Ventricular Function, Left

1996
[Epidural anesthesia for herniorrhaphy in a patient with severe dilated cardiomyopathy (DCM) under pimobendan control].
    Masui. The Japanese journal of anesthesiology, 1997, Volume: 46, Issue:1

    Topics: Anesthesia, Epidural; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Dopamine; Fentanyl; Heart Failure; Hernia, Inguinal; Humans; Hypotension; Intraoperative Complications; Male; Middle Aged; Postoperative Complications; Pyridazines

1997
Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
    European heart journal, 1997, Volume: 18, Issue:2

    Topics: Alprostadil; Cardiotonic Agents; Catheters, Indwelling; Chronic Disease; Disease Progression; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Safety; Treatment Outcome; Vasodilator Agents

1997
The effect of positive inotropes on the failing human myocardium.
    Cardiology, 1997, Volume: 88 Suppl 2

    Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Calcium; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Milrinone; Myocardial Contraction; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones

1997
Cardiac risk assessment before vascular surgery: a prospective study comparing clinical evaluation, dobutamine stress echocardiography, and dobutamine Tc-99m sestamibi tomoscintigraphy.
    Cardiovascular surgery (London, England), 1997, Volume: 5, Issue:1

    Topics: Aged; Aortic Aneurysm, Abdominal; Carotid Stenosis; Coronary Artery Bypass; Dobutamine; Echocardiography; Endarterectomy, Carotid; Exercise Test; Female; Heart Failure; Humans; Intraoperative Complications; Ischemia; Leg; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Prospective Studies; Risk Factors; Sympathomimetics; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vascular Diseases

1997
[Current views on Milrinon--a PDE-III-inhibitor].
    Der Anaesthesist, 1994, Volume: 43, Issue:3 Suppl

    Topics: Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Heart Ventricles; Humans; Milrinone; Oxygen Consumption; Pyridones

1994
Is dobutamine stress echocardiography useful for noninvasive differentiation of ischemic from idiopathic dilated cardiomyopathy?
    Angiology, 1997, Volume: 48, Issue:9

    Topics: Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Echocardiography; Exercise Test; Feasibility Studies; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Ventricular Function, Left

1997
Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes.
    Chest, 1997, Nov-05, Volume: 112, Issue:5

    Topics: Cardiotonic Agents; Cause of Death; Costs and Cost Analysis; Direct Service Costs; Dobutamine; Female; Heart Failure; Home Care Services; Humans; Length of Stay; Male; Middle Aged; Milrinone; Pyridones; Retrospective Studies; Stroke Volume; Survival Rate; Treatment Outcome

1997
Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.
    American heart journal, 1997, Volume: 134, Issue:5 Pt 1

    Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Dopamine; Drug Delivery Systems; Female; Heart Failure; Hemodynamics; Home Nursing; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors; Treatment Outcome

1997
[Improvement of short-term prognosis in patients with refractory heart failure].
    Giornale italiano di cardiologia, 1997, Volume: 27, Issue:10

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Assisted Circulation; Cardiotonic Agents; Coronary Care Units; Data Interpretation, Statistical; Dobutamine; Dopamine; Epinephrine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Hemofiltration; Humans; Male; Middle Aged; Norepinephrine; Prognosis; Survival Rate; Sympathomimetics; Time Factors; Ventilators, Mechanical

1997
Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure.
    Journal of cardiac failure, 1994, Volume: 1, Issue:1

    Topics: Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinolones; Ventricular Function, Left

1994
Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    American heart journal, 1997, Volume: 134, Issue:6

    Topics: Atrial Function, Left; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Mitral Valve; Nitroprusside; Pulmonary Wedge Pressure; Vasodilator Agents; Ventricular Function, Left

1997
Hyperkalemia: a dangerous diagnosis for patients with congestive heart failure.
    Progress in cardiovascular nursing, 1997,Fall, Volume: 12, Issue:4

    Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Electrocardiography; Heart Failure; Humans; Hyperkalemia

1997
Acute changes of left atrial distensibility in congestive heart failure.
    Clinical cardiology, 1998, Volume: 21, Issue:1

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiomyopathy, Dilated; Dobutamine; Echocardiography; Female; Heart Atria; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Propanolamines; Vasodilator Agents

1998
Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure.
    Journal of cardiovascular pharmacology, 1998, Volume: 31, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Body Weight; Cardiomyopathies; Celiprolol; Cricetinae; Dobutamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Hemodynamics; Liver; Lung; Mesocricetus; Motor Activity; Myocardium; Organ Size; Random Allocation; Receptors, Adrenergic, beta; Renin; Survival Rate; Ventricular Function, Left

1998
Lack of beneficial effects of growth hormone treatment in conscious dogs during development of heart failure.
    The American journal of physiology, 1998, Volume: 274, Issue:2

    Topics: Adrenergic beta-Agonists; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cardiac Pacing, Artificial; Dobutamine; Dogs; Growth Hormone; Heart Failure; Insulin-Like Growth Factor I; Isoproterenol; Kidney; Microscopy, Electron; Myocardial Contraction; Myocardium; Vascular Resistance; Ventricular Function, Left

1998
[Perioperative management of two patients with severe dilated cardiomyopathy].
    Masui. The Japanese journal of anesthesiology, 1998, Volume: 47, Issue:2

    Topics: Aged; Aged, 80 and over; Anesthesia, General; Cardiomyopathy, Dilated; Cardiotonic Agents; Diuretics; Dobutamine; Dopamine; Female; Furosemide; Heart Failure; Humans; Intraoperative Complications; Male; Middle Aged; Monitoring, Intraoperative; Perioperative Care; Postoperative Complications

1998
Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
    Arzneimittel-Forschung, 1998, Volume: 48, Issue:2

    Topics: Acute Disease; Adrenergic beta-Agonists; Anesthesia; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Dobutamine; Dogs; Female; Heart Conduction System; Heart Failure; Heart Rate; Hemodynamics; Male; Nicardipine; Nitroglycerin; Vasodilator Agents

1998
[Peritoneal dialysis and chronic dobutamine, two experiences contrasted. Possible role and indications in refractory cardiac decompensation].
    Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1998, Volume: 50, Issue:1

    Topics: Aged; Cardiotonic Agents; Dobutamine; Drug Evaluation; Feasibility Studies; Female; Heart Failure; Hemofiltration; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Salvage Therapy; Survival Rate; Treatment Outcome; Water-Electrolyte Balance

1998
Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine.
    American heart journal, 1998, Volume: 135, Issue:3

    Topics: Aged; Aged, 80 and over; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Middle Aged; Milrinone; Monitoring, Physiologic; Observer Variation; Oxygen; Pyridones; Retrospective Studies; Thermodilution; Tricuspid Valve Insufficiency

1998
Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure.
    Heart (British Cardiac Society), 1998, Volume: 79, Issue:3

    Topics: Cardiotonic Agents; Chronic Disease; Coronary Artery Bypass; Coronary Disease; Dobutamine; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Stunning; Patient Selection; Predictive Value of Tests; Regression Analysis; Tomography, Emission-Computed

1998
Value of the venous-arterial PCO2 gradient to reflect the oxygen supply to demand in humans: effects of dobutamine.
    Critical care medicine, 1998, Volume: 26, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Arteries; Carbon Dioxide; Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Intensive Care Units; Male; Middle Aged; Oxygen Consumption; Prospective Studies; Veins

1998
Dissociation between regional dysfunction and beta-adrenergic receptor signaling in heart failure.
    The American journal of physiology, 1998, Volume: 275, Issue:4

    Topics: Adenylyl Cyclases; Animals; Atrial Function, Left; beta-Adrenergic Receptor Kinases; Blood Pressure; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Echocardiography; Female; G-Protein-Coupled Receptor Kinase 5; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Heart; Heart Failure; Hemodynamics; Isoproterenol; Myocardium; Norepinephrine; Protein Serine-Threonine Kinases; Receptor Protein-Tyrosine Kinases; Receptors, Adrenergic, beta; Signal Transduction; Swine

1998
Atrioventricular plane displacement during low dose dobutamine infusion predicts recovery of left ventricular dyssynergies.
    Heart (British Cardiac Society), 1998, Volume: 80, Issue:2

    Topics: Atrioventricular Node; Cardiotonic Agents; Dobutamine; Echocardiography; Heart Failure; Humans; Prognosis

1998
Dobutamine-induced changes in pulmonary artery pressure in patients with congestive heart failure and their relation to abnormalities of lung diffusing capacity.
    The American journal of cardiology, 1998, Nov-15, Volume: 82, Issue:10

    Topics: Adult; Aged; Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pulmonary Diffusing Capacity; Pulmonary Wedge Pressure; Respiratory Function Tests; Ventricular Dysfunction, Left

1998
[The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    Minerva cardioangiologica, 1998, Volume: 46, Issue:5

    Topics: Aged; Amrinone; Cardiotonic Agents; Diuresis; Dobutamine; Dopamine; Drug Evaluation; Drug Therapy, Combination; Edema, Cardiac; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Contraction; Prospective Studies

1998
[Extracorporeal membrane oxygenation in myocardial failure after pediatric heart surgery].
    Revista espanola de anestesiologia y reanimacion, 1998, Volume: 45, Issue:10

    Topics: Bioprosthesis; Cardiac Output, Low; Cardiotonic Agents; Child, Preschool; Combined Modality Therapy; Dobutamine; Dopamine; Down Syndrome; Electric Countershock; Epinephrine; Extracorporeal Membrane Oxygenation; Female; Heart Failure; Heart Septal Defects; Hemodynamics; Humans; Infant; Male; Postoperative Complications; Reoperation; Surgical Wound Dehiscence; Tetralogy of Fallot; Ventricular Fibrillation

1998
Reversal of severe pulmonary hypertension with beta blockade in a patient with end stage left ventricular failure.
    Heart (British Cardiac Society), 1998, Volume: 80, Issue:6

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Cardiac Output; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Heart Failure; Heart Transplantation; Humans; Hypertension, Pulmonary; Male; Metoprolol; Middle Aged; Patient Selection; Vascular Resistance

1998
Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability.
    Journal of the American College of Cardiology, 1999, Volume: 33, Issue:3

    Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Echocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Ischemia; Prognosis; Prospective Studies; Quality of Life; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left

1999
Torsade de pointes ventricular tachycardia during low dose intermittent dobutamine treatment in a patient with dilated cardiomyopathy and congestive heart failure.
    Pacing and clinical electrophysiology : PACE, 1999, Volume: 22, Issue:2

    Topics: Adrenergic beta-Agonists; Cardiomyopathy, Dilated; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Humans; Infusions, Intravenous; Middle Aged; Potassium; Torsades de Pointes

1999
Arrhythmic effects of intermittent dobutamine therapy in chronic heart disease failure. The Working Group of Cardiology of the Academic Committee of Veszprém, Hungary.
    American journal of therapeutics, 1998, Volume: 5, Issue:6

    Topics: Adrenergic beta-Agonists; Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged

1998
Effects of dobutamine on ischemic vasodilation of the forearm in patients with severe congestive heart failure.
    Journal of cardiac failure, 1999, Volume: 5, Issue:1

    Topics: Adrenergic beta-Agonists; Aged; Dobutamine; Forearm; Heart Failure; Humans; Hyperemia; Ischemia; Middle Aged; Peripheral Vascular Diseases; Regional Blood Flow; Vascular Resistance; Vasodilation; Ventricular Dysfunction, Left

1999
Partial left ventriculectomy in a two-year-old girl with dilated cardiomyopathy.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:4

    Topics: Antihypertensive Agents; Captopril; Cardiomyopathy, Dilated; Cardiotonic Agents; Child, Preschool; Digoxin; Diuretics; Dobutamine; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Heart Ventricles; Hemodynamics; Humans; Mitral Valve; Mitral Valve Insufficiency; Papillary Muscles

1999
Dobutamine: a drug utilization evaluation.
    Hospital formulary, 1988, Volume: 23, Issue:5

    Topics: Boston; Dobutamine; Drug Utilization; Heart Failure; Hospital Bed Capacity, 500 and over; Humans; Hypotension

1988
Dynamic cardiomyoplasty in patients with end-stage heart failure: anaesthetic considerations.
    British journal of anaesthesia, 1999, Volume: 82, Issue:1

    Topics: Adult; Aged; Anesthesia, General; Cardiomyopathy, Dilated; Cardiomyoplasty; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Intraoperative Care; Male; Middle Aged; Monitoring, Intraoperative

1999
Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure.
    Journal of the American College of Cardiology, 1999, Volume: 33, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Circadian Rhythm; Coronary Angiography; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Predictive Value of Tests; Prospective Studies; ROC Curve; Survival Rate; Ventricular Dysfunction, Left

1999
Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography.
    Journal of the American College of Cardiology, 1999, Volume: 34, Issue:1

    Topics: Aged; Cardiotonic Agents; Chronic Disease; Coronary Disease; Dobutamine; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; ROC Curve; Stroke Volume; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left

1999
Intermittent inotropes for advanced heart failure: inquiring minds want to know.
    American heart journal, 1999, Volume: 138, Issue:2 Pt 1

    Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone; Treatment Outcome

1999
Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction.
    The American journal of cardiology, 1999, Sep-01, Volume: 84, Issue:5

    Topics: Adolescent; Adult; Aged; Brain Death; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Exercise Test; Female; Graft Survival; Heart Arrest; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Contraction; Troponin T

1999
Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
    The American journal of cardiology, 1999, Oct-15, Volume: 84, Issue:8

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Infusions, Parenteral; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Retrospective Studies; Treatment Outcome; Vasodilator Agents

1999
Can dobutamine stress echocardiography predict cardiac events in nonrevascularized diabetic patients following acute myocardial infarction?
    Chest, 1999, Volume: 116, Issue:5

    Topics: Aged; Angina, Unstable; Cardiac Catheterization; Cardiotonic Agents; Coronary Angiography; Diabetes Complications; Disease-Free Survival; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Infarction; Prognosis; Prospective Studies; Recurrence; Survival Rate

1999
Heart failure management.
    The Journal of nursing administration, 1999, Volume: 29, Issue:11

    Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Male; United States

1999
Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
    Scandinavian cardiovascular journal : SCJ, 1999, Volume: 33, Issue:6

    Topics: Acute Disease; Adult; Aged; Biomarkers; Body Mass Index; Cachexia; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Prognosis; Tumor Necrosis Factor-alpha

1999
Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
    The Annals of pharmacotherapy, 1999, Volume: 33, Issue:12

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Dobutamine; Drug Interactions; Fatal Outcome; Heart Failure; Heart Rate; Humans; Hypotension; Male; Propanolamines

1999
Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake.
    Heart (British Cardiac Society), 2000, Volume: 83, Issue:4

    Topics: Adult; Aged; Biopsy; Cardiotonic Agents; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Dobutamine; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Stunning; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome

2000
Inotropes in the beta-blocker era.
    Clinical cardiology, 2000, Volume: 23, Issue:3 Suppl

    Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Phosphodiesterase Inhibitors; Signal Transduction

2000
Hemodynamic effects of a novel sodium channel activator in dogs with chronic heart failure.
    Cardiovascular drugs and therapy, 2000, Volume: 14, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chronic Disease; Digoxin; Disease Models, Animal; Dobutamine; Dogs; Heart Failure; Hemodynamics; Sodium Channels; Sympathomimetics; Ventricular Function

2000
Transpulmonary passage of Albunex as a marker of intracardiac hemodynamics and outcome in chronic congestive heart failure.
    American heart journal, 2000, Volume: 139, Issue:5

    Topics: Adult; Aged; Albumins; Capillary Permeability; Cardiotonic Agents; Chronic Disease; Contrast Media; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prognosis; Survival Rate; Treatment Outcome

2000
Pre-operative coagulopathy management of a neonate with complex congenital heart disease: a case study.
    Perfusion, 2000, Volume: 15, Issue:2

    Topics: Acidosis, Respiratory; Anti-Bacterial Agents; Antithrombin III; Antithrombin III Deficiency; Blood Coagulation Tests; Colloids; Combined Modality Therapy; Disseminated Intravascular Coagulation; Dobutamine; Dopamine; Drug Therapy, Combination; Endocarditis, Bacterial; Fatal Outcome; Fungemia; Heart Defects, Congenital; Heart Diseases; Heart Failure; Humans; Infant, Newborn; Male; Nitric Oxide; Plasma; Platelet Transfusion; Postoperative Complications; Preoperative Care; Sodium Bicarbonate; Streptococcal Infections; Thrombosis

2000
Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    European heart journal, 2000, Volume: 21, Issue:11

    Topics: Adrenergic beta-Agonists; Aged; Cardiomyopathy, Dilated; Disease Progression; Dobutamine; Exercise Test; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen Consumption; Prognosis; Reproducibility of Results

2000
Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients.
    Journal of the American College of Cardiology, 2000, Volume: 35, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Cause of Death; Coronary Disease; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Risk Assessment

2000
Carbamazepine-associated severe left ventricular dysfunction.
    Journal of toxicology. Clinical toxicology, 2000, Volume: 38, Issue:3

    Topics: Adult; Antimanic Agents; Carbamazepine; Cardiotonic Agents; Dobutamine; Drug Overdose; Echocardiography; Female; Heart Failure; Humans; Suicide, Attempted; Ventricular Dysfunction, Left; Ventricular Function, Left

2000
Neuroadrenergic activation and response to dobutamine in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    The American journal of cardiology, 2000, Aug-15, Volume: 86, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Cardiotonic Agents; Chromatography, High Pressure Liquid; Dobutamine; Echocardiography; Female; Heart Failure; Heart Rate; Humans; Linear Models; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Stroke Volume

2000
Prognostic value of 12-lead electrocardiogram during dobutamine stress echocardiography.
    Echocardiography (Mount Kisco, N.Y.), 2000, Volume: 17, Issue:5

    Topics: Angina Pectoris; Death, Sudden, Cardiac; Dobutamine; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Prognosis; Retrospective Studies; Risk Factors

2000
Differential alteration of cardiotonic effects of EMD 57033 and beta-adrenoceptor agonists in volume-overload rabbit ventricular myocytes.
    Journal of cardiac failure, 2000, Volume: 6, Issue:4

    Topics: Adrenergic beta-Agonists; Animals; Cardiomegaly; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Evaluation, Preclinical; Electrocardiography; Heart Failure; Hemodynamics; Isoproterenol; Male; Myocardial Contraction; Myofibrils; Phosphodiesterase Inhibitors; Quinolines; Rabbits; Thiadiazines

2000
Transient dobutamine-mediated pulsus alternans.
    The Canadian journal of cardiology, 2001, Volume: 17, Issue:2

    Topics: Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Dobutamine; Electrocardiography; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Myocardial Contraction

2001
Dobutamine as bridge to angiotensin-converting enzyme inhibitor-nitrate therapy in endstage heart failure.
    Clinical cardiology, 2001, Volume: 24, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Isosorbide Dinitrate; Lisinopril; Prospective Studies; Stroke Volume; Treatment Outcome; Ultrasonography; Vasodilator Agents

2001
Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy.
    European heart journal, 2001, Volume: 22, Issue:10

    Topics: Adult; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radionuclide Ventriculography; Stroke Volume; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left

2001
Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 281, Issue:1

    Topics: Adrenergic beta-Agonists; Animals; Cyclic GMP; Diastole; Dobutamine; Dogs; Drug Synergism; Heart; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Nitric Oxide; Reference Values; Second Messenger Systems; Systole; Ventricular Function, Left

2001
Can pre-treatment with beta-agonists reduce stress test time and the use of atropine in dobutamine stress testing?
    Cardiology, 2001, Volume: 95, Issue:3

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Atropine; Coronary Disease; Diabetes Mellitus; Dobutamine; Dose-Response Relationship, Drug; Electrocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Hypertension; Male; Middle Aged; Premedication; Risk Factors; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed, Single-Photon

2001
Mitochondrial ATPase and high-energy phosphates in failing hearts.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 281, Issue:3

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiac Pacing, Artificial; Coronary Circulation; Disease Models, Animal; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Infusions, Intravenous; Magnetic Resonance Spectroscopy; Mitochondria, Heart; Myocardial Infarction; Organ Size; Phosphocreatine; Protein Subunits; Proton-Translocating ATPases; Swine; Ventricular Remodeling

2001
How many patients with ischemic cardiomyopathy exhibit viable myocardium?
    The American journal of cardiology, 2001, Sep-01, Volume: 88, Issue:5

    Topics: Aged; Comorbidity; Disease Progression; Dobutamine; Echocardiography, Doppler; Exercise Test; Female; Heart Failure; Heart Function Tests; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Prevalence; Prognosis; Prospective Studies; Risk Factors; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left

2001
Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.
    European journal of heart failure, 2001, Volume: 3, Issue:5

    Topics: Cardiac Output, Low; Chi-Square Distribution; Dobutamine; Heart Failure; Heart Transplantation; Humans; Middle Aged; Nitroprusside; Treatment Outcome; Vascular Resistance; Vasodilator Agents

2001
Long-term results of coronary artery bypass grafting procedure in the presence of left ventricular dysfunction and hibernating myocardium.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2001, Volume: 20, Issue:5

    Topics: Adult; Aged; Coronary Artery Bypass; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Stunning; Prognosis; Prospective Studies; Recurrence; Risk Factors; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left

2001
Nitric oxide and cardiac contractility in human heart failure: time for reappraisal.
    Circulation, 2001, Nov-06, Volume: 104, Issue:19

    Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Failure; Humans; Isoenzymes; Myocardial Contraction; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Substance P; Ventricular Function, Left

2001
Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    American heart journal, 2001, Volume: 142, Issue:6

    Topics: Cost-Benefit Analysis; Dobutamine; Dopamine; Drug Costs; Female; Heart Failure; Hemodynamics; Humans; Length of Stay; Male; Middle Aged; Milrinone; Nitroglycerin; Nitroprusside; Retrospective Studies; Treatment Outcome; United States

2001
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
    International journal of cardiology, 2001, Volume: 81, Issue:2-3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Propanolamines; Prospective Studies; Pulmonary Wedge Pressure; Stroke Volume; Treatment Outcome; Ventricular Function, Left

2001
The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure.
    Journal of the American College of Cardiology, 2002, Apr-17, Volume: 39, Issue:8

    Topics: Adrenergic beta-Agonists; Aged; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Middle Aged; Treatment Outcome; Ventricular Function, Left

2002
Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
    Home healthcare nurse, 2002, Volume: 20, Issue:4

    Topics: Cardiotonic Agents; Chronic Disease; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Monitoring, Physiologic; Patient Selection; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome

2002
Value of Doppler index combining systolic and diastolic myocardial performance in predicting cardiopulmonary exercise capacity in patients with congestive heart failure: effects of dobutamine.
    Chest, 2002, Volume: 121, Issue:6

    Topics: Adrenergic beta-Agonists; Dobutamine; Echocardiography, Doppler; Exercise Test; Female; Heart; Heart Failure; Humans; Lung; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Severity of Illness Index

2002
Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure.
    Journal of the American College of Cardiology, 2002, Jun-19, Volume: 39, Issue:12

    Topics: Animals; Cardiomyopathy, Dilated; Coronary Thrombosis; Dobutamine; Dogs; Heart Failure; Image Processing, Computer-Assisted; Models, Animal; Myocardial Contraction; Polyesters; Prostheses and Implants; Ventricular Dysfunction, Left; Ventricular Pressure; Ventricular Remodeling

2002
[Catecholamines for treatment of severe heart failure (author's transl)].
    Zeitschrift fur Kardiologie, 1979, Volume: 68, Issue:5

    Topics: Catecholamines; Coronary Circulation; Dobutamine; Dopamine; Epinephrine; Heart Failure; Humans; Isoproterenol; Microcirculation; Myocardial Infarction; Norepinephrine; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stimulation, Chemical; Strophanthins

1979
The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure.
    The American journal of medicine, 1979, Volume: 66, Issue:2

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume

1979
Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
    Canadian Medical Association journal, 1979, Oct-06, Volume: 121, Issue:7

    Topics: Chronic Disease; Dobutamine; Dopamine; Heart; Heart Failure; Hemodynamics; Humans; Hydralazine; Monitoring, Physiologic; Nitrates; Nitroprusside; Phentolamine; Prazosin; Teprotide; Vasodilator Agents

1979
Dobutamine in left heart failure after acute myocardial infarction.
    Acta medica Scandinavica, 1979, Volume: 206, Issue:4

    Topics: Acute Disease; Blood Pressure; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction

1979
[Hemodynamic effects of dobutamine in the low-output cardiac syndrome].
    Giornale italiano di cardiologia, 1979, Volume: 9, Issue:7

    Topics: Adult; Aged; Catecholamines; Coronary Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged

1979
Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.
    Circulation, 1978, Volume: 58, Issue:3 Pt 1

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Dopamine; Dyspnea; Heart Failure; Hemodynamics; Humans; Kidney; Lung; Middle Aged; Regional Blood Flow

1978
Selection of vasodilator, inotropic or combined therapy for the management of heart failure.
    The American journal of medicine, 1978, Volume: 65, Issue:1

    Topics: Blood Pressure; Cardiac Output; Coronary Disease; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Myocardial Contraction; Myocardium; Oxygen Consumption; Sympathomimetics; Time Factors; Vascular Resistance; Vasodilator Agents

1978
Efficacy of new inotropic drugs in clinical coronary heart failure.
    The American journal of medicine, 1978, Volume: 65, Issue:1

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Phonocardiography; Phosphodiesterase Inhibitors; Piperidines; Pressure; Quinazolines; Vascular Resistance

1978
New and traditional therapy of congestive heart failure. A European view.
    The American journal of medicine, 1978, Volume: 65, Issue:1

    Topics: Delayed-Action Preparations; Digitalis Glycosides; Diuretics; Dobutamine; Heart Failure; Humans; Isosorbide Dinitrate; Nitroprusside; Phentolamine

1978
Vasodilator and inotropic therapy of heart failure [panel discussion].
    The American journal of medicine, 1978, Volume: 65, Issue:1

    Topics: Animals; Cardiac Output; Coronary Circulation; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Failure; Humans; Hydralazine; Myocardial Contraction; Myocardial Infarction; Nitroprusside; Phentolamine; Prazosin; Propranolol; Vasoconstrictor Agents; Vasodilator Agents

1978
Dobutamine pharmacokinetics in severe heart failure.
    Clinical pharmacology and therapeutics, 1978, Volume: 24, Issue:5

    Topics: Adult; Aged; Catecholamines; Dobutamine; Female; Heart Failure; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged

1978
[The effect of sodium nitroprusside and dobutamine on the ventricular myocardium in patients with severe left cardiac insufficiency].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1978, Issue:84

    Topics: Catecholamines; Dobutamine; Female; Ferricyanides; Heart; Heart Failure; Hemodynamics; Humans; Male; Nitroprusside

1978
Dobutamine (Dobutrex).
    The Medical letter on drugs and therapeutics, 1979, Feb-09, Volume: 21, Issue:3

    Topics: Cardiovascular System; Catecholamines; Dobutamine; Heart Failure; Humans

1979
Haemodynamic effects of dobutamine in patients with coronary artery disease.
    The Journal of international medical research, 1977, Volume: 5, Issue:1

    Topics: Aged; Blood Pressure; Cardiac Output; Catecholamines; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Vascular Resistance

1977
Cardiovascular effects of dobutamine in severe congestive heart failure.
    American heart journal, 1977, Volume: 94, Issue:2

    Topics: Adult; Aged; Catecholamines; Dobutamine; Drug Evaluation; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction

1977
The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
    Circulation, 1977, Volume: 56, Issue:3

    Topics: Adolescent; Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Diuresis; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Female; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Pulmonary Circulation; Sodium; Stimulation, Chemical; Vascular Resistance

1977
Comparative haemodynamic effects of dobutamine and isoproterenol in man.
    Intensive care medicine, 1977, Volume: 3, Issue:2

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Drug Evaluation; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isoproterenol; Male; Middle Aged; Vascular Resistance

1977
Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
    Circulation, 1977, Volume: 56, Issue:4 Pt 1

    Topics: Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Drug Evaluation; Ferricyanides; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Nitroprusside; Pulmonary Circulation; Vascular Resistance

1977
[Haemodynamic effect of dobutamine in cardiac failure (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1976, Nov-26, Volume: 101, Issue:48

    Topics: Adult; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Humans; Middle Aged; Myocardial Contraction; Vascular Resistance

1976
[Hemodynamic effect of dobutamine in patients with cardiac insufficiency].
    Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung, 1976, Volume: 42

    Topics: Adult; Catecholamines; Coronary Disease; Dobutamine; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardial Contraction

1976
Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy.
    Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:5

    Topics: Adult; Cardiomyopathy, Dilated; Catecholamines; Dobutamine; Dopamine; Electrocardiography; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Neuropeptide Y; Receptors, Adrenergic, beta

1992
Alterations in left ventricular mechanics, energetics, and contractile reserve in experimental heart failure.
    Circulation research, 1992, Volume: 70, Issue:3

    Topics: Animals; Body Weight; Cardiac Output; Cardiac Pacing, Artificial; Dobutamine; Dogs; Dose-Response Relationship, Drug; Energy Metabolism; Heart Failure; Models, Cardiovascular; Myocardial Contraction; Organ Size; Receptors, Adrenergic, beta; Ventricular Function, Left

1992
Dobutamine therapy for outpatients.
    MNA accent, 1992, Volume: 64, Issue:2

    Topics: Community Health Nursing; Dobutamine; Heart Failure; Humans; Outpatients

1992
Increased uncoupling of beta-, beta 1- and beta 2-adrenoceptor to myocardial contraction in failing human myocardium.
    Japanese circulation journal, 1992, Volume: 56, Issue:7

    Topics: Adult; Aged; Binding, Competitive; Dobutamine; Down-Regulation; Female; Heart Failure; Humans; Iodocyanopindolol; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Pindolol; Quinazolines; Receptors, Adrenergic, beta; Terbutaline

1992
[A study on the human beta-receptor regulation by dobutamine and propranolol].
    Zhonghua xin xue guan bing za zhi, 1992, Volume: 20, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Propranolol; Receptors, Adrenergic, beta; Up-Regulation

1992
Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy.
    Journal of cardiovascular pharmacology, 1992, Volume: 19, Issue:1

    Topics: 3-Iodobenzylguanidine; Adult; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Iodobenzenes; Male; Middle Aged; Myocardial Contraction; Neurons; Norepinephrine; Radionuclide Imaging; Receptors, Adrenergic, beta

1992
Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
    European heart journal, 1992, Volume: 13, Issue:9

    Topics: Adult; Cardiac Output; Cardiomyopathy, Dilated; Chronic Disease; Coronary Vessels; Dobutamine; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neuropeptide Y; Norepinephrine; Sympathetic Nervous System

1992
Late doxorubicin cardiotoxicity.
    Anti-cancer drugs, 1992, Volume: 3, Issue:4

    Topics: Coronary Angiography; Dobutamine; Doxorubicin; Female; Heart Failure; Humans; Middle Aged; Time Factors; Ventricular Function, Left

1992
Effect of dobutamine on pulmonary gas exchange in patients with severe heart failure.
    European heart journal, 1992, Volume: 13, Issue:11

    Topics: Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Gas Exchange

1992
Continuous measurement of the pressure-volume relationship in experimental heart failure produced by rapid ventricular pacing in conscious dogs.
    European heart journal, 1992, Volume: 13 Suppl E

    Topics: Animals; Blood Pressure; Blood Volume; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiac Volume; Diastole; Dobutamine; Dogs; Heart Failure; Heart Rate; Manometry; Models, Cardiovascular; Myocardial Contraction; Stroke Volume; Ventricular Function, Left

1992
Dobutamine-induced fever.
    The Annals of pharmacotherapy, 1992, Volume: 26, Issue:12

    Topics: Aged; Dobutamine; Female; Fever; Heart Failure; Humans; Vancomycin

1992
Ventricular-load optimization in patients with heart failure.
    Japanese circulation journal, 1992, Volume: 56, Issue:7

    Topics: Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Phenylephrine; Ventricular Function, Left

1992
Ventricular contractility evaluated by mechanical perturbation of the myocardium--experimental and clinical approach adopting small amplitude vibration input.
    Japanese circulation journal, 1992, Volume: 56, Issue:7

    Topics: Animals; Dobutamine; Dogs; Heart Failure; Humans; Myocardial Contraction; Propranolol; Ventricular Function, Left; Vibration

1992
Effects of cardiovascular drugs on oxygen consumption/oxygen delivery relationship in patients with congestive heart failure.
    Chest, 1992, Volume: 101, Issue:6

    Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Catheterization, Swan-Ganz; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxygen Consumption; Phosphodiesterase Inhibitors; Pulmonary Edema

1992
Perioperative management of a case of severe peripartum cardiomyopathy.
    Anaesthesia and intensive care, 1992, Volume: 20, Issue:1

    Topics: Adult; Captopril; Cardiomegaly; Cesarean Section; Critical Care; Digoxin; Dobutamine; Dopamine; Female; Furosemide; Heart Failure; Heparin; Humans; Potassium; Pregnancy; Pregnancy Complications, Cardiovascular

1992
[Additive effects of milrinone and dobutamine in severe heart failure].
    Zeitschrift fur Kardiologie, 1992, Volume: 81, Issue:5

    Topics: Aged; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Pyridones

1992
Effects of beta-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle.
    Circulation, 1991, Volume: 84, Issue:3

    Topics: Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Receptors, Adrenergic, beta; Ventricular Function, Left

1991
Acute effects of beta-adrenergic stimulation with dobutamine on the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with chronic heart failure.
    European heart journal, 1991, Volume: 12, Issue:8

    Topics: Aged; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Chronic Disease; Cyclic GMP; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Male; Middle Aged

1991
Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing.
    Circulation research, 1991, Volume: 69, Issue:6

    Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Catecholamines; Dihydropyridines; Dobutamine; Dogs; Electric Stimulation; GTP-Binding Proteins; Heart Failure; Heart Rate; Hemodynamics; Pertussis Toxin; Receptors, Adrenergic, beta; Virulence Factors, Bordetella

1991
Combined intravenous pharmacotherapy in the treatment of patients with decompensated congestive heart failure.
    American heart journal, 1991, Volume: 121, Issue:6 Pt 1

    Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Goals; Heart Failure; Heart Transplantation; Humans; Injections, Intravenous; Phosphodiesterase Inhibitors; Vasodilator Agents

1991
Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs.
    Circulation, 1991, Volume: 84, Issue:1

    Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Aorta; Blood Pressure; Dobutamine; Dogs; Heart Failure; Heart Rate; Isoproterenol; Myocardial Contraction; Myocardium; Nadolol; Norepinephrine; Receptors, Adrenergic, beta

1991
Acute neurohormonal and hemodynamic response to a new peak III phosphodiesterase inhibitor (ICI 153,110) in patients with chronic heart failure.
    Journal of cardiovascular pharmacology, 1990, Volume: 16, Issue:3

    Topics: Dihydropyridines; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Norepinephrine; Phosphodiesterase Inhibitors; Pyridazines; Renin

1990
Two weeks of intermittent dobutamine therapy restores cardiac performance and inotropic responsiveness in conscious rats with heart failure.
    Journal of cardiovascular pharmacology, 1991, Volume: 17, Issue:6

    Topics: Animals; Coronary Vessels; Dobutamine; Drug Administration Schedule; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Myocardial Infarction; Rats; Rats, Inbred Strains

1991
Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure.
    Clinical physiology (Oxford, England), 1991, Volume: 11, Issue:3

    Topics: Adult; Aged; Albuterol; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Dobutamine; Female; Furosemide; Heart Failure; Heart Rate; Hematocrit; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardium; Pulmonary Wedge Pressure

1991
Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    European heart journal, 1991, Volume: 12, Issue:9

    Topics: Cardiac Volume; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Myocardial Contraction; Phosphodiesterase Inhibitors; Radionuclide Angiography; Stroke Volume

1991
Could glucose-insulin-potassium be considered only a step of a complete nutritional program for complicated cardiac patients?
    The Annals of thoracic surgery, 1991, Volume: 51, Issue:2

    Topics: Cardiopulmonary Bypass; Chronic Disease; Dobutamine; Glucose; Heart Failure; Humans; Insulin; Parenteral Nutrition; Potassium

1991
[Hemodynamic changes in patients with myocardial infarct complicated by acute left ventricular failure during combined nitroglycerin and dobutamine therapy].
    Kardiologiia, 1991, Volume: 31, Issue:4

    Topics: Aged; Blood Pressure; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Nitroglycerin

1991
Mechanics of contraction and relaxation of the ventricle in experimental heart failure produced by rapid ventricular pacing in the conscious dog.
    European heart journal, 1991, Volume: 12 Suppl C

    Topics: Animals; Cardiac Pacing, Artificial; Dobutamine; Dogs; Heart Failure; Imidazoles; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Ventricular Function, Left

1991
Dobutamine stress testing in chronic heart failure--dose-response effects assessed by echo-Doppler.
    Postgraduate medical journal, 1991, Volume: 67 Suppl 1

    Topics: Aged; Chronic Disease; Dobutamine; Drug Administration Schedule; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged

1991
Physical and pharmacological conditioning in chronic heart failure: a proposal for pulsed inotrope therapy.
    Postgraduate medical journal, 1991, Volume: 67 Suppl 1

    Topics: Chronic Disease; Dobutamine; Drug Administration Schedule; Exercise Therapy; Heart Failure; Humans

1991
Usefulness of hydralazine to withdraw from dobutamine in severe congestive heart failure.
    The American journal of cardiology, 1991, Oct-15, Volume: 68, Issue:10

    Topics: Adult; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male

1991
Effects of short-term administration of dobutamine on left ventricular performance, exercise capacity, norepinephrine levels, and lymphocyte adrenergic receptor density in congestive heart failure.
    Cardiovascular drugs and therapy, 1990, Volume: 4, Issue:4

    Topics: Dobutamine; Heart Failure; Hemodynamics; Humans; Lymphocytes; Male; Middle Aged; Norepinephrine; Physical Exertion; Receptors, Adrenergic, beta; Ventricular Function, Left

1990
Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
    Circulation, 1990, Volume: 81, Issue:3

    Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Ethanolamines; Female; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Stimulation, Chemical

1990
Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output.
    The American journal of cardiology, 1990, Mar-15, Volume: 65, Issue:11

    Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Male; Middle Aged; Time Factors; Urine

1990
[Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
    Nederlands tijdschrift voor geneeskunde, 1990, Nov-24, Volume: 134, Issue:47

    Topics: Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Heart Failure; Hemodynamics; Humans; Vasodilator Agents

1990
Effects of chronic dobutamine on cardiac mechanics and biochemistry after myocardial infarction in rats.
    The American journal of physiology, 1991, Volume: 260, Issue:2 Pt 2

    Topics: Animals; Contractile Proteins; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; In Vitro Techniques; Myocardial Infarction; Myocardium; Organ Size; Oxygen Consumption; Rats; Rats, Inbred Strains; Time Factors

1991
[Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
    Zeitschrift fur Kardiologie, 1991, Volume: 80, Issue:2

    Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Pyridones

1991
Ventricular-load optimization by inotropic stimulation in patients with heart failure.
    International journal of cardiology, 1991, Volume: 31, Issue:1

    Topics: Adult; Aged; Dobutamine; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Oxygen Consumption; Stroke Volume; Ventricular Function, Left

1991
Systolic time intervals as indicators for cardiac function in rat models for heart failure.
    European heart journal, 1990, Volume: 11 Suppl I

    Topics: Age Factors; Animals; Blood Flow Velocity; Captopril; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Heart Ventricles; Humans; Hypertension; Milrinone; Myocardial Infarction; Pyridones; Rats; Rats, Inbred SHR; Systole

1990
[Medical strategy in patients awaiting emergency heart transplantation].
    Archives des maladies du coeur et des vaisseaux, 1990, Volume: 83 Spec No 3

    Topics: Adult; Assisted Circulation; Cardiac Output, Low; Cardiotonic Agents; Contraindications; Critical Care; Diuretics; Dobutamine; Dopamine; Emergencies; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Shock, Cardiogenic

1990
Intra-cellular electrolyte changes and levels of endogenous digoxin-like substance within the plasma in patients with congestive heart failure.
    International journal of cardiology, 1990, Volume: 27, Issue:1

    Topics: Adult; Aged; Blood Proteins; Cardenolides; Digoxin; Dobutamine; Electrolytes; Erythrocyte Membrane; Female; Heart Failure; Humans; Male; Middle Aged; Monitoring, Physiologic; Saponins; Sodium-Potassium-Exchanging ATPase

1990
A new direction for dobutamine.
    Nursing, 1990, Volume: 20, Issue:10

    Topics: Aged; Dobutamine; Heart Failure; Home Care Services; Humans; Infusions, Intravenous; Male; Patient Discharge

1990
Outpatient dobutamine for end-stage congestive heart failure.
    Critical care medicine, 1990, Volume: 18, Issue:1 Pt 2

    Topics: Adult; Aged; Ambulatory Care; Catheterization, Peripheral; Dobutamine; Heart Failure; Humans; Infusion Pumps; Infusions, Intravenous; Middle Aged

1990
[Short-term dobutamine therapy in severe cardiac insufficiency].
    Schweizerische medizinische Wochenschrift, 1990, Feb-10, Volume: 120, Issue:6

    Topics: Adult; Aged; Dobutamine; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Lidocaine; Male; Middle Aged

1990
Inotropic response to dobutamine in elderly patients with decompensated congestive heart failure.
    The American journal of cardiology, 1990, Feb-15, Volume: 65, Issue:7

    Topics: Aged; Aged, 80 and over; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Stimulation, Chemical

1990
Effect of inotropic and vasodilator therapy on left ventricular diastolic filling in dogs with severe left ventricular dysfunction.
    Journal of the American College of Cardiology, 1990, Volume: 15, Issue:5

    Topics: Animals; Diastole; Disease Models, Animal; Dobutamine; Dogs; Echocardiography; Ferricyanides; Heart Failure; Hemodynamics; Myocardial Contraction; Nitroprusside

1990
Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure.
    The American journal of cardiology, 1990, May-01, Volume: 65, Issue:16

    Topics: Dobutamine; Femoral Vein; Heart Failure; Hemodynamics; Humans; Hydrogen-Ion Concentration; Leg; Magnetic Resonance Spectroscopy; Middle Aged; Muscles; Oxygen Consumption; Phosphorus; Regional Blood Flow

1990
Oxygen uptake/supply dependency. Effects of short-term dobutamine infusion.
    The American review of respiratory disease, 1990, Volume: 142, Issue:1

    Topics: Acidosis, Lactic; Aged; Bacterial Infections; Dobutamine; Female; Heart Failure; Humans; Lactates; Lactic Acid; Male; Middle Aged; Oxygen Consumption; Oxyhemoglobins; Respiration, Artificial; Respiratory Distress Syndrome

1990
Intermittent dobutamine infusion in severe chronic heart failure in elderly patients.
    Gerontology, 1990, Volume: 36, Issue:1

    Topics: Aged; Chronic Disease; Clinical Protocols; Dobutamine; Drug Administration Schedule; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male

1990
Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
    Journal of cardiovascular pharmacology, 1987, Volume: 9, Issue:5

    Topics: Aged; Captopril; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurosecretory Systems; Nitroglycerin; Time Factors; Vasodilator Agents

1987
Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
    Journal of cardiovascular pharmacology, 1987, Volume: 10, Issue:5

    Topics: Animals; Cardiotonic Agents; Coronary Circulation; Dobutamine; Dogs; Heart Failure; Hemodynamics; Male; Milrinone; Pyridones; Regional Blood Flow; Vasodilator Agents

1987
Chronic therapy of severe heart failure with enoximone.
    Journal of cardiovascular pharmacology, 1989, Volume: 14 Suppl 1

    Topics: Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged

1989
A one-sided affair? Myocardial infarction with pulmonary edema and forward failure.
    Chest, 1989, Volume: 95, Issue:3

    Topics: Aged; Dobutamine; Female; Furosemide; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; Posture; Pulmonary Edema; Radiography

1989
Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure.
    Circulation, 1989, Volume: 80, Issue:2

    Topics: Aged; Cardiac Catheterization; Cardiac Output; Dobutamine; Echocardiography, Doppler; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Nitroglycerin; Stroke Volume

1989
Potentiation of the effects of enoximone by a dobutamine infusion.
    Intensive care medicine, 1989, Volume: 15, Issue:8

    Topics: Aged; Aged, 80 and over; Cardiac Output; Dobutamine; Drug Synergism; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Humans; Imidazoles; Phosphodiesterase Inhibitors

1989
[Severe cardiac decompensation: value in the early hours of a combination of amrinone and dobutamine].
    Cahiers d'anesthesiologie, 1989, Volume: 37, Issue:8

    Topics: Aged; Aged, 80 and over; Amrinone; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Stimulation, Chemical

1989
The effect of dobutamine on myocardial performance and high-energy phosphate metabolism at different stages of heart failure in cardiomyopathic hamsters: a 31P MRS study.
    American heart journal, 1989, Volume: 118, Issue:1

    Topics: Adenosine Triphosphate; Animals; Cricetinae; Dobutamine; Heart; Heart Failure; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Mesocricetus; Myocardium; Oxygen Consumption; Phosphates; Phosphocreatine

1989
Assessing cardiac pumping capability by exercise testing and inotropic stimulation.
    British heart journal, 1989, Volume: 62, Issue:1

    Topics: Adult; Aged; Cardiac Output; Cardiomyopathy, Dilated; Dobutamine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Stimulation, Chemical

1989
[Acute postoperative psychosyndromes. A prospective study and multivariate analysis of risk factors].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1989, Volume: 60, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Brain Damage, Chronic; Delirium; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Neurocognitive Disorders; Oxygen; Postoperative Complications; Prospective Studies; Respiration, Artificial; Risk Factors; Tomography, X-Ray Computed

1989
Dynamics of functional mitral regurgitation during dobutamine therapy in patients with severe congestive heart failure: a Doppler echocardiographic study.
    American heart journal, 1989, Volume: 118, Issue:4

    Topics: Aged; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Stroke Volume

1989
Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs.
    European journal of pharmacology, 1987, Aug-11, Volume: 140, Issue:2

    Topics: 5'-Nucleotidase; Adenylyl Cyclases; Animals; Chlorides; Colforsin; Dihydroalprenolol; Dobutamine; Dogs; Guanylyl Imidodiphosphate; Heart Failure; Hemodynamics; In Vitro Techniques; Isoproterenol; Kinetics; Manganese; Manganese Compounds; Myocardium; Norepinephrine; Nucleotidases; Receptors, Adrenergic, beta

1987
Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
    The Journal of clinical investigation, 1988, Volume: 81, Issue:4

    Topics: Catecholamines; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Middle Aged; Milrinone; Myocardial Contraction; Pyridones; Receptors, Adrenergic, beta

1988
[The sympathetic nervous activity and beta-adrenergic receptor function in congestive heart failure].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1987, Volume: 76, Issue:12

    Topics: Bucladesine; Dobutamine; Heart Failure; Humans; Lymphocytes; Norepinephrine; Receptors, Adrenergic, beta; Sympathetic Nervous System

1987
Cardiovascular effects of dibutyryl cyclic AMP in patients with congestive heart failure--comparison with dobutamine and captopril.
    Japanese circulation journal, 1988, Volume: 52, Issue:6

    Topics: Aged; Blood Pressure; Bucladesine; Captopril; Cardiac Output; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Vascular Resistance

1988
The role of adrenergic and dopamine receptors.
    Hospital practice (Office ed.), 1985, Jun-15, Volume: 20, Issue:6

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Adrenergic; Receptors, Dopamine

1985
[Positive inotropic agents. Generalities and classification].
    Annales de medecine interne, 1985, Volume: 136, Issue:3

    Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Calcium; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Ethanolamines; Heart Failure; Heart Ventricles; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Practolol; Prenalterol

1985
Comparison of the renal and pulmonary hemodynamic effects of fenoldopam, dobutamine, dopamine and norepinephrine in the anesthetized dog.
    Pharmacology, 1988, Volume: 36, Issue:1

    Topics: Animals; Benzazepines; Cardiotonic Agents; Dobutamine; Dogs; Dopamine; Female; Fenoldopam; Heart Failure; Humans; Male; Norepinephrine; Pulmonary Circulation; Renal Circulation; Vascular Resistance

1988
[Use of new inotropic agents in the treatment of acute cardiac failure].
    Annales francaises d'anesthesie et de reanimation, 1988, Volume: 7, Issue:2

    Topics: Adrenergic Agonists; Amrinone; Calcium Channel Blockers; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones

1988
Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? III. Antagonist's viewpoint.
    Journal of the American College of Cardiology, 1988, Volume: 12, Issue:2

    Topics: Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Chronic Disease; Death, Sudden; Dobutamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones

1988
[Effects of prazosin, SGB-1534, dobutamine and isoproterenol on congestive heart failure in dogs].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1988, Volume: 92, Issue:2

    Topics: Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Dobutamine; Dogs; Heart Failure; Hemodynamics; Isoproterenol; Prazosin; Quinazolines

1988
Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.
    The American journal of cardiology, 1989, Jan-03, Volume: 63, Issue:2

    Topics: Coronary Circulation; Coronary Vessels; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Milrinone; Phosphodiesterase Inhibitors; Pyridones

1989
Effect of dobutamine on plasma potassium in congestive heart failure secondary to idiopathic or ischemic cardiomyopathy.
    The American journal of cardiology, 1989, Apr-01, Volume: 63, Issue:12

    Topics: Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Potassium

1989
Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
    The American journal of cardiology, 1986, Jun-01, Volume: 57, Issue:15

    Topics: Adult; Aged; Cardiomyopathies; Cardiomyopathy, Dilated; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged

1986
Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
    The American journal of cardiology, 1986, Jul-01, Volume: 58, Issue:1

    Topics: Aged; Arginine Vasopressin; Cardiotonic Agents; Depression, Chemical; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Norepinephrine; Renin; Stimulation, Chemical

1986
Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy.
    The American journal of cardiology, 1986, Sep-15, Volume: 58, Issue:7

    Topics: Administration, Oral; Cardiac Output; Cardiotonic Agents; Dobutamine; Drug Evaluation; Enoximone; Heart Failure; Heart Rate; Humans; Imidazoles; Injections, Intravenous; Physical Exertion

1986
Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?
    Postgraduate medical journal, 1986, Volume: 62, Issue:728

    Topics: Amrinone; Cardiotonic Agents; Digoxin; Dobutamine; Enoximone; Ethanolamines; Heart; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Imidazoles

1986
General overview and update of positive inotropic therapy.
    The American journal of medicine, 1986, Oct-31, Volume: 81, Issue:4C

    Topics: Amrinone; Blood Pressure; Cardiotonic Agents; Digitoxin; Dobutamine; Dopamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoproterenol; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Time Factors

1986
New positive inotropic drugs for the treatment of congestive heart failure.
    The American journal of cardiology, 1985, Jan-11, Volume: 55, Issue:2

    Topics: Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Dipeptides; Dobutamine; Enalapril; Heart Failure; Humans; Milrinone; Myocardial Contraction; Pyridones; Stimulation, Chemical; Vascular Resistance; Vasodilator Agents

1985
Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response.
    Circulation, 1986, Volume: 74, Issue:6

    Topics: Adult; Biopsy; Calcium Gluconate; Cardiac Catheterization; Dobutamine; Endocardium; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Radioligand Assay; Receptors, Adrenergic, beta

1986
Synergistic effect of captopril and dobutamine on left ventricular pressure-volume and pressure-shortening relations in severe cardiac failure.
    International journal of cardiology, 1988, Volume: 21, Issue:2

    Topics: Aged; Blood Pressure; Captopril; Cardiac Output; Cardiac Volume; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Stroke Volume

1988
[Therapy of acute heart failure].
    Der Internist, 1986, Volume: 27, Issue:5

    Topics: Acute Disease; Combined Modality Therapy; Digitalis Glycosides; Dobutamine; Dopamine; Drug Therapy, Combination; Epinephrine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Nitroglycerin; Norepinephrine; Oxygen; Vascular Resistance

1986
Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
    American heart journal, 1985, Volume: 109, Issue:1

    Topics: Aged; Blood Pressure; Catecholamines; Dobutamine; Enoximone; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged; Pulmonary Artery; Stroke Volume; Vascular Resistance

1985
CI-930, a new cardiotonic and vasodilating agent: hemodynamic comparison to dobutamine and long-term clinical effects.
    American heart journal, 1988, Volume: 116, Issue:4

    Topics: Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Middle Aged; Phosphodiesterase Inhibitors; Pyridazines; Time Factors

1988
Dobutamine rescue for intractable CHF.
    The American journal of nursing, 1988, Volume: 88, Issue:12

    Topics: Chronic Disease; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Monitoring, Physiologic

1988
Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy.
    Chest, 1987, Volume: 92, Issue:4

    Topics: Adult; Amrinone; Arginine Vasopressin; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Renin; Renin-Angiotensin System

1987
[Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
    Zeitschrift fur Kardiologie, 1987, Volume: 76, Issue:8

    Topics: Animals; Captopril; Dobutamine; Heart Failure; Hemodynamics; Male; Milrinone; Muscles; Myocardial Infarction; Pyridones; Rats; Rats, Inbred Strains; Regional Blood Flow; Renal Circulation; Skin; Splanchnic Circulation

1987
Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of isosorbide dinitrate, dobutamine and captopril.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:3

    Topics: Animals; Captopril; Cardiomyopathies; Dobutamine; Doxorubicin; Heart Failure; Hemodynamics; Isosorbide Dinitrate; Rabbits; Regional Blood Flow

1987
Inotropic therapy for cardiac failure associated with acute myocardial infarction.
    Chest, 1988, Volume: 93, Issue:1 Suppl

    Topics: Amrinone; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Myocardial Infarction; Vasodilator Agents

1988
Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
    The American journal of cardiology, 1988, Aug-11, Volume: 62, Issue:5

    Topics: Blood Pressure; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Myocardial Contraction; Neurosecretory Systems; Norepinephrine; Vascular Resistance; Vasodilation

1988
[Determination of active components of amrinone by analysis of pressure-volume results; use of the conductance (volume) catheter technic and rapid load change by balloon occlusion of the inferior vena cava].
    Zeitschrift fur Kardiologie, 1987, Volume: 76, Issue:9

    Topics: Amrinone; Cardiac Catheterization; Cardiac Output, Low; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardium; Nitroprusside; Oxygen Consumption

1987
[Combination of different inotropic agents in the treatment of chronic refractory cardiac insufficiency].
    Medicina, 1987, Volume: 47, Issue:6

    Topics: Amrinone; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged

1987
Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals.
    European journal of pediatrics, 1987, Volume: 146, Issue:2

    Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infant, Newborn; Myocardial Contraction

1987
Short- and long-term dobutamine treatment in chronic ischemic heart failure.
    Clinical cardiology, 1987, Volume: 10, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Radionuclide Angiography; Stroke Volume; Time Factors

1987
Hemodynamic and regional blood flow response to piroximone (MDL 19,205) in dogs with congestive heart failure: a comparison with dobutamine.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:3

    Topics: Animals; Coronary Circulation; Dobutamine; Dogs; Heart Failure; Heart Rate; Hemodynamics; Imidazoles; Regional Blood Flow

1987
[Effects of dobutamine on hemodynamics, myocardial metabolism and mechanical efficiency in patients with old myocardial infarctions].
    Kokyu to junkan. Respiration & circulation, 1987, Volume: 35, Issue:5

    Topics: Adult; Aged; Coronary Circulation; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Vascular Resistance

1987
Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.
    American heart journal, 1987, Volume: 114, Issue:3

    Topics: Adult; Aged; Ambulatory Care; Cardiac Output; Chronic Disease; Dobutamine; Dopamine; Equipment Failure; Female; Heart Failure; Humans; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; Stroke Volume

1987
Prolonged beneficial effects of dobutamine in refractory heart failure--case histories.
    Angiology, 1987, Volume: 38, Issue:8

    Topics: Dobutamine; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Time Factors

1987
[Treatment of cardiac insufficiency in adults].
    Revue de l'infirmiere, 1986, Volume: 36, Issue:14

    Topics: Adult; Anticoagulants; Digitalis Glycosides; Diuretics; Dobutamine; Heart Failure; Humans; Isoproterenol; Vasodilator Agents

1986
Beta-adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion.
    Circulation research, 1987, Volume: 61, Issue:4 Pt 2

    Topics: Blood Pressure; Coronary Vessels; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Injections; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Sympathomimetics

1987
The hemodynamic effects of ventricular pacing with and without atrioventricular synchrony in patients with normal and diminished left ventricular function.
    American heart journal, 1987, Volume: 114, Issue:4 Pt 1

    Topics: Adult; Aged; Aged, 80 and over; Atrioventricular Node; Cardiac Pacing, Artificial; Dobutamine; Female; Heart Conduction System; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Syncope

1987
Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside.
    The American journal of cardiology, 1987, Sep-15, Volume: 60, Issue:8

    Topics: Adult; Aged; Dobutamine; Drug Administration Schedule; Ferricyanides; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside; Radionuclide Imaging

1987
Acute hemodynamic effects of dopamine, dobutamine, and isoproterenol in congested infants or young children with large ventricular septal defect.
    Japanese circulation journal, 1987, Volume: 51, Issue:9

    Topics: Dobutamine; Dopamine; Heart Failure; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Infant; Isoproterenol; Pulmonary Circulation

1987
[Tolerance development during a 1-week course of dobutamine treatment].
    Deutsche medizinische Wochenschrift (1946), 1986, Jun-27, Volume: 111, Issue:26

    Topics: Adult; Aged; Blood Pressure; Cardiac Output; Dobutamine; Drug Tolerance; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Stimulation, Chemical; Water-Electrolyte Balance

1986
Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure.
    Circulation, 1986, Volume: 74, Issue:2

    Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Dobutamine; Drug Synergism; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Stroke Volume

1986
[Effects of intravenous amrinone (Win 40680) on heart failure complicated by acute myocardial infarction: comparative study with dopamine and dobutamine].
    Kokyu to junkan. Respiration & circulation, 1986, Volume: 34, Issue:6

    Topics: Aged; Amrinone; Dobutamine; Dopamine; Female; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction

1986
Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure.
    American heart journal, 1986, Volume: 112, Issue:4

    Topics: Aged; Ambulatory Care; Cardiac Output; Dobutamine; Follow-Up Studies; Heart Failure; Humans; Infusion Pumps; Male; Middle Aged; Time Factors

1986
Effects of intravenous amrinone on heart failure complicated by acute myocardial infarction: comparative study with dopamine and dobutamine.
    Japanese circulation journal, 1986, Volume: 50, Issue:7

    Topics: Aged; Amrinone; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction

1986
Drug therapy for congestive heart failure.
    Clinical pharmacy, 1986, Volume: 5, Issue:11

    Topics: Amrinone; Dobutamine; Heart Failure; Humans

1986
The value of mixed venous oxygen saturation as a therapeutic indicator in the treatment of advanced congestive heart failure.
    American heart journal, 1987, Volume: 113, Issue:3

    Topics: Cardiac Output; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Monitoring, Physiologic; Oxygen; Prognosis; Veins

1987
Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses.
    The Veterinary clinics of North America. Equine practice, 1985, Volume: 1, Issue:2

    Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Cardiovascular Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Drug Administration Schedule; Edema; Heart Diseases; Heart Failure; Heart Rate; Hemodynamics; Horse Diseases; Horses; Injections, Intravenous; Lidocaine; Procainamide; Propranolol; Quinidine

1985
[Significance of nitrates in acute therapy of heart failure with and without lung edema].
    Zeitschrift fur Kardiologie, 1985, Volume: 74 Suppl 1

    Topics: Cardiac Output, Low; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Pulmonary Edema; Regional Blood Flow; Shock, Cardiogenic

1985
Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure.
    The American journal of cardiology, 1986, Feb-01, Volume: 57, Issue:4

    Topics: Cardiac Output; Dobutamine; Exercise Test; Heart Failure; Humans; Male; Middle Aged; Physical Exertion; Prazosin; Pulmonary Gas Exchange; Pulmonary Wedge Pressure

1986
Chronic congestive heart failure. Where have we been? Where are we heading?
    The American journal of medicine, 1986, Feb-28, Volume: 80, Issue:2B

    Topics: Aminopyridines; Amrinone; Biopsy; Calcium Channel Blockers; Cardiology; Chronic Disease; Digitalis; Dobutamine; Dopamine; Forecasting; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Contraction; Myocardium; Plants, Medicinal; Plants, Toxic; Prognosis; Quality of Life; Vasodilator Agents

1986
Arrhythmias associated with intermittent outpatient dobutamine infusion.
    Angiology, 1986, Volume: 37, Issue:2

    Topics: Ambulatory Care; Arrhythmias, Cardiac; Dobutamine; Heart Failure; Humans; Infusions, Parenteral

1986
Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery.
    International journal of clinical pharmacology, therapy, and toxicology, 1986, Volume: 24, Issue:2

    Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Computers; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Nitroprusside; Pulmonary Circulation; Vascular Resistance

1986
Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.
    Journal of the American College of Cardiology, 1986, Volume: 7, Issue:5

    Topics: Aged; Coronary Circulation; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Myocardium; Pyridones

1986
Outpatient dobutamine infusion using a totally implantable infusion pump for refractory congestive heart failure.
    Chest, 1985, Volume: 88, Issue:2

    Topics: Aged; Ambulatory Care; Catecholamines; Dobutamine; Equipment Design; Heart Failure; Humans; Infusions, Parenteral; Male; Prostheses and Implants

1985
Comparative vasoactive therapy for heart failure.
    The American journal of cardiology, 1985, Jul-22, Volume: 56, Issue:3

    Topics: Adult; Aged; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Tachycardia; Vascular Resistance

1985
Pathophysiology of cardiac failure.
    The American journal of cardiology, 1985, Jul-22, Volume: 56, Issue:3

    Topics: Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; Furosemide; Heart; Heart Failure; Humans; Myocardial Contraction; Nitroprusside; Norepinephrine; Oxygen Consumption; Vascular Resistance; Vasoconstriction

1985
[Regional left ventricular function in dilated cardiomyopathy: observation of regional left ventricular wall motion before and during dobutamine administration].
    Journal of cardiography, 1985, Volume: 15, Issue:2

    Topics: Adult; Cardiomyopathy, Dilated; Dobutamine; Echocardiography; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve; Myocardial Contraction; Papillary Muscles; Prognosis

1985